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ABSTRACT 
The human immunodeficiency virus-1 (HIV-1) infects CD4+ helper T cells by fusing its lipid 
membrane to the host cell plasma membrane. HIV-1 Envelope (Env) glycoprotein, a trimer of 
gp120-gp41 heterodimers, is the fusion machinery that mediates viral and host cell membrane 
fusion, which is initiated by interaction between the host cell receptor CD4 and viral glycoprotein 
gp120. Receptor binding induces conformational changes in the Env trimer such that coreceptor 
CCR5/CXCR4 can bind to gp120 and trigger subsequent membrane fusion steps. Previous cryo-
electron tomography (cryoET) and spectroscopy studies have shown that CD4 binding induces 
changes in Env trimer from the closed, prefusion conformation to an open, CD4-bound 
conformation. However, the CD4-bound Env trimer is dynamic and flexible such that structural 
biology study of CD4-bound Env trimer is difficult.  
As the sole glycoprotein located on HIV-1 viral surface, Env trimer is the only target for 
neutralizing antibodies. Since HIV-1 mutates rapidly, most neutralizing antibodies are strain-
specific. However, a small percent of HIV-1 infected patients can develop broadly neutralizing 
antibodies (bNAbs) that neutralize a wide spectrum of viruses. In 2011, our collaborator isolated a 
bNAb called 8ANC195. To understand how 8ANC195 recognizes Env trimer and prevents 
infection, we used a combination of structural biology and biochemistry tools. Interestingly, we 
found that 8ANC195 can recognize Env trimer in both its prefusion and CD4-bound conformations 
by targeting an epitope at gp120-gp41 interface. Furthermore, 8ANC195 stabilizes the Env-CD4 
complex, allowing us to investigate the conformational changes induced by CD4 in atomic 
resolution. By solving and comparing single-particle cryo-EM structures of Env trimer in complex 
with CD4 and/or antibodies, we found that: 1) CD4 binding induces coreceptor binding site 
exposure through a β-sheet rearrangements in each gp120 monomer. Several key residues 
allosterically regulate this coreceptor binding site exposure. 2) CD4 binding induces Env trimer 
opening together with gp41 conformational changes, which represents an intermediate between 
prefusion gp41 and postfusion gp41. 3) Env trimer opening is necessary but not sufficient for 
coreceptor binding site exposure, while CD4 binding induces both, some antibodies can open Env 
trimer without exposing the coreceptor binding site. These conclusions further illuminate how Env 
trimer mediates membrane fusion and inform potential strategies blocking viral entry.  
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C h a p t e r  1  
Introduction 
HIV-1 Env mediated membrane fusion 
The human immunodeficiency virus (HIV) is a single-stranded, positive-sense, enveloped RNA 
virus. It causes HIV infection and eventually leads to acquired immunodeficiency syndrome 
(AIDS). Between the two species of HIV (HIV type I or HIV-1 and HIV type II or HIV-2), HIV-1 
has been the major cause of HIV infections globally and remains a thread to public health, while 
HIV-2-infected patients remain mostly asymptomatic, with low plasma viral loads (Kanki et al., 
1994). HIV-1 targets CD4+ helper T cells, which regulate the activity of B cells and cytotoxic T 
cells in adaptive immune system (Murphy and Reiner, 2002). Viral infection happens through 
fusion of the viral and host cell lipid bilayers to allow the HIV-1 capsid and its genetic material to 
enter the target cell. Then the viral RNA genome is reversely transcribed into proviral DNA, which 
is then integrated into host cell genome (Laskey and Siliciano, 2014). Following that, integrated 
DNA is transcribed into viral RNA, which is then translated into viral proteins using host cell 
machinery inside cytoplasm. Viral proteins assemble with the viral RNA genome at the cell surface 
and release through membrane budding to produce immature virions. The budding event is 
mediated by the host ESCRT (endosomal sorting complexes required for transport) machinery 
(Sundquist and Kräusslich, 2012). Imature virions mature via proteolytic processing mediated by 
the viral protease, which ultimately results in mature virions that are capable of infecting new cells 
(Freed, 2015) (Figure 1.1).  
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Figure 1. 1. HIV life cycle. Adapted from (Barre-Sinoussi et al., 2013).  
 
Viral and host cell membrane fusion is accomplished by the HIV-1 Envelope (Env) trimer, a class I 
viral fusion protein and the sole glycoprotein located on HIV-1 lipid membrane surface (Harrison, 
2015). Env trimer is encoded by env gene in HIV-1 genome. The mature, full-length product of the 
env gene is a homotrimer of heterodimers. Each heterodimer contains two subunits, the 
extracellular surface protein gp120 and the membrane-associated gp41. While inside the target cell 
cytoplasm, the env gene encodes gp160 protein, which is cleaved by the host cell protease furin, 
into gp120 and gp41. In the mature, active form of Env trimer, three gp120s and three gp41s are 
non-covalently associated to serve as a functional fusion protein. The gp120 subunit contains 
receptor and coreceptor binding sites, and is thus responsible for receptor and coreceptor binding. 
The gp41 protein, which can be further divided into ecto domain, transmembrane domain (TM) 
and cytoplasmic tail (CT), will undergo conformational changes upon receptor/coreceptor binding 
and leads to membrane fusion through a spring loaded mechanism (Carr and Kim, 1993). The 
HIV-1 Env trimer mediated membrane fusion is similar to other class I viral membrane fusion such 
as influenza hemagglutinin mediated membrane fusion. Receptor binding initiates fusion process. 
After that, the fusion peptide from gp41 will be inserted into host cell membrane, and thus creating 
the pre-hairpin conformation. From the pre-hairpin conformation, gp41 will undergo further 
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conformational changes to form helical bundles. During this process the target cell membrane and 
viral membrane will also be brought closer and lead to hairpin formation. The formation of 
multiple gp41 helical bundles is needed for a fusion pore to form. Finally, the target cell membrane 
and viral membrane are fused together and gp41 will switch into postfusion conformation, in 
which the fusion peptides and TM regions likely interact with each other (Chan and Kim, 1998). 
 
Typically, the very first step during HIV-1 infection is gp120 binding to host cell receptor CD4. 
CD4 binding will induce conformational changes of Env that expose the binding site for 
coreceptor, either CC-chemokine receptor 5 (CCR5) or CXC-chemokine receptor 4 (CXCR4). 
Studies have suggested that the HIV-1 can infect target cell through a CD4-independent manner in 
which the coreceptor-binding site is constantly exposed (Endres et al., 1996; Hoffman et al., 1999). 
Nevertheless, for most HIV-1 strains the coreceptor binding site on gp120 is occluded during the 
prefusion state such that CD4 binding is required to induce the conformational changes that are 
necessary for coreceptor binding and membrane fusion initiation. Coreceptor binding will induce 
further conformational changes, including insertion of fusion peptide into target cell membrane 
(Kong et al., 2016), gp120 dissociation (Moore et al., 1990),  etc. Eventually, these conformational 
changes will lead to fusion of the two lipid bilayers (Pancera et al., 2017). 
 
As mentioned above, HIV-1 Env trimer belongs to the classic, and still best characterized class I 
viral fusion protein. Other examples include influenza virus hemagglutinin (HA) and MHV spike 
glycoprotein (Harrison, 2015; Walls et al., 2016; Walls et al., 2017). Figure 1. 2 shows the closed, 
prefusion and postfusion conformation of HIV-1 Env and the presumed sequence of states that 
links the two conformations. One signature state representing the transition is the prehairpin 
intermediate, in which the fusion peptide at the N-terminus of gp41 inserted into the target 
membrane, creating a bridge between the two bilayers destined to fuse. Evidence for this 
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intermediate is indirect (Chan and Kim, 1998). 
 
Fig 1. 2. Schematic diagram of HIV-1 Env mediated membrane fusion.  
 
 
Broadly Neutralizing Antibodies 
As the sole glycoprotein on HIV-1 virion surface, Env trimer is the only target for neutralizing 
antibodies. Several features of Env trimer enable HIV-1 to evade human antibody response. 
First, HIV-1 mutates at a high rate and produces diverse Env variants in infected people, 
resulting in a continuing race between newly developed antibodies and the rapidly mutating Env 
trimer (Roberts et al., 1988). This extraordinary potential enables HIV-1 to escape from developing 
antibodies. Secondly, the many N-linked glycans covering the surface of Env form a shield that 
reduces access to protein epitopes. These glycans are attached by the same host cell machinery as 
host glycoproteins, and thus usually indistinguishable from host glycans, impeding development 
of neutralizing antibodies targeting glycans (Scanlan et al., 2007). Thirdly, conformational 
masking of conserved functional sites on Env trimer diminishes the effects of antibodies that 
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target these regions by restricting access (Kwong et al., 2002). For example, the coreceptor-
binding site is not exposed until gp120 is engaged by CD4 receptor (Trkola et al., 1996). 
Similarly the fusion machinery in the membrane-proximal external region (MPER) of gp41 is 
not exposed until the fusion process begins. Last but not least, the potency of antibodies is 
reduced by their limited ability to bind with avidity to the small number of spikes on viral 
surface (Klein and Bjorkman, 2010). While most viruses present dense arrays of antigens, HIV-1 
displays only ∼14 Env trimers per virion (Zhu et al., 2006). The sparse distribution of Env 
trimers makes it difficult to achieve bivalent antibody binding to two adjacent spikes. 
Furthermore, the Env trimer geometry generally prevents bivalent antibody binding to epitopes 
on adjacent monomers in the same trimer. This idea is supported by the small differences 
between IgG potency and Fab potency of HIV-1 antibodies (Klein and Bjorkman, 2010). 
 
However, a small percentage of HIV-1-infected individuals can still produce antibodies that 
neutralize a broad range of viral strains. By targeting CD4-binding site, MPER, and the variable 
loops, these antibodies neutralize multiple lab-adapted and primarily isolated HIV-1 strains with 
low potency. These broadly neutralizing antibodies (bNAbs) establish the principle that antibodies 
to HIV-1 can have neutralization breadth (Burton et al., 1994).  
 
With the introduction of single-cell cloning techniques, new bNAbs have been cloned from B cells 
of infected patients (Scheid et al., 2009). The best of these are two to three orders of magnitude 
more potent than the previously characterized antibodies and can still neutralize up to 90% of the 
HIV-1 strains tested. The targets of these new antibodies can be divided into the following major 
groups: (1) CD4-binding site, (2) MPER, (3) V1V2 loop located at the apex of Env trimer, and (4) 
V3 loop, which contains the coreceptor bindng site and partially shielded by V1V2 loop.  In 
addition, there are yet to be defined conformational epitopes, e.g., antibody 3BC176 (Klein et al., 
2012a) (Figure 1.3). 
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Figure 1.3. Major groups of epitopes of bNAbs on HIV-1 Env. Adapted from (West et al., 2014) 
 
It has been shown that HIV-1 infection in humanized mice can be blocked by passive transfer of 
bNAbs (Klein et al., 2013b). Therefore, it is believed that a vaccine that can elicit bNAbs would be 
effective in preventing HIV-1 infection. However, extensive experiments in animal models and 
clinical trials in humans failed to elicit bNAbs by vaccination (McCoy and Weiss, 2013). 
Molecular characterization of bNAbs and their interactions with Env trimer has provided clues to 
understand why these antibodies are difficult to elicit. First, many bNAbs have unusually long 
CDRH3 loops. For example, In humans the average CDRH3 is 16 residues (Tiller et al., 2007), 
but in bNAb PGT145 the CDRH3 is 33 residues. These antibodies with very long CDRH3 
loops are frequently deleted at the first tolerance checkpoint (Meffre et al., 2001). Another 
feature shared by all bNAbs is a high degree of somatic hypermutation. Most affinity-matured 
human VH domains carry 15–20 somatic mutations at the nucleotide level (Tiller et al., 2007), 
while bNAbs are generally more extensively mutated  (Scheid et al., 2009). These mutations are 
essential for the binding and neutralizing activity of the bNAbs since reverting the antibodies to 
their germline coding sequence results in loss of neutralizing activity (Klein et al., 2013a).  
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Interestingly, bNAbs are frequently polyreactive, but they appear to be not removed (Haynes et 
al., 2005) even though polyreactive antibodies are supposed to be removed from the B cell 
repertoire during development (Wardemann et al., 2003). One possible explanation is that the 
low viral surface density of Env trimer and Env trimer geometry prevent bivalent binding. 
Therefore, polyreactivity is selected to provide a second binding interaction for bNAbs and thus 
improve avidity effects (Mouquet et al., 2010).  
 
The interactions between bNAbs and Env trimer have been intensively investigated in molecular 
details by biochemistry and structural biology. Unfortunately, the initial attempt of eliciting 
bNAbs in animal models using immunogens designed based on these interactions failed (Burton 
et al., 2012; Kwong and Mascola, 2012). One problem of the design is that the germline 
precursors of bNAbs do not bind to Env trimer with high affinity (Klein et al., 2013a). Therefore, 
these immunogens were not able to recruit B cells producing bNAb precursors such that they 
failed to induce expected immune responses. New strategies have been proposed in order to 
overcome this issue. For example, germline antibody recognition of HIV-1 immunogens has 
been studied to design new immunogens that can bind to both bNAbs and their precursors with 
high affinity (Scharf et al., 2016). Besides, immunologists are searching for bNAbs with lower 
degree of somatic hypermutation while maintaining reasonable breadth and potency. These 
antibodies are potentially better targets to elicit (Gristick et al., 2016).  
 
In collaboration with Michel Nussenzweig’s molecular immunology group at Rockefeller 
University, I’m involved in a long-term team effort to characterize new bNAbs isolated from HIV-
1 infected patients using structural biology and biochemistry. Using single particle cryo-EM and 
cryoET, I’ve not only discovered novel epitopes on Env trimer targeted by these new bNAbs, but 
demonstrated the molecular mechanism of their neutralizing activity as well (Freund et al., 2017; 
Wang et al., 2017). These studies add new descriptions of the host immune response to HIV and 
provide critical information for vaccine design.  
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Conformational changes of Env 
As the sole glycoprotein on HIV-1 membrane surface, Env trimer is responsible for both 
receptor/coreceptor binding and membrane fusion. In order to perform these sophisticated 
functions, Env trimer, including both gp120 and gp41, adopt different conformations in different 
stages throughout the membrane fusion process.  
 
Low-resolution subtomogram averaging structures of Env trimers on HIV-1 virions revealed 
distinct Env conformations including the prefusion, closed conformation in which Env trimer is 
unliganded and a soluble CD4 (sCD4)-bound, open conformation in which the gp120 subunits 
were displaced and outwardly rotated to disrupt the interaction at the trimer apex (Liu et al., 2008). 
Subsequent crystallography and single particle cryo-EM studies of native-like Env trimers lacking 
TM regions and cytoplasmic tails and with stabilizing mutations (SOSIPs) (Sanders et al., 2013) 
resulted in higher-resolution Env structures of the prefusion conformation. These structures 
revealed how gp120 V1V2 loops interact at the trimer apex and shield the coreceptor binding site 
on V3 loops (Ward and Wilson, 2017). Later on, advances in single particle cryo-EM enabled the 
solution of sCD4-bound SOSIPs structures at near atomic resolution. (Ozorowski et al., 2017; 
Wang et al., 2018; Wang et al., 2016a). Consistent with subtomogram averaged structures of 
sCD4-bound Envs on virion surface (Liu et al., 2008), high resolution single-particle cryo-EM 
structures of sCD4-bound SOSIPs demonstrated rotation and displacement of gp120s, an ~40Å 
movement of V1V2 to the sides of Env trimer to expose the coreceptor binding site on V3, and 
minor rearrangements of gp41.  
 
The conformational states of HIV-1 Envs has been studied by single-molecule Förster resonance 
energy transfer (smFRET), in which donor and acceptor fluorophores were placed within a gp120 
monomer in a Env trimer on virion surface, allowing intra-subunit dynamics of Env trimers to be 
monitored over time (Ma et al., 2018; Munro et al., 2014; Munro and Lee, 2018; Munro and 
Mothes, 2015). These studies suggested that Env trimers transition between three states (States 1, 2, 
and 3), with State 1 corresponding to unliganded state. Adding antibodies or small molecule HIV-1 
entry inhibitors (Li et al., 2013) stabilized State 1 (Munro et al., 2014). Unfortunately, due to the 
size and flexibility of fluorophores, distances measured in smFRET cannot be directly correlated 
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with Env structures, resulting in a gap in understanding the relationship between Env structure 
and dynamics. In addition, most atomic-resolution Env structures were solved using SOSIP Envs, 
while the smFRET studies were mainly done on virion-bound Envs. Within the 20Å resolution 
limitation (Liu et al., 2008), the closed and open conformations of native Envs on virion surface 
revealed by cryo-ET superimpose with closed and open conformations of SOSIP Envs. But 
whether SOSIP Envs structures represent the biologically relevant conformations adopted by 
virion-bound Envs still requires detailed assessment. 
 
The conformational states of SOSIP Envs have also been investigated by double electron-electron 
resonance (DEER) spectroscopy, in which the SOSIP Envs were spin-labeled with a nitroxide free 
radical (Stadtmueller et al., 2018). In DEER spectroscopy, size and flexibility of probes are 
minimized so that the distances measured can be directly correlated with structures. The DEER 
measurements of unliganded SOSIP Envs show consistence with closed structures. Furthermore, 
the distance distribution diagram demonstrated homogeneity at Env trimer apex and flexibility near 
Env trimer base, and thus suggested decoupling between the base and apex. After adding CD4, the 
distances distribution suggested increased inter-subunit distances and heterogeneity, consistent 
with conformational changes required for coreceptor binding. These results indicate that SOSIP 
Envs show similarities with Envs on native virions. 
 
Summary 
Although our understanding of Env trimer structures and dynamics has increased tremendously 
over the last decade, there are many questions that remain unanswered. For instance, what 
conformational changes induced by CD4 allow coreceptor to bind, i.e., what is the structural basis 
of coreceptor binding site exposure? The work presented here answers this fundamental question 
by providing high-resolution structures of CD4-bound Env trimer and gives insight into the 
mechanism of Env trimer mediated membrane fusion. Chapter 2 presents the cryoET and negative 
stain EM structures of Env trimer in CD4-bound, coreceptor binding site-exposed conformation. 
These structures not only showed that 8ANC195, a bNAb isolated from HIV-1 infected patient, 
can neutralize Env trimer in both prefusion and CD4-bound conformation, but also suggested that 
8ANC195 can be used to stabilize CD4-bound Env trimer for structural biology studies. With this 
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knowledge, Chapter 3 presents two high-resolution structures of Env trimer in CD4-bound 
conformations. By comparing our structures with other high-resolution Env trimer structures in 
different conformations, we were able to draw a very interesting conclusion, that the Env trimer 
opening and coerceptor binding site exposure are two independent steps. Finally, in Chapter 4, we 
present structural biology studies of BG1, another bNAb isolated from HIV-1 infected donor. The 
results suggested that BG1 recognize symmetric Env trimer’s V1V2 loop in a novel, asymmetric 
mechanism, demonstrating that there is more diversity in recognizing V1V2 epitope than 
previously assumed.  
In summary, the thesis lead important progress in HIV structural biology field, including (1) 
proposing a model describing mechanistic details of CD4 induced coreceptor binding site 
exposure, (2) describing elements of conformational plasticity of Env trimer, especially in CD4-
bound conformation, (3) suggesting an order for Env trimer conformational changes, and (4) 
revealing the structures of V1V2 regions in both prefusion and CD4-bound conformations. These 
findings further our understanding of Env trimer mediated membrane fusion and indicated how we 
can block membrane fusion by targeting epitopes on Env trimer.  
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C h a p t e r  I I  
Antibody 8ANC195 Targets Env in Both Prefusion and CD4-Bound Conformations 
Abstract 
Only limited regions on HIV-1 Env contains are epitopes for broadly neutralizing antibodies 
(bNAbs), those regions are usually conserved regions among all HIV-1 viral strain, and 
neutralizing antibodies targeting other regions are usually strain specific. The epitope of antibody 
8ANC195, defined by crystal structures of monomeric gp120-sCD4-8ANC195 complex and 
BG505 SOSIP-8ANC195 complex, showed that 8ANC195 binds to the gp120-gp41 interface and 
insert into a glycan gap. To determine if 8ANC195 recognizes Env in CD4-bound conformation 
that has been shown as a state before coreceptor binding and fusion, we solved cryoET and 
negative stain EM structures of an BG505 SOSIP-sCD4-17b-8ANC195 complex. The results 
suggested 8ANC195 can bind to Env in both prefusion, closed and CD4-bound, open 
conformations. Furthermore, 8ANC195 binding partially reversed the CD4 induced Env opening, 
and lead to a previously unseen partially-open conformation. Overall, these discoveries showed 
that HIV-1 Env can exist in different conformations, confirming its structural plasticity. 
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Introduction 
HIV-1 Env is the glycoprotein located on viral membrane surface. It’s a homotrimer of gp120-
gp41 heterodimer. Since HIV-1 viruses are assembled within target cells and release through 
membrane budding, the viral membrane is the same as host cell membrane. Therefore, Env 
trimer will be the only target of neutralizing antibodies and thus the focus on vaccine design 
efforts. A small subset of HIV-1 infected patients has developed broadly neutralizing antibodies 
(bNAbs) targeting conserved epitopes on Env trimer. It has been shown in humanized mouse that 
bNAbs can prevent and treat infection (Klein et al., 2012b). Moreover, bNAbs exhibited efficacy 
against HIV-1 in a human clinical trial (Caskey et al., 2015).  
 
Previously, there were four defined bNAbs epitopes on HIV-1 Env trimer: the CD4 binding site 
epitope, the V1V2 epitope, the V3 epitope, and the gp41 membrane-proximal external region 
(MPER) (West et al., 2014). In 2014, three bNAbs were discovered to recognize new regions 
around gp120-gp41 interface, including PGT151 and 35O22, that are subunit-spanning, trimer 
specific bNAbs (Blattner et al., 2014; Huang et al., 2014), and 8ANC195, that is gp120-gp41-
spanning, recogzning both Env trimer and monomeric gp120 (Scharf et al., 2014; Scheid et al., 
2011).  
 
Originally, 8ANC195 was isolated in a screen that discovered many bNAbs recognizing CD4 
binding site. But 8ANC195’s epitope, defined based on neutralization assay, did not match 
conventional CD4 binding site Abs (Scheid et al., 2011). In 2013, our group applied 
computational analyses, used neutralization assay data to predict that N-linked glycosylation at 
position 234 and 276 on gp120 are essential for the neutralizing activity of 8ANC195. The  
results suggested a model that 8ANC195 fit to a pocket between N-linked glycans at Asn234 and 
Asn276 and bind to gp120-gp41 interface. After that, our group has solved a crystal structure of 
8ANC195 Fab in complex with monomeric gp120 and soluble CD4 (sCD4), further confirmed 
our previous prediction that 8ANC195 make contacts with N-linked glycans at Asn276 and 
Asn234, recognizing gp120-gp41 interface region that is not targeted by other bNAbs (Scharf et 
al., 2014).  
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In order to further illustrate 8ANC195’s epitopes in the context of HIV-1 Env trimer, we used a 
native-like soluble Env trimer (BG505 SOSIP.664, usually refered to as BG505 SOSIP) (Sanders 
et al., 2013). We first solved a low resolution, negative stain single particle EM structure of 
BG505 SOSIP in complex with 8ANC195 to show that the binding pattern of 8ANC195 on Env 
trimer is the same as it is been shown using monomeric gp120 (Scharf et al., 2014). All together, 
these data demonstrated that 8ANC195 could bind to Env trimer and neutralize viral activity by 
preventing CD4-induced conformational changes required for Env mediated membrane fusion, 
rather than directly binding to CD4 binding site and prevent CD4 from binding.  
 
Because the low resolution negative stain EM structure cannot precisely describe how 8ANC195 
recognize residues and glycans on Env trimer, our group went further and solved a crystal 
structure of BG505 SOSIP in complex with 8ANC195 Fab (Scharf et al., 2015). The structure, at 
atomic resolution, defined 8ANC195 epitope. Since the previous crystal structure of 8ANC195 
in complex with monomeric gp120 was obtained while gp120 was also bound to sCD4, we were 
interested in whether 8ANC195 can recognize CD4-bound Env trimer as well. Our group applied 
binding studies using SPR to confirm that 8ANC195 can recognize CD4-bound Env trimers. 
Thus, it would be either that the conformational changes induced by CD4 did not change 
8ANC195 binding site, or 8ANC195’s binding is robust enough such that it can accommodate 
the conformational changes. To further answer this question and visualize the conformational 
changes induced by CD4, we used 3D EM reconstruction to demonstrate that 1) CD4 binding 
induced opening on Env trimer, while 8ANC195’s epitope regions did not undergo 
conformational changes during this process 2) 8ANC195 binding partially close Env trimer, 
leading to a partially-open conformation. These results provide structural biology evidence of 
8ANC195 recognizing both closed and open conformational states of HIV-1 Env and suggest its 
ability to prevent the full opening of Env trimer that is associated with coreceptor binding and 
viral-host cell membrane fusion.  
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Results 
To elucidate 8ANC195’s epitope on CD4-boun Env trimer, we solved cryoET and negative stain 
EM structures of a more potent 8ANC195 variant, γ52HCκ5LC  (Scharf et al., 2014) (referred to as 
8ANC195G52K5), complexed with BG505 SOSIP, sCD4, and bNAb 17b. We prepared complexes 
of BG505 SOSIP Env trimers, sCD4, 17b Fab, and 8ANC195G52K5 Fab for EM structure 
determination. 17b, as a CD4 induced bNAb, binds to the coreceptor binding site (CoBS) on Env 
trimer (Sullivan et al., 1998). We added 17b because: 1) binding of 17b Fab to a CD4-bound 
open trimer would further stabilize the complex in CD4-bound conformation and, 2) With 17b 
bound, the Env-sCD4 complex is bulkier, potentially provide a more random orientation 
distribution on EM grids and facilitate 3D reconstruction (Naydenova and Russo, 2017). To 
ensure that the Env trimers were in CD4-bound conformation before 8ANC195G52K5 binding, we 
first purified BG505 SOSIP-sCD4-17b complexes by SEC, added 8ANC195G52K5 Fab, and then 
subjected the four-component mixture to SEC again, obtaining stable quaternary complexes, as 
confirmed by SDS-PAGE (Supplementary Figure 2.1A).  
 
We want to obtain a totally reference-free reconstruction of the BG505 SOSIP-sCD4-17b-
8ANC195G52K5 complex that excludes presumptions about Env conformation or how ligands 
were bound. We determined a 23 Å resolution structure by sub-tomogram averaging of cryo-ET 
data obtained from 3D reconstruction of a tilt series of 2D projections (Figures 2.1A and 
Supplementary Figure 2.1B-C). With no symmetry imposed, the sub-tomogram-averaged 
structure showed a 3-fold symmetric particle with densities for three 17b Fabs at the CoBS, three 
sCD4 molecules, and three 8ANC195G52K5 Fabs at the gp120-gp41 interface. Since a co-crystal 
structure of monomeric gp120-sCD4-17b is stable enough to be considered as a rigid body, we 
can fit gp120-sCD4-17b as a whole into EM structures of CD4-bound Env trimers (Harris et al., 
2011; Liu et al., 2008). We first fit the density with gp120-sCD4-17b coordinates (PDB: 1RZK), 
resulting in a 3-fold symmetric distribution of gp120, sCD4, and 17b. We next fit 8ANC195 Fab 
(PDB: 4P9M) into three densities at the predicted 8ANC195 epitopes (Figures 2.1A). 
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To verify the subtomogram averaged structure and obtain more structural details about the 
complex, we proceeded to determine a negative stain EM structure of BG505 SOSIP-sCD4-17b-
8ANC195G52K5 by single particle analysis (Figures 2.1B). 3D classification procedure after 
reference-free 2D classification resulted in selection of approximately half of the initially selected 
particles from good 2D classes, and the final 3D Refined reconstruction was improved to ∼17 Å 
resolution (Supplementary Figure 2.2C). The negative stain EM structure showed density for three 
copies of 8ANC195G52K5, 17b, and sCD4 bound to BG505 SOSIP, and we again fit the density 
using coordinates for gp120-sCD4-17b and 8ANC195 Fab structures (Figure 2.1B). The two 
reconstructions showed similar placements of three gp120s, three sCD4s, and six Fabs (Figure 
2.1C). We used the negative stain EM single-particle reconstruction for following analyses and 
discussions. 
By comparing to other Fab- and/or Fab-sCD4-Env structures in different conformations, it is 
evident that the Env trimer in our BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex structure is 
not in a prefusion, closed conformation (Figure 2.2 and Supplementary Table 2.1). To determine 
whether the trimer in the EM structure is fully open as seen in some other CD4-bound Env 
structures, we investigated the positions of 17b Fabs, noting that they are arranged differently in 
the BG505 SOSIP-sCD4-17b-8ANC195G52K5 structure than in open trimer structures (Figures 2.2A 
and 2.2B) (Harris et al., 2011; Liu et al., 2008; Tran et al., 2012), suggesting that the Env in the 
BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex adopt a new conformation in comparison to 
other Env structures. To more precisely describe the conformational state of the Env trimer in the 
BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex, we measured distances between a CD4bs 
residue in each gp120 protomer of the trimer and compared them to the corresponding distances in 
structures of trimers in different conformational states (Figures 2.2C and Supplementary Table 
2.1). This measurement showed that the Env trimer in the BG505 SOSIP-sCD4-17b-
8ANC195G52K5 structure adopts a previously unseen partially open state conformation that is in 
between the prefusion, closed conformation and the CD4-bound, open conformation observed for 
the sCD4/17b-bound open trimer (Merk and Subramaniam, 2013). Thus, addition of 
8ANC195G52K5 Fab to the BG505 SOSIP-sCD4-17b complex resulted in partial closure of the open 
trimer, suggesting that stabilized 8ANC195G52K5 binding is incompatible with fully open Env 
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trimer conformation. Therefore, 8ANC195 can block viral infection by partially reversing CD4 
induced Env trimer opening, which is an essential conformational change leading to fusion 
between the viral and host membranes.  
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Discussion 
In addition to recognizing both monomeric gp120 and closed Env trimer, we also provide 
structural biology evidence that 8ANC195 can bind to Env trimers complexed with sCD4 and the 
CD4-induced bNAb 17b. CD4 binding normally induces an open conformation of virion-bound 
and soluble HIV-1 Env trimers involving both translational and rotational movements of gp120 
monomers away from the trimer 3-fold axid (Harris et al., 2011; Liu et al., 2008; Tran et al., 
2012).  
8ANC195, however, binds to both CD4-bound Env trimers and closed Env trimers with similar 
affinity (Scharf et al., 2015). Suggesting the gp120-gp41 regions it recognizes undergo small or no 
conformational changes upon CD4 binding.  
When Env trimer binds to CD4, 8ANC195 could stabilize a partially open conformation in 
equilibrium with fully open CD4-bound Env. Taken together with our crystal structure showing a 
closed 8ANC195G52K5-bound Env trimer despite pre-incubation of trimer with sCD4 (Scharf et al., 
2015), the observation that the trimer in the BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex is 
partially open, rather than fully open, implies that 8ANC195 prefers binding to the closed trimer. 
8ANC195’s preference of binding closed trimer suggests that its mechanism of neutralization 
likely involves preventing the complete conformational change necessary for the trimer to bind co-
receptor and/or expose the fusion peptide and fuse with the target cell membrane. 
Although our results indicate that 8ANC195 preferentially recognizes closed Env trimers, its 
ability to recognize other Env conformations suggests that 8ANC195 can neutralize virions 
regardless of Env conformational state, including virions with constitutively open Env trimer such 
as those found on CD4-independent strains (White et al., 2011; White et al., 2010). The fact that 
8ANC195 can recognize other Env trimer conformations also suggests that, in addition to 
neutralizing free virions, 8ANC195 could neutralize virions engaged by CD4 at target cell 
membrane. By neutralizing CD4 engaged virions, 8ANC195 could inhibit cell-to-cell spread of 
HIV-1, which is most effectively prevented by Abs that bind triggered Env conformations (Abela 
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et al., 2012). Finally, recent evidence from single-molecule FRET studies (Munro et al., 2014) 
and molecular ruler measurements of virion-associated Env trimers (Galimidi et al., 2015) suggests 
that Env on free virions can exhibit multiple conformations, including CD4-bound like, open 
conformation; thus, recognition of Env states other than the closed state should be useful for 
neutralization of cell-bound as well as free virions. 
The finding that the trimer in our BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex structure was 
partially open, rather than fully open, as observed in previous CD4-, 17b-, and CD4/17b-bound 
trimer structures (Harris et al., 2011; Liu et al., 2008; Tran et al., 2012), suggests that the trimer 
re-closed upon 8ANC195 binding. This result implies more structural plasticity of HIV-1 Env than 
previously assumed. We hypothesize that, when 8ANC195 engages a CD4-bound (open) trimer, it 
partially recloses the trimer or captures and stabilizes a pre-existing conformation because the 
complex with a partially open nv trimer is more favorable for Ab binding. This model suggests that 
CD4 engagement of HIV-1 spike trimers does not lead to an immediate irreversible conformational 
change. Alternatively, the highly stabilized design of SOSIP trimers may be responsible for the 
apparent reversibility of CD4-induced conformational changes.  
Combinations of bNAbs are being considered for treatment and prevention of HIV-1 infection by 
passive delivery methods because mixtures of active molecules (bNAbs or small molecule drugs) 
are required to prevent the appearance of escape mutants in a rapidly mutating virus such as HIV-1 
(Horwitz et al., 2013; Klein et al., 2012b). Two or more bNAbs targeting different epitopes are 
favored because the virus is presumed unable to mutate several potentially conserved sites 
simultaneously. In addition to targeting gp120-gp41 interface epitope distinct from other known 
bNAbs, 8ANC195 can accommodate different conformational states (including CD4-bound 
conformation), making it an attractive candidate for use in combination therapies with bNAbs that 
(1) do not bind to gp120-gp41 interface, (2) are unable to engage a CD4-bound Env trimer, and/or 
(3) allow HIV-1 to spread through cell-to-cell transmission, as is the case for potent CD4-binding 
site Abs in the VRC01 family (Abela et al., 2012). 8ANC195 may also be a target for vaccine 
development since it targets conserved regions on Env such as gp41 and the Asn276gp120 glycan. 
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Methods 
Protein Production and Purification 
8ANC195G52K5 and 17b Fabs were produced by transient transfection and purified using affinity 
chromatography and SEC, as described in previous studies (Scharf et al., 2014). sCD4 (domains 1 
and 2; residues 1–186 of mature CD4) was produced in baculovirus-infected Hi5 insect cells and 
was purified using affinity chromatography and SEC, as described previously (Diskin et al., 2011; 
Scharf et al., 2014). Untagged BG505 SOSIP.664 was constructed, expressed, and purified as 
described (Sanders et al., 2013). In brief, HEK293-6E cells treated with 5 µM kifunensine (Sigma) 
were co-transfected with plasmids encoding BG505 SOSIP.664 and soluble furin, and trimers were 
purified from cell supernatants using a 2G12 immunoaffinity chromatography and SEC. 
BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex samples were produced by incubating BG505 
SOSIP with a 3-fold molar excess of sCD4 and were purified by SEC. The resulting complex was 
incubated with a 3-fold molar excess of 8ANC195G52K5 Fab and purified by SEC. 
Cryoelectron Tomography 
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted to 60 µg/ml in TBS 
immediately before plunge freezing to avoid complex dissociation at low concentration. Quantifoil 
R2/2 NH2 copper finder grids were vitrified in liquid ethane using a Mark IV Vitrobot (FEI 
Company) and Tilt series (±60°, 1° angular increments) were collected on a FEI Tecnai G2 Polara 
transmission electron microscope equipped with 300 keV FEG, a Gatan energy filter, and a Gatan 
K2 Summit direct detector using the UCSF tomography software package (Zheng et al., 2007) 
under low-dose conditions (120 e–/Å2 total for the tilt series at ∼8 µm underfocus) at a nominal 
magnification of 41,000× so that each pixel represented 2.6 Å. Tomographic reconstructions and 
CTF corrections were calculated using IMOD (Kremer et al., 1996). Subtomogram averaging of 
1,745 subvolumes was performed using PEET (Nicastro et al., 2006) without an external reference 
or applying C3 symmetry, resulting in a ∼23 Å structure estimated by a 0.143 gold-standard 
Fourier shell correlation (FSC) calculated using IMOD (Kremer et al., 1996). 
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Negative-Stain Single-Particle EM 
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted to 10 µg/ml in TBS 
immediately before adding 3 µl to a glow discharged ultrathin C film on holey carbon support film, 
400 mesh, Cu grids (Ted Pella) followed by cross-linking using glutaraldehyde vapor and staining 
with uranyl acetate. Data were collected using a FEI Tecnai T12 transmission electron microscope 
operating at 120 keV equipped with a Gatan Ultrascan 2k × 2k CCD using a 0.5 s exposure time at 
a nominal magnification of 42,000× at 1 µm defocus, resulting in 2.5 Å per pixel. A total of 23,951 
particles were picked using EMAN2.1 (Tang et al., 2007) and RELION (Scheres, 2012), and the 
CTF correction was done using EMAN2.1. Initial reference-free 2D class averaging was 
performed using RELION, and the particles were further sorted using 3D classification in 
RELION. Refinement was conducted using 80 Å low-pass-filtered structures calculated from 
models of 8ANC195-sCD4-17b docked onto gp120 cores of partially open (PDB: 3DNL) trimer 
and 7,174 particles with C3 symmetry applied. The resolution of the final reconstruction was ∼17 
Å calculated with RELION (Scheres, 2012) using a gold-standard FSC and a 0.143 cutoff, as 
recommended for resolution estimations for single-particle EM reconstructions (Scheres and Chen, 
2012). Coordinates from crystal structures were fit into the sub-tomogram averaged or negative-
stain single-particle EM structures using UCSF Chimera (Pettersen et al., 2004). 
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Figures 
 
Figure 2.1 
 
Figure 2.1 EM Reconstructions of BG505 SOSIP-sCD4-17b-8ANC195G52K5 Complex 
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Crystal structures of a monomeric gp120-sCD4-17b complex (PDB: 1RZK) and 8ANC195 
Fab (PDB: 4P9M) were fit to EM densities and are shown from top (left), side (middle), and 
bottom (right).  
(A) ∼23 Å resolution EM density derived from cryo-ET and sub-tomogram averaging. 
(B) ∼17 Å resolution EM density derived from negative-stain single-particle reconstruction. 
(C) Superposition of densities from cryo-ET/sub-tomogram averaging (cyan) and negative-stain 
single-particle (light gray) reconstructions. 
 
Figure 2.2 
 
Figure 2.2 Comparison of Different Conformations of Env Trimers in BG505 SOSIP-sCD4-17b-
8ANC195G52K5 and Other Env Trimer Complexes Illustrated by 17b and gp120 Positions 
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 (A) Overlay of 17b Fabs from BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex (gray 
space-filling representations) with 17b Fabs complexed with Env trimers in different 
conformational states (thick Ca traces in shades of blue). 17b Fabs shown after superimposition of 
gp120s from trimers (trimers and other ligands not shown). (Left) 17b modeled onto 3DNN 
coordinates of a closed trimer. (Middle) 17b modeled onto 3DNL coordinates of a partly open 
trimer. (Right) 17b taken from 3DNO structure of a CD4- and 17b-bound open trimer. Note that 
three 17b Fabs cannot be accommodated without clashes when modeled onto the gp120s of closed 
and partly open trimer structures. 
 
(B) Ca trace of the three 17b Fabs from the BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex. 
 
(C) Positions of gp120s (gray space-filling representation with locations of CD4-binding site in 
yellow, V3 loop in green, and base of V1V2 domain in red) in Env trimers adopting the indicated 
conformations. The locations of Asp368gp120 are shown as a black dot for each trimer 
conformation, with the distance between the Cα of this residue in adjacent protomers indicated. 
Distances are presented as the mean and SD for the analogous distance in representative structures 
in each conformation. 
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Supplementary Figures 
Supplementary Figure 2.1 
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Supplementary Figure 2.1 BG505 SOSIP.664-sCD4-17b-8ANC195G52K5 Complex 
Analyzed by Cryo-ET and Sub-Tomogram Averaging 
(A) Left: Size exclusion chromatography profile and associated SDS-PAGE analysis of fractions 
for the BG505 SOSIP.664-sCD4-17b-8ANC195G52K5 complex used for EM studies compared  
with migration of BG505 SOSIP.664 alone and a BG505 SOSIP.664-sCD4-17b complex. Right: 
SDS-PAGE analysis under non-reducing (-DTT) and reducing (+DTT) conditions to assess 
complex formation compared with control Fabs and sCD4. Irrelevant lanes were digitally removed 
as indicated by a space between lanes 3/4 and 8/9 in the panel. 
 
(B) Slice of cryo-EM image volume from samples containing BG505 SOSIP.664-sCD4-17b-
8ANC195G52K5 complexes. 
 
(C) Gold-standard Fourier shell correlation (FSC) curve for refinement. The resolution 
corresponding to the 0.143 FSC cutoff was ∼23 Å. 
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Supplementary Figure 2.2 
 
 
 
 
Supplementary Figure 2.2 Negative-Stain EM Data for the BG505 SOSIP.664-sCD4-17b-
8ANC195G52K5 Complex 
 
(A) 2D class averages of trimer-sCD4-17b-8ANC195G52K5 complexes. A total of 23,951 
particles were picked and 2D class averaging was performed using 2D classification in RELION 
(Scheres, 2012). The following options were used: Number of classes = 480; Regularization 
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parameter T = 2; In-plane angular sampling = 5; Offset search range = 5 pixels; Offset search 
step = 1 pixel. 
 
(B–D) Reference models for refinement were generated using 80 Å low-pass filtered density maps 
calculated from models of 8ANC195, sCD4, and 17b docked onto partially open (PDB 3DNL) (B); 
open (PDB 3DNO) (C); or closed (PDB 3DNN) (D) trimer structures. Low-pass filtered reference 
models are shown at the top of each panel, and the corresponding results after refinement are 
shown at the bottom. Reference models based on partially open and open structures generated 
similar structures at < 20 Å resolution, while the model generated with the closed trimer structure 
did not generate an interpretable structure. The final refinement for the BG505 SOSIP.664–sCD4-
17b-8ANC195G52K5 structure was performed using RELION (Scheres, 2012) 3D auto-refine 
functions with the following options: Reference: as shown in (B) (top); Particle Mask diameter = 
320 Å; Symmetry = C3; Mask individual particles with zeros; Initial angular sampling = 7.5 
degrees; Initial offset range = 5 pixels; initial offset step = 1 pixel; local searches from auto-
sampling = 1.8 degrees. Density for 8ANC195G52K5 Fab was apparent after refinement when 
starting with an initial reference model that included only sCD4, 17b, and Env trimer (data not 
shown). 
 
(E) Gold-standard Fourier shell correlation (FSC) curve for refinement. Resolutions corresponding 
to 0.143 FSC cutoff was 16.8 Å. We used the 0.143 FSC cutoff as recommended for single particle 
EM reconstruction to report a resolution of ∼17 Å for the BG505 SOSIP.664–sCD4-17b-
8ANC195G52K5 complex. 
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Supplementary Tables 
Supplementary Table 2.1 
 
Supplementary Table 2.1 Distance comparisons in Env trimer structures 
 
Env trimer structures are grouped into four conformational states: closed (unliganded and bound to 
Fabs), partially open (bound to A12 or b12), partially open* (bound to 8ANC195, sCD4, 17b; this 
study), and open (bound to sCD4 and/or 17b, or Z13e1). The EMDB or PDB identifier is given for 
each structure. When available, PDB coordinates for gp120 subunits within a trimer were used to 
measure the distances between CD4 binding site residue Asp368gp120 on adjacent protomers 
Table S5: Distance comparisons in Env trimer structures, Related to Figure 6. 
Trimer&
conformational&
state&
&
Ligand&
&
+/4&
sCD4&
&
Trimer&type&
&
Method&
&
EMDB/PBD&
ID&
&
Resolution&
(Å)&
Distance&between&
CD4bs&(D368)&(Å)&
closed' 8ANC195G52K5' 2' BG505'SOSIP.664' crystal'structure' this'study' 3.58''' 54'
closed' PGT122,'35O22' 2' BG505'SOSIP.664' crystal'structure' 4TVP' 3.5' 55'
closed' PGT122' 2' BG505'SOSIP.664' crystal'structure' 4NCO' 4.7' 56'
closed' PG04'' 2' BG505'SOSIP.664' single'particle'cryo2EM' 3J5M' 5.8' 53'
closed' VRC03' 2' KNH1144'SOSIP.681' single'particle'cryo2EM' 4CC8' 6' 57'
closed' VRC01' 2' JRFL'SOSIP.681' single'particle'NS'EM' 6194' 20' 55'
closed' no'ligand' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNN' 20' 63'
closed' VRC01' 2' BG505'SOSIP.664' single'particle'NS'EM' 6252' 22' 61'
closed' VRC01' '' BaL'virion' cryo2ET,'sub2tomogram'ave' 5457' 24' 68'
'' '' '' '' '' '' '' 55&±&5&
partially'open' A12' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5544' N/A' 75'
partially'open' b12' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNL' 20' 76'
'' '' '' '' '' '' '' 75&±&1&
partially'open*' 8ANC195G52K5,'
sCD4,'17b'
+' BG505'SOSIP.664' single'particle'NS'EM' this'study' 17' 79'
partially'open*' 8ANC195G52K5,'
sCD4,'17b'
+' BG505'SOSIP.664' cryo2ET,'sub2tomogram'ave' this'study' 23' 82'
'' '' '' '' '' '' '' 80&±&2&
open' sCD4' +' JR2FL'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5322' 20' 94'
open' sCD4' +' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5321' 20' 94'
open' sCD4' +' BaL'virion' cryo2ET,'sub2tomogram'ave' 5455' 24' 82'
open' sCD4,'17b' +' BaL'virion' cryo2ET,'sub2tomogram'ave' 3DNO' 20' 87'
open' sCD4,'17b' +' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5323' 20' 87'
open' sCD4,'17b' +' JR2FL'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5324' 20' 90'
open' sCD4,'17b' +' BG505'SOSIP.664' single'particle'NS'EM' 5723' 22' 85'
open' 17b' 2' KNH1144'SOSIP.681' single'particle'cryo2EM' 5462*' 8.8' 88'
open' 17b' 2' KNH1144'SOSIP.681' cryo2ET,'sub2tomogram'ave' 5325' 20' 85'
open' 17b' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5456' 22' 85'
open' 17b,'VRC01' 2' BaL'virion' cryo2ET,'sub2tomogram'ave' 5461' 28' 88'
open' Z13e1' 2' KNH1144'SOSIP.681' single'particle'cryo2EM'' 5680' 18.5' 83'
' ' ' ' ' ' '
87&±&4&
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(PDB coordinates for EMDB entry 5462, marked with an asterisk, were obtained from Sriram 
Subramaniam). When PDB coordinates were not available, gp120s were fit to density maps in the 
EMDB using UCSF Chimera. The mean and standard deviation for distances are listed for each 
category of trimer structure. 
  
30 
C h a p t e r  I I I  
High resolution cryo-EM structures of sCD4, 17b, 8ANC195-bound Env show partially-
open conformation, revealing CD4 induced coreceptor binding site exposure  
 
Abstract 
 
HIV-1 Env, a homotrimer of gp120-gp41 heterodimers, mediates membrane fusion after binding 
host receptor CD4 and coreceptor CCR5 or CXCR4. CD4 receptor binding displaces V1V2 loops 
from Env's apex, allowing coreceptor binding and opening Env to enable gp41-mediated fusion. 
We present 3.54 Å cryoelectron microscopy structures of a partially open soluble native-like Env 
trimers (BG505 SOSIP) bound to CD4. Comparing partially and fully open Envs with closed Envs 
shows that gp41 rearrangements are independent of the CD4-induced rearrangements that result in 
V1V2 displacement and formation of a 4-stranded bridging sheet. These findings suggest ordered 
conformational changes before coreceptor binding: (1) gp120 opening and gp41 conformational 
changes, including a compact gp41 central helix conformation, and (2) 4-stranded bridging-sheet 
formation and V1V2 displacement. These analyses illuminate potential receptor-induced Env 
changes and inform design of therapeutics disrupting viral entry. 
 
 
 
 
 
 
 
Adapted from 
Wang, Haoqing*, Christopher O. Barnes*, Zhi Yang, Michel C. Nussenzweig, and Pamela J. 
Bjorkman. "Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant 
for Coreceptor Binding and Fusion." Cell host & microbe 24, no. 4 (2018): 579-592. 
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Introduction 
The first step in HIV-1 infection is fusion of the viral and host cell membrane to allow the HIV-1 
capsid to enter the target cell (Harrison, 2015). Fusion is accomplished by HIV-1 Envelope (Env), 
a trimeric glycoprotein containing three copies of the receptor-binding gp120 and three copies of 
the membrane-attached gp41 (West et al., 2014). Binding of gp120 to the host cell receptor CD4 
induces conformational changes that expose the binding site for GPCR coreceptor, CCR5 or 
CXCR4, whose binding results in further changes culminating in insertion of the fusion peptide 
into the host cell membrane and fusion of the two bilayers (Pancera et al., 2017). 
cryoET and subtomogram averaging of Env trimers on HIV virions surface revealed different 
conformations, including unliganded Env in a prefusion, closed state with interaction across the 
gp120 trimer apex, and CD4-bound, open Env that exhibitd outwardly displaced and rotated gp120 
monomers (Liu et al., 2008). The low resolution of these structures precluded detailed 
interpretations of CD4 induced conformational changes, but higher resolution X-ray and single-
particle cryoelectron microscopy (cryo-EM) structures of soluble native-like Env trimers (SOSIPs) 
(Sanders et al., 2013) in the closed, prefusion conformation were consistent with unliganded 
virion-bound cryoelectron tomography Env structures, and also revealed juxtaposition of the three 
gp120 V1V2 loop regions at the trimer apex that shield underlying regions of the coreceptor 
binding site on V3 (Ward and Wilson, 2017). In 2016, our group published an intermediate 
resolution (8.9 Å) single-particle cryo-EM structure of an SOSIP Env complexed with soluble CD4 
(sCD4), coreceptor-mimicking antibody 17b (Sullivan et al., 1998), and gp120-gp41 spanning 
antibody 8ANC195 (Scheid et al., 2011). The structure was consistent with the electron 
tomography structures of CD4-bound Env on virions (Liu et al., 2008) and showed ∼40 Å 
displacement of the V1V2 loops to the sides of the Env trimer to expose V3 (Wang et al., 2016a). 
These results were verified and extended in a 3.7 Å sCD4-and 17b-bound SOSIP structure, which 
also described side-chain rearrangements in gp120 and gp41 that were visible at higher resolution, 
but did not show ordered density for the rearranged V1V2 loops (Ozorowski et al., 2017). 
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We present two cryo-EM sCD4-bound SOSIP Env structures in complex with CD4-induced 
(CD4i) coreceptor-mimicking antibodies and with 8ANC195, a broadly neutralizing antibody 
(bNAb) that recognizes the gp120-gp41 interface (Scharf et al., 2014; Scharf et al., 2015; Scheid et 
al., 2011). The first structure, a complex of clade A/E BG505 SOSIP Env with sCD4 and Fabs 17b 
and 8ANC195, was solved to a resolution of 3.54 Å (BG505-sCD4-17b-8ANC195 complex), 
allowing a detailed description of partial closure of the open sCD4-bound Env state that results 
from 8ANC195 binding. The second structure, solved at 4.06 Å resolution, is a complex of the 
clade B B41 SOSIP Env (Pugach et al., 2015) with sCD4, the CD4i antibody 21c (Xiang et al., 
2002), and 8ANC195 (B41-sCD4-21c-8ANC195 complex). Despite binding of the 8ANC195 Fab 
that partially closes the open, sCD4-bound Env conformation, the structures show rearrangements 
in gp120, including displacement of V1V2, exposure of V3, formation of the 4-stranded bridging 
sheet, and formation of the α0 helix. In addition, unlike the V1V2 regions in the BG505-sCD4-
17b-8ANC195 and B41-sCD4-17b structures, the displaced V1V2 loops in the B41-sCD4-21c-
8ANC195 structure exhibited ordered density, allowing the structure of the displaced V1V2 to be 
determined. Comparisons of the partially open Env structure with fully open structures, including 
an open B41 Env complexed with b12 antibody against CD4-binding site (Ozorowski et al., 2017), 
showed that Env opening results in shifting of the gp41 helices to match post-fusion gp41 
structures (Chan et al., 1997; Weissenhorn et al., 1997), and that Env opening and structural 
changes in gp120, such as V1V2 displacement and bridging-sheet formation, are independent 
steps. These comparisons suggest that Env opening in the absence of V1V2 displacement, a state 
that may exist in equilibrium with closed Env, triggers gp41 rearrangements as an initial step in the 
conformational changes required for fusion. A second, CD4-dependent step, involves V1V2 
displacement and formation of the gp120 bridging sheet and α0 helix. Analyses of these results 
further our understanding of HIV-1 Env conformational changes leading to fusion and provide 
templates for designing agents to disrupt HIV-1 entry into target cells. 
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Results 
EM studies confirmed that recombinant native-like soluble gp140 Env trimers (SOSIPs) (Sanders 
et al., 2013) can adopt the closed and open architectures seen on virion-bound Env trimers (Harris 
et al., 2011; Sanders et al., 2013; Tran et al., 2012). Thus the SOSIP substitutions (SOS, a disulfide 
bond linking gp120 to gp41, and IP, an Ile to Pro mutation in gp41) do not prevent transition to the 
open Env state, although interpretations of sCD4-induced changes in gp41 must be interpreted 
cautiously since SOSIP Envs lack the membrane-proximal external regions, the transmembrane 
domains, and the cytoplasmic tails of gp41. For our cryo-EM structures, each sCD4-bound SOSIP 
Env was complexed with Fabs from a CD4i coreceptor-mimicking antibody (either 17b or 21c) 
(Sullivan et al., 1998; Xiang et al., 2002) and from 8ANC195, a gp120-gp41 interface bNAb 
(Scharf et al., 2014; Scharf et al., 2015; Scheid et al., 2011). CD4i Fabs were added to stabilize the 
coreceptor-binding site and prevent Env closure because three CD4i Fabs cannot be 
accommodated on closed Env trimers due to steric clashes (Scharf et al., 2015). 8ANC195 Fab was 
added to rigidify the gp120-gp41 interface and induce partial closure of fully-open, sCD4-bound 
Env (Scharf et al., 2015; Wang et al., 2016a), allowing investigation of the partially-open Env 
conformation.  
 
Env-sCD4-Fab samples were prepared by adding 8ANC195 Fab to pre-formed open Env-sCD4-
CD4i Fab complexes. Single-particle cryo-EM structures of BG505-sCD4-17b-8ANC195 and 
B41-sCD4-21c-8ANC195 complexes were solved to resolutions of 3.54 Å and 4.06 Å, 
respectively (Figure 3.1; Table 3.1, 3.2; Supplementary Figure 3.1-3.4) (Env sequence alignments 
and definitions of secondary structural elements are shown in Supplementary Figure 3.5). Each 
trimeric Env complex included three copies each of sCD4, CD4i Fab, and 8ANC195 Fab. The 17b 
and 21c Fabs exhibited distinct orientations relative to gp120s (Figure 3.1B,D), each consistent 
with crystal structures of these Fabs complexed with sCD4-bound gp120 cores (Diskin et al., 2010; 
Kwong et al., 1998). However, the BG505 and B41 Env trimers in our two structures were similar 
to each other (Supplementray Table 3.1), thus the binding of 17b versus 21c to the sCD4-bound 
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Envs did not influence the extent of Env opening or the overall conformation of the Env trimers. 
As described in the 8.9 Å Env-sCD4-17b-8ANC195 structure (Wang et al., 2016a), the V1V2 
loops were displaced from their location at the trimer apex to the sides of the trimer in the new 
partially-open BG505 and B41 Env structures; however, portions of the displaced V1V2 were 
ordered in the B41-sCD4-21c-8ANC195 complex structure (Figure 3.1D). As seen in other sCD4-
bound Env structures (Ozorowski et al., 2017; Wang et al., 2016a), the rearranged V3 loops were 
largely disordered in the two partially-open sCD4-bound Envs (Figure 3.1B,D and 3.2A). 
 
To evaluate conformational changes resulting from sCD4 and 8ANC195 Fab binding, we 
compared the partially-open Env trimers to a 3.7 Å fully-open B41 SOSIP in a B41-sCD4-17b 
complex (PDB 5VN3) (Ozorowski et al., 2017) and closed SOSIP Env structures (e.g., PDB 
5T3X) (Figure 3.2, Supplementary Table 3.3). We also included a 3.6 Å cryo-EM structure of B41 
Env complexed with the CD4-binding site bNAb b12 (PDB 5VN8) in which the Env trimer 
exhibited an open conformation with respect to rotation and displacement of the gp120 subunits, 
but the V1V2 loops were not displaced to the sides of the Env trimer (Ozorowski et al., 2017).  
We illustrated differences in gp120 positions in partially-open, open, and closed Env trimers by 
measuring distances between gp120 landmarks (the CD4bs, the base of V1V2, and the base of V3) 
(Supplementary Table 3.1) and highlighting their positions on Env structures (Figure 3.2A). To 
facilitate visualization of different gp120 orientations, we also highlighted the gp120 landmark 
residues on Env structures in which the coordinates for V1V2 and V3 residues were removed, 
demonstrating a progression of gp120 displacement relative to closed Env in partially-open versus 
open Env structures (Figure 3.2B). The sCD4-bound Envs showed outward displacements and 
rotations of gp120s compared with closed Env, with the partially-open sCD4-8ANC195-bound 
structures exhibiting smaller displacements from the closed Env conformation relative to the open, 
sCD4-bound Env conformation (Figure 3.2B, Supplementary Table 3.1). The b12-bound open Env 
trimer also showed outward displacement of gp120s similar to the open sCD4-bound Envs (Figure 
3.2A,B), but unlike the partially-open and open sCD4-bound Envs in which the V1V2 loops were 
displaced to the side of Env trimer, the V1V2 loops remained “on top” of the displaced gp120s in 
b12-bound Env, where it was oriented equivalently with respect to the rest of gp120 as seen in 
closed Env structures (Figure 3.2D). Thus, opening of the b12-bound Env trimer involves a rigid 
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body movement of the gp120-V1V2 unit such that the coreceptor binding site on the V3 loop 
remains largely buried, whereas the opening of gp120 subunits in sCD4-bound Envs includes 
repositioning of V1V2 to expose the V3 loop (Figure 3.2D). This rigid body movement suggests 
that Env trimer opening and CD4-induced coreceptor binding site exposure represent two distinct 
steps.  
 
To evaluate differences in Env trimer openness, we aligned a gp120 monomer of our partially-open 
BG505-sCD4-17b-8ANC195 structure with gp120 monomers from the partially-open B41-sCD4-
21c-8ANC195 structure, closed Env, and the two forms of open Envs. The gp120 subunits of 
partially-open and fully-open sCD4-bound Envs aligned with low root mean square deviation 
(rmsd) values in all regions except for the N- and C-terminal strands (β4 and β26), where the rmsds 
increased to beyond 4 Å (Figure 3.3A). The β4 and β26 strands in the partially-open sCD4-bound 
Envs were most similar in orientation to closed Envs, with closer agreement to an 8ANC195-
bound closed Env structure than a closed Env solved in the absence of 8ANC195 (Figure 3.3A). 
Taken together, these results suggest that the β4 and β26 strands serve as a pivot point about which 
the rest of the gp120 subunit moves as a rigid body to either open Env trimer upon sCD4 or b12 
binding or to partially close the sCD4-bound Env trimer conformation upon binding to 8ANC195.   
We next investigated whether gp41 moves along with the gp120 β4 and β26 strands by aligning 
gp140s that were superimposed on their gp120-gp41 interface residues (defined as the gp120 and 
gp41 residues that include atoms within 5 Å of each other) (Figure 3.3B; Supplementary Figure 6). 
With the exception of interface residues on HR1 and the fusion peptide, the gp120-gp41 interfaces 
(highlighted in green on Figures 3.3B and Supplementary Figure 6) were mostly unchanged for 
different degrees of openness (Figure 3.3B). Thus, interactions across the gp120-gp41 interface in 
SOSIP Envs remain relatively unchanged during trimer opening. If this result extends to full-length 
Env trimers that do not contain the stabilizing SOSIP mutations, it suggests rigid body 
displacement of gp120 β4, β26, and the core portion of gp41 except for HR1C.  
 
Each gp41 protomer in Env trimer comprises an N-terminal fusion peptide sequence, followed by 
two helical regions, HR1 and HR2 (Supplementary Figure 5). The fusion peptides in the partially-
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open SOSIP Env structures reside in a pocket at the gp120-gp41 interface as seen in the fully-
open Env conformation (Supplementary Figure 7). Although the ordered residues of the fusion 
peptide in closed and fully-open Env structures form loops, the BG505-sCD4-17b-8ANC195 and 
B41-sCD4-21c-8ANC195 partially-open Env structures include ordered fusion peptide residues in 
an a-helical conformation (Supplementary Figure 4E,F; Supplementary Figure 7A). The finding of 
helical fusion peptide residues likely represents the beginning of the formation of an energetically 
stable fusion peptide conformation that inserts into the target cell membrane during the fusion 
process (Harrison, 2015). HR1C, the C-terminal portion of HR1, forms a parallel 3-helix bundle in 
Env trimers. The HR1C helical bundle in partially-open Env gp41 subunits is extended at its N-
termini by ordered residues at the C-termini of HR1N (N-terminal portion of HR1) to form longer 
and continuous a-helices (Supplementary Figure 7A). We observed extended HR1C helices in 
fully-open SOSIP Env structures, including the b12-bound open Env, but not in closed Envs 
(Supplementary Figure 7A). In addition, the HR1C helical bundle is more compact in both 
partially-open and fully-open Envs than the 3-helical bundles in pre-fusion, closed Env structures 
(Supplementary Figure 7A). Since the compact HR1C conformation was also observed in the B41-
b12 structure (Ozorowski et al., 2017) (Supplementary Figure 7A), these changes do not require 
V1V2 displacement. Notably, the compact HR1C conformation observed in all forms of open 
SOSIP Env matches the HR1C conformation seen in post-fusion gp41 structures in which HR1N 
forms a continuous a-helix with HR1C (Chan et al., 1997; Weissenhorn et al., 1997) 
(Supplementary Figure 7A,B). Taken together, these observations suggest that the change to a 
compact HR1C bundle that is extended at its N-terminus with HR1N helical residues represents 
one of the first intermediate conformations in open structures on the path to the fusion-active 
conformation (Supplementary Figure 7C). As these changes are also observed in the partially-open 
Env trimers, 8ANC195 binding and partial closure of the open Env conformation does not reverse 
HR1C and HR1N changes induced by trimer opening. 
 
gp120 folding topologies are divided into two categories based on formation of the bridging sheet, 
an antiparallel b-sheet involving gp120 b-strands β2, β3, β20, and β21 (Figure 3.4). The bridging 
sheet was first observed in structures of gp120 cores (gp120 monomers with truncations in V1V2, 
V3, and the N- and C-termini) in the presence and absence of sCD4 (Kwon et al., 2012; Kwong et 
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al., 1998) (Figure 3.4A). However, the sheet is not fully formed in closed, prefusion Env trimers; 
instead of a 4-stranded anti-parallel β-sheet, the β3, β20, and β21 strands form a mixed parallel and 
anti-parallel 3-stranded sheet, and the β2 residues adopt an a-helical conformation (Ward and 
Wilson, 2017) (Figure 3.4B).  
 
The 4-stranded bridging sheet is found in both partially-open sCD4-bound Env structures, with the 
rearranged V1V2 region located between b2 and b3 strands, similar to the fully-open Env in the 
B41-sCD4-17b structure (Ozorowski et al., 2017). By contrast, the open Env in the B41-b12 
complex adopts the 3-stranded b-sheet conformation of closed Env trimers (Figure 3.4B). Thus, the 
formation of the 4-stranded bridging sheet correlates with, and is likely required for, V1V2 
displacement and exposure of the coreceptor binding site on V3. Also, in common with the open 
form of B41 bound to sCD4 and 17b (Ozorowski et al., 2017), the partially-open BG505 and B41 
Envs include the gp120 α0 helix, which interacts with the HR1 in the gp41 of an adjacent 
protomer, whereas the α0 region of the gp120s in the b12-bound open B41 Env and in closed Envs 
formed irregular loops (Figure 3.2C).  
 
The B41-sCD4-17b structure revealed a series of gp120 side chain rearrangements relative to 
closed Env structures; these side chain rearrangements were not seen in the open B41-b12 complex 
(Ozorowski et al., 2017) (Figure 3.4A,B; Supplementary Figure 4A), suggesting they are related to 
4-stranded bridging sheet formation induced by sCD4 binding rather than Env opening. A subset of 
the gp120 side chain rearrangements (Tyr435gp120, Trp427gp120, Trp112gp120, Leu111gp120, and 
Trp69gp120) were observed in the 17b-bound partially-open structure and monomeric gp120 
structures (Figure 3.4A, Supplementary Figure 4A), demonstrating that (i) gp120 side chain 
rearrangements occur both in BG505 and in B41 Envs upon binding to sCD4, (ii) 8ANC195 
binding and partial Env closure does not reverse these rearrangements, and (iii) the rearrangements 
are related to 4-stranded bridging sheet formation. The fact that the side chain positions found in 
sCD4-bound Env trimers are also found in monomeric gp120 core structures, whether or not they 
are complexed with sCD4, indicates that this collection of side chain conformations is related to 
formation of the 4-stranded bridging sheet (Figure 3.4A).  
 
  
38 
 
Discussion 
The HIV-1 Env glycoprotein must adopt multiple conformations to function in fusion of the viral 
and host cell membranes (Ward and Wilson, 2017). Although we cannot define mechanisms for 
structural transitions from static structures that, by necessity, contain bound ligands and antibodies, 
by comparing our cryo-EM structures of sCD4-bound partially-open SOSIP Env trimers with 
structures of Env in other conformational states, we reveal information about how Env trimers 
rearrange to expose the coreceptor binding site and describe which parts of the rearrangement are 
reversible upon binding to a gp120-gp41 interface bNAb (Figure 3.5A). In particular, we captured 
an ordered conformation of the displaced V1V2 loops that move from the trimer apex to the sides 
of open Env upon sCD4 binding. We also showed that the structural rearrangements of extending 
and compacting the gp41 central helices are an initial step to achieving an open Env conformation 
(Figure 3.5) in the SOSIP Env trimers under comparison.  
  
With respect to the coreceptor binding site, the most relevant feature of the closed Env trimer 
structure is the location of the V1V2 loops at the trimer apex that shield the coreceptor binding site 
on V3 (Figure 3.5A; panel 1). The apex location of the V1V2 loops and their burial of V3 requires 
the 3-stranded form of the gp120 bridging sheet. The HR1C region of the three central gp41 
helices are relatively separated from each other in the closed conformation, and the a0 region 
adjacent to HR1C adopts a loop conformation (Figure 3.5A; panel 1).  
We hypothesize that a later, but still early, conformation on the pathway towards coreceptor 
binding site exposure is represented by the b12-bound open conformation of the B41 HIV-1 Env 
(Figure 3.5A; panel 2) (Ozorowski et al., 2017). In this structure, the gp120 subunits have rotated 
outwards from the trimer axis. However, although the Env trimer is open, the V1V2 loops are not 
displaced from their location at the top of each gp120 subunit, thus leaving the V3 loop partially 
buried by V1V2 (Figure 3.5A; panel 2). It is unclear if the b12 antibody captures a pre-existing 
open Env state that is in equilibrium with closed Env; if so, this state is not detectable in DEER 
spectroscopy analyses of SOSIP Env conformations (Stadtmueller et al., 2018). Thus, the b12-
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bound open state could either be induced by b12 binding or exist at levels that are 
spectroscopically undetectable but that can nevertheless can be captured by b12. This state may 
represent an early intermediate after sCD4 binding to the closed, prefusion state, in which gp120 
rotation is a prerequisite to V1V2 displacement (Figure 3.5A; panel 3).  
 
The B41-b12 structure demonstrates that Env trimer can open even without forming the 4-stranded 
gp120 bridging sheet, likely based on gp41 rearrangements and rotation about the pivot point 
defined by the gp120 β4 and β26 strands. Moreover, gp120 opening in the absence of 4-stranded 
bridging sheet formation triggers some of the structural rearrangements seen in sCD4-bound 
structures; for example, some conserved gp120 side chains (Trp69gp120, His72gp120, Leu111gp120) are 
rearranged with respect to the closed structure (Figure 3.5A, panels 1 and 2). Interestingly, the 
HR1C helices adopt the compact conformation found in post-fusion gp41 structures (Chan et al., 
1997; Weissenhorn et al., 1997) and also include HR1N residues as part of a longer central gp41 
helical region.  
 
The final conformation of open Env on the pathway to coreceptor binding appears in the sCD4-
bound Env structures in which the gp120 subunits have opened, as in the b12-bound conformation, 
but the V1V2 loops have also been displaced to the sides of Env trimer to expose the V3 loop for 
interactions with coreceptor (Figure 3.5A, panel 3). However, the V3 residues are largely 
disordered in this structure and in the partially-open Env structures with displaced V1V2 loops, 
suggesting that flexibility in V3 facilitates interactions with coreceptor. In coreceptor binding site-
exposed open conformations, the gp120 bridging sheet adopts a 4-stranded conformation in which 
the b2 residues form a b-strand connected to the N-terminal strand A of V1V2. The b2 and b3 
gp120 elements also swap positions so that the four strands of the bridging sheet are now 
antiparallel, allowing the displacement of V1V2 from the top of each gp120 to its side, thereby 
exposing V3. The HR1C helices in gp41 retain their compact configuration with extended helical 
regions from HR1N residues at their N-termini. Some conserved gp120 residues adopt altered side 
chain conformations that were proposed to allosterically transfer the signal from the sCD4 binding 
site to the gp120-gp41 interface, such the structure of gp41 is altered (Ozorowski et al., 2017). For 
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example, the gp120 a0 residues are now in a helical conformation that tops the HR1C from a 
neighboring gp41protomer.  
 
The open, coreceptor-binding site exposed conformation goes on to bind CCR5 or CCR4, adopting 
uncharacterized fusion-active conformation(s) that promotes fusion of the viral and host cell 
membranes. The only available structures of a conformational state that follows the open, 
coreceptor binding site-exposed conformation, are structures of 6-helical bundles of HR1 and HR2 
portions of gp41 (Chan et al., 1997; Weissenhorn et al., 1997) (Figure 3.5A, panel 5), which 
presumably represent post-fusion conformations of gp41. These structures contain the continuous 
HR1N-HR1C helix in a compact 3-helix bundle, which is similar to open, but not closed, Env 
trimer structures.  
 
Having categorized features of available Env structures in terms of their relationship to each other 
and to the post-fusion gp41 conformation, our structures address the pliability of the sCD4-bound 
conformation by showing that the sCD4-bound open conformation can partially close through 
binding to 8ANC195 (Figure 3.5A), a gp120-gp41 interface bNAb that also binds closed Envs 
(Scharf et al., 2015). In our two Env-sCD4-8ANC195 structures, the gp120 subunits are not as 
separated from each other as in fully-open conformations, therefore we refer to this conformation 
as partially open (Figure 3.5A, panel 4). The complexes for these structure determinations were 
formed by incubating fully-open, sCD4-bound Env trimers with 8ANC195, suggesting that 
8ANC195 either captured a partially-open, sCD4-bound conformation or its binding triggered 
partial closure of the open conformational state. Whether the partially-open sCD4-bound 
conformation of Env trimer represents a dead-end conformation of Env or a coreceptor binding 
site-exposed conformation of Env that could proceed along the pathway to viral/host cell 
membrane fusion is unknown. In any case, the structural comparisons show that partial closure of 
the sCD4-bound open state does not reverse the formation of 4-strand bridging sheet, V1V2 
displacement, coreceptor binding site exposure, a0 helix conformation, or the formation of 
compact gp41 HR1C helices with HR1N extensions (Figure 3.5A, panel 4). However, not all of the 
gp120 side chain rearrangements are conserved with the fully-open sCD4-bound structure. 
Interestingly, an ordered portion of the gp41 fusion peptide, which adopts a loop conformation in 
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closed and other open Env structures, is a-helical in both partially-open Env structures. As the 
fusion peptide is thought to insert into the target membrane as a helix (Harrison, 2015), the 
partially-open structures show a propensity of the fusion peptide to shift from a loop into a helix in 
preparation for mediating fusion of the viral and host membranes.  
 
Although disordered in other sCD4-bound complexes, the conformation of the displaced V1V2 
region was revealed in the B41-sCD4-21c-8ANC195 complex. The secondary structural elements 
of V1V2 and regions of flexibility indicated by disorder are mostly maintained whether V1V2 is 
displaced to the sides of Env trimer, interacts about the apex of a closed Env trimer, or was 
expressed as a monomeric V1V2 scaffold. This suggests that, in the CD4-bound conformation, the 
V1V2 secondary structural elements move as a rigid body about the loops extending from strands 
A and D. Thus the B41-sCD4-21c-8ANC195 structure likely reveals their architecture because of 
the stabilizing effects of 21c via interactions with the B-C loop region, while in the 17b-bound 
open structures, the displaced V1V2 occupies multiple positions that are averaged out during map 
reconstruction.  
 
Comparisons of available Env structures provide clues as to what controls displacement of V1V2 
to expose the coreceptor binding site in sCD4-bound structures. We note that in all Env structures 
with a 4-stranded bridging sheet, including Env trimers in fully- and partially-open conformations 
as well as gp120 monomer structures plus and minus bound sCD4, the side chain conformations of 
conserved gp120 residues Tyr435gp120, Trp427gp120, Trp112gp120, Leu111gp120, and Trp69gp120 are 
consistent. By contrast, in all structures with 3-stranded bridging sheets (closed Env trimers and 
b12-bound open Env), the conserved residues adopt distinct conformations. These results suggest 
that the side chain rearrangements in these residues control the reorganization of the β2, β3, β20, 
and β21 structural elements and thus regulate 4-stranded bridging sheet formation and coreceptor 
binding site exposure. Thus, structures of monomeric gp120 cores, which include a 4-stranded 
bridging sheet, mimic the sCD4-bound and coreceptor binding site-exposed conformation of gp120 
in Env trimers, rather than the conformation in closed, pre-fusion Env trimers. 
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Many structural questions related to Env conformations remain to be elucidated, most notably 
the fusion-active conformation that results from coreceptor binding. However, the structures 
reported here provide critical information for understanding steps leading up to coreceptor binding 
site exposure including: (i) suggesting an order for Env conformational changes, (ii) describing 
elements of conformational plasticity in the sCD4-bound Env state, and (iii) revealing a structure 
for the V1V2 regions displaced by sCD4 binding. This information adds mechanistic details to 
Env-mediated membrane fusion and provides a more complete sCD4-bound structure that serves 
as a template for understanding non-neutralizing, and potentially neutralizing, antibody responses 
to open Env conformations.  
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Methods 
Protein Expression and Purification 
His6-tagged Fabs from 17b, and the 8ANC195G52K5 variant of 8ANC195 were expressed by 
transient transfection in HEK293-6E cells (National Research Council of Canada) and purified 
from cell supernatants using Ni-NTA chromatography and size exclusion chromatography (SEC) 
as described (Scharf et al., 2015). The heavy and light chain genes encoding 21c IgG were isolated 
as described (West et al., 2010) from an Epstein Barr virus-transformed human B-cell line (Xiang 
et al., 2002) obtained from James Robinson (Tulane University), and 21c IgG was expressed by 
transient transfection in HEK 293-6E cells. 21c IgG was isolated from transfected cell supernatants 
by Protein A chromatography (GE Healthcare), and 21c Fab was obtained by digesting with 
immobilized papain (Pierce) at 10 mg ml−1 and purified by protein A (GE Healthcare) and SEC 
chromatography as described (Diskin et al., 2010). His6-tagged sCD4 D1D2 (domains 1 and 2; 
residues 1–186 of mature CD4) was expressed by transient transfection in HEK293-6E cells and 
purified by Ni-NTA chromatography and SEC. 
 
BG505 SOSIP.664 v3.2 (in vector pTT5, National Research Council of Canada), a native-like 
soluble gp140 trimer (Sanders et al., 2013) including the ‘SOS’ substitutions (A501Cgp120, 
T605Cgp41), the ‘IP’ substitution (I559Pgp41), the N-linked glycan sequence at residue 332gp120 
(T332Ngp120), an enhanced gp120-gp41 cleavage site (REKR to RRRRRR), and a stop codon after 
residue 664gp41 (Env numbering according to HX nomenclature) was expressed in HEK293-6E 
cells in the absence of kifunensine and was purified from cell supernatants by 2G12 
immunoaffinity chromatography and SEC as previously described (Wang et al., 2017). B41 
SOSIP.664 v4.2 (Pugach et al., 2015) was expressed in CHO Flp-InTM cells (Invitrogen) using 
vector pIPP4 (Chung et al., 2014) using cell lines kindly provided by Al Cupo and John Moore 
(Weill Cornell Medical College) and purified as described for BG505. All proteins were stored at 
4˚C in 20 mM Tris, pH 8.0, and 150 mM sodium chloride (TBS buffer) supplemented with 0.02% 
(w/v) sodium azide. 
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Sample preparation 
BG505-sCD4-17b-8ANC195 and B41-sCD4-21c-8ANC195 complexes were prepared by 
incubating purified Env with sCD4 at a 1:3 molar ratio (gp140 protomer:sCD4) for 4 h at room 
temperature, followed by subsequent incubation with a 1:3 molar ratio of CD4i Fab (gp140 
protomer:17b or 21c) overnight at 4°C. Complexes were isolated by SEC in TBS (20 mM Tris pH 
8.0, 100mM NaCl) using a Superose 6 10/300 column (GE Healthcare) and peak fractions 
analyzed by SDS-PAGE. Fractions corresponding to the Env-sCD4-CD4i complex were pooled 
and a 10-fold molar excess of 8ANC195 Fab was added before incubation at room temperature for 
2 h. Complexes were again isolated by SEC using a Superose 6 10/300 column (GE 
Healthcare),analyzed by SDS-PAGE, and pooled. Purified BG505-sCD4-17b-8ANC195 and B41-
sCD4-21c-8ANC195 complexes were diluted to 200 µg/mL and 350 µg/mL in TBS, respectively, 
and vitrified in liquid ethane using a Mark IV Vitrobot (FEI). Sample grids were prepared by 
adding 3 µL of complex to glow discharged 400 Mesh Quantifoil R1.2/1.3 copper grids. 
 
BG505-sCD4-17b-8ANC195 complex cryo-EM data collection and processing 
Images were recorded using SerialEM (Mastronarde, 2005) on a Titan Krios electron microscope 
equipped with Gatan K2 Summit direct detector. Exposures (15 s) were divided into 50 subframes 
with a dose rate of 3 electrons⋅pixel−1⋅subframe−1. After binning by two, each image was 4k×4k 
and 1.31 Å per pixel. A total of 3454 movies were collected using a 1-2.5 µm defocus range. The 
micrographs were motion corrected using MotionCor2 (Zheng et al., 2017) (Supplementary Figure 
3.1A) and contrast transfer function (CTF) estimations were calculated using CTFFIND4 (Rohou 
and Grigorieff, 2015) (Supplementary Figure 3.1B). 2215 micrographs with CTF fitting beyond 4 
Å were selected for automated particle picking using EMAN 2.2 (Ludtke et al., 2017). Subsequent 
steps were performed using RELION2 (Kimanius et al., 2016). A total of 548,229 particles were 
picked and sorted using initial 2D classifications. 213,791 particles from good 2D classes were 
selected for another round of 2D classification, which generated 195,755 “good” particles 
(Supplementary Figure 3.1C). For 3D classification, an intermediate resolution cryo-EM structure 
of the BG505-sCD4-17b-8ANC195 complex (EMDB 8407) (Wang et al., 2016a) was low-pass 
filtered to 60 Å to serve as the reference, and then 195,755 particles were classified into 10 
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different 3D classes assuming only C1 symmetry (Supplementary Figure 3.1C). Using 143,099 
particles from six 3D classes as input for 3D refinement with C3 symmetry resulted in the highest 
resolution (4.68 Å) (Supplementary Figure 3.1C). These particles were movie refined and polished 
before the final 3D refinement step, during which the Fab CHCL and sCD4 D2 domains were 
masked out. After post-processing, the final resolution estimated by the gold-standard FSC 
(Scheres and Chen, 2012) was 3.54 Å (Supplementary Figure 3.1C, 3.3A) 
 
B41-sCD4-21c-8ANC195 complex cryo-EM data collection and processing 
Images were recorded using SerialEM (Mastronarde, 2005) on a Titan Krios electron microscope 
equipped with Gatan K2 Summit direct detector. Exposures (10 s) were divided into 50 subframes 
with a dose rate of 2 electrons⋅pixel−1⋅subframe−1. After binning by two, each image was 4k×4k 
and 1.31 Å per pixel. A total of 2531 movies were collected using a 1.7-3.5 µm defocus range. 
Subsequent steps were performed in RELION2 (Kimanius et al., 2016). The micrographs were 
motion corrected using MotionCor2 (Zheng et al., 2017) (Supplementary Figure 3.2A) and CTF 
estimations were calculated using CTFFIND4 (Rohou and Grigorieff, 2015) (Supplementary 
Figure 3.2B). Single particles were manually selected in Relion (~1000 particles) and used to 
create an initial particle stack that was 2D classified to generate a template for autopicking in 
Relion. Reference free, 2D classification of 474645 auto-picked particles was performed, and 
346264 particles corresponding to class averages of the complex were selected (Supplementary 
Figure 3.2C). For 3D classification, a model structure of the Env-sCD4-21c-8ANC195 complex 
was generated by replacing 17b Fab with 21c Fab in the partially-open BG505-sCD4-17b-
8ANC195 structure (PDB 5THR) (Wang et al., 2016a). The 21c Fab binding angle was determined 
by aligning gp120s from the gp120-sCD4-21c crystal structure (PDB 3LQA)(Diskin et al., 2010) 
and the BG505-sCD4-17b-8ANC195 structure. The modeled structure was low-pass filtered to 60 
Å to serve as the initial 3D reference, and then 346264 particles were classified into 4 different 3D 
classes, during which C3 symmetry was assumed and the Fab CHCL domains were masked out 
(Supplementary Figure 3.2C). Using 305049 particles from three 3D classes as input for 3D 
refinement with C3 symmetry resulted in the highest resolution (4.39 Å) (Supplementary Figure 
3.2C). These particles were movie refined and polished before the final 3D refinement step. After 
post-processing, the final resolution estimated by the gold-standard FSC (Scheres and Chen, 2012) 
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was 4.06 Å (Supplementary Figure 3.3A). Regions distal to the gp120-gp41 core, including 21c, 
sCD4, and the displaced V1V2, were further classified and refined in Relion to enable de novo 
model building (See Supplementary Figure 3.2C, 3.3 for details).  
 
Cryo-EM model building 
Coordinates for individual components of the 3.54 Å BG505-sCD4-17b-8ANC195 cryo-EM 
structure were docked into their corresponding density regions using UCSF Chimera (Pettersen et 
al., 2004). The following coordinate files were used for docking: gp120 from a B41-sCD4-17b 
complex structure in an open conformation (PDB 5VN3), gp41 from the same structure, sCD4 D1 
domain (PDB 2NXY), 17b Fab (PDB 2NXY) (Zhou et al., 2007), 8ANC195 Fab (PDB 4P9M) 
(Scharf et al., 2014). The docked coordinates were used as the template for RosettaCM (Song et 
al., 2013) to build an initial model of BG505 Env, after which the model were manually modified 
in Coot (Emsley and Cowtan, 2004) to remove residues that did not fit into density or clashed with 
other components. Coordinates for BG505 plus sCD4 and the Fabs were refined by applying C3 
symmetry using Rosetta (Tange, 2011; Wang et al., 2016b). Coordinates for ordered N-linked 
glycans from PDB 5T3X and PDB 5VN3 Env structures (Gristick et al., 2016; Ozorowski et al., 
2017) were fit separately as rigid bodies at potential N-linked glycosylation sites (PNGSs) at which 
EM density was apparent (Supplementary Figure 3.4B), and glycan rings outside of EM density 
were removed. The entire complex was refined using phenix.real_space_refine with secondary 
structure restraints for protein and geometric restraints for protein and N-glycan residues (Adams 
et al., 2010; Afonine et al., 2018; Agirre et al., 2015; Gristick et al., 2017) (Table 3.1).   
 
An initial model was generated for the 4.06 Å B41-sCD4-21c-8ANC195 cryo-EM map by docking 
coordinates of individual components into their corresponding density regions with UCSF Chimera 
(Pettersen et al., 2004). Coordinates for gp120-gp41, sCD4 D1 domain, 21c Fab, and 8ANC195 
Fab were obtained from PDB codes 5VN3, 2NXY, 3LMJ, and 4P9M, respectively. Docked 
coordinates were initially rigid-body refined in Coot (Emsley and Cowtan, 2004), followed by 
several cycles of refinement in Phenix (Adams et al., 2010; Afonine et al., 2018) and manual 
rebuilding in Coot. Coordinates for ordered N-linked glycans from PDB 5T3X and PDB 5VN3 
Env structures (Gristick et al., 2016; Ozorowski et al., 2017) were fit separately as rigid bodies at 
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potential N-linked glycosylation sites (PNGSs) where EM densities for N-glycans were apparent 
(Supplementary Figure 3.4B), and subsequently trimmed and refined in Coot to fit the cryo-EM 
map. 
 
Density corresponding to the previously-uncharacterized V1V2 residues 129-195 was interpreted 
in the B41-sCD4-21c-8ANC195 structure as follows. After focus classification and refinement on 
the 21c, sCD4, V1V2 region (Supplementary Figure 3.2C, Supplementary Figure 3.3), we 
identified density characteristic of a 2-stranded anti-parallel b-sheet that resembled the strand B–
connecting loop–strand C conformation in known V1V2 structures (Supplementary Figure 3.4G). 
An initial polyalanine model for strand B-connecting loop-strand C residues 154-174 was 
generated using coordinates from a closed BG505 crystal structure (PDB 5T3Z) and manually 
docked into density (Supplementary Figure 3.4G). The remaining portions of V1V2 could be 
placed by first building residues to continue the b2 strand into strand A and residues preceding b3 
as strand D. We next found density compatible with a b-strand that could form a b-sheet interaction 
with strand D and assigned that as the V2 strand. Remaining density appearing to connect strands 
A and B via a long loop were left unmodeled due to uncertainty of the sequence register. b-strand 
restraints were applied to strands A-D and V2 throughout refinement in both Coot and Phenix. The 
entire complex was refined using phenix.real_space_refine with secondary structure restraints for 
protein and geometric restraints for protein and N-glycan residues (Adams et al., 2010; Afonine et 
al., 2018; Agirre et al., 2015; Gristick et al., 2017) (Table 3.2).   
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Figures 
Figure 3.1 
 
 
Figure 3.1. Cryo-EM Structures of sCD4-Bound Env Trimers.  
(A) 3.54 Å density map of BG505-sCD4-17b-8ANC195 complex. 
(B) Fitted coordinates of BG505-sCD4-17b-8ANC195 complex. 
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 (C) 4.06 Å density map of B41-sCD4-21c-8ANC195 complex. 
(D) Fitted coordinates of B41-sCD4-21c-8ANC195 complex. The CH and CL domains of the Fabs 
and D2 domain of sCD4 were disordered in both structures and not fit into density. 
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Figure 3.2 
 
Figure 3.2. Comparison of Env Conformations 
 
(A) Top and side views of surface representations of Env trimers in partially open, sCD4-bound 
open, b12-bound open, and closed conformations. PDB: 5T3X is shown as a representative 
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example of a closed Env structure; inter-protomer distances on closed Env structures are 
similar to each other despite strain-specific sequence differences and binding of different Fab 
ligands (Stadtmueller et al., 2018). 
 
(B) Structures shown in (A) with coordinates for residues 126–198 in V1V2 and 296–330 in V3 
removed to facilitate seeing positions of landmark residues: CD4bs residues 364–372 (yellow), 
residue 125 and 199 at the base of V1V2 (red), and residues 295 and 331 at the base of V3 
(blue). Positions of CD4bs residue 368, V1V2 base residue 124, and V3 base residue 330 are 
shown as spheres below their respective Env structures. 
 
(C) Conformational changes of α0. Structures in (A) and (B) are shown with coordinates for 
residues 64–73 in α0 and 98–117 in α1 in cartoon depiction overlaid on a transparent trimer 
surface. 
 
(D) gp120 monomers from structures shown in (A) and (B). β2, β3, β20, β21, V1V2 residues 
126–198, and V3 residues 296–330 are shown in cartoon representations overlaid on a 
transparent gp120 surface. 
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Figure 3.3 
 
Figure 3.3. Conformations of the gp140 Protomer 
 
(A) Superimpositions of gp120 monomer from the BG505-sCD4-17b-8ANC195 Env trimer 
structure with gp120s from other Env trimer structures. Left: gp120 monomer from the BG505-
sCD4-17b-8ANC195 structure with highlighted structural elements of interest. Right: gp120 from 
the BG505-sCD4-17b-8ANC195 structure (blue-red colors indicating RMSDs) superimposed with 
the indicated gp120s (gray). 
(B) Superimpositions of gp140 protomer from the BG505-sCD4-17b-8ANC195 Env trimer 
structure with gp140s from other Env trimer structures. Left: gp140 protomers from the BG505-
sCD4-17b-8ANC195 structure with highlighted structural elements of interest (first structure) and 
highlighted gp120-gp41 interface regions (second structure). Right: gp140 from the BG505-sCD4-
17b-8ANC195 structure (blue-red colors indicating RMSDs) superimposed with the indicated 
gp120s (gray). 
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Figure 3.4 
 
Figure 3.4. Network of Conserved Residues Regulating gp120 Conformational Changes 
(A) Bridging-sheet and conserved side-chain conformations in open Env trimer and gp120 
monomer structures. Left: topology diagram of 4-stranded bridging sheet. Right: cartoon 
representations of β20, β21, β2, β3, α1, V1V2, and V3 overlaid on a transparent gp120 monomer 
surface (top) and stick representations of side chains of conserved residues of corresponding 
structures (bottom). 
 
(B) Bridging-sheet and conserved side-chain conformations in b12-bound open Env and closed 
Env trimer structures. Left: topology diagram of 3-stranded bridging sheet. Right: cartoon 
representations of β20, β21, β2, β3, α1, V1V2, and V3 overlaid on a transparent gp120 monomer 
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surface (top) and stick representations of side chains of conserved residues of corresponding 
structures (bottom). 
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Figure 3.5 
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Figure 3.5. Model for Order of Conformational Changes Leading to Coreceptor Binding and 
Fusion 
(A) Overview of features in different HIV-1 Env trimer conformational states. Five conformations 
that have been characterized by X-ray crystallography or cryo-EM are listed with their 
corresponding structural features. (1) PDB: 5T3Z; (2) PDB: 5VN8; (3) PDB: 5VN3; (4) this study; 
(5) PDB: 1AIK. 
 
(B) Table summarizing structural features of the conformational states listed in (A). coBS, 
coreceptor binding site; FP, fusion peptide. 
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Tables 
Table 3.1 
 
Model Statistics
Mask CC 0.7744
Reconstruction
Symmetry C3
Particles refined 143k
Software Relion-2.0
3.54Final Resolution(Å)
-95.4595Map sharpening B-factor ( Å2)
87.5 electrons/Å2
1.31 Å
Total dose 
Magnified pixel size
Data collection/processing
Voltage 300kV
Camera Gatan K2 Summit
Microscope Titan Krios
Super-resolution
1.0-2.5
Camera mode
Defocus range
15
1.75 electrons/Å2/subframe
Exposure time
Dosage rate
0.00
0.87RMSD (angles) (°)
RMSD (bonds) (Å)
0.11%
93.22%
C-beta deviations
Rotamer outliers
favored
All-atom clashscore 5.41
0.00%
Ramachandran plot:
outliers 
6.78%allowed  
0.00%
EMRinger Score 2.32
Volume CC
Peak CC
0.759
0.602
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Table 3.1. Data collection and model statistics for the BG505-sCD4-17b-8ANC195 
complex structure, related to Figure 3.1. 
 
Table 3.2 
 
Model Statistics
Mask CC 0.808
Reconstruction
Symmetry C3
Particles refined 215k
Software Relion-2.1
4.24Final Resolution(Å)
 -220.00Map sharpening B-factor ( Å2)
58.28 electrons/Å2
1.31 Å
Total dose 
Magnified pixel size
Data collection/processing
Voltage 300kV
Camera Gatan K2 Summit
Microscope Titan Krios
Super-resolution
1.7-3.5
Camera mode
Defocus range
10
1.16 electrons/Å2/subframe
Exposure time
Dosage rate
0.01
1.12RMSD (angles) (°)
RMSD (bonds) (Å)
0.34%
88.21%
C-beta deviations
Rotamer outliers
favored
All-atom clashscore 8.68
0.19%
Ramachandran plot:
outliers 
11.60%allowed  
0.00%
EMRinger Score 1.06
Volume CC
Peak CC
0.805
0.550
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Table 3.2. Data collection and model statistics for the B41-sCD4-21c-8ANC195 complex 
structure, related to Figure 3.1. 
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Supplementary Figures 
Supplementary Figure 3.1 
 
A B
Autopicking 
2D classification 
196k particles
143k particles
4.68 Å
Movie refinement and particle polishing
followed by focused 3D refinement
Fab CHCL  and sCD4 D2 masked out 
3D refinement
C3 symmetry
C
Am
pl
itu
de
Spatial frequency (1/Å)
9.17% 7.87% 17.72% 9.43%10.80% 4.80%17.76% 9.20% 3.68%9.57%
3D Classification
C1 symmetry
143k particles
3.93 Å
Postprocessing
Fab CHCL  and sCD4 D2 masked out
143k particles
3.54 Å
50nm
18k particles
9.36 Å
3D refinement
C1 symmetry
Postprocessing
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Supplementary Figure 3.1. Data processing for the BG505-sCD4-17b-8ANC195 complex 
structure, related to Figure 3.1.  
 
(A) Representative motion corrected and dose-weighted micrograph of BG505-sCD4-17b-
8ANC195 complex (examples of individual particles in boxes). Scale bar of 50nm is shown. The 
defocus value was ~2.3 µm underfocus. (B) CTF fitting of the micrograph shown in (A) using 
CTFFIND4 (Rohou and Grigorieff, 2015), showing a good fit to 3.3 Å. (C) Data processing 
scheme. 2D classification of autopicked particles resulted in 196k “good” particles that were 3D 
classified using a 60 Å low-pass-filtered cryo-EM structure (EMDB 8407) as the reference model. 
The 143k particles from the best six 3D classes were refined to 4.68 Å resolution using C3 
symmetry. The particles in the 4.68 Å reconstruction were further movie refined and polished 
using RELION (Scheres, 2012), and then refined with the Fab CHCL domains and sCD4 D2 
domains masked out. The final post-processing step generated a 3.54 Å structure with three bound 
sCD4 plus three 17b and three 8ANC195 Fabs per Env trimer. One 3D class with 18k particles 
with two sCD4, two 17b, and two 8ANC195 bound to each Env trimer was refined with C1 
symmetry, resulting in a 9.36 Å structure.  
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Supplementary Figure 3.2 
 
Am
pl
itu
de
Spatial frequency (1/Å)
50nm
Autopicking 
2D classification 
346k particles
3D Classification
C3 symmetry
Fab CHCL  masked out 
22.9% 12.4%38.9%25.8%
Movie refinement and particle polishing
followed by 3D refinement
Fab CHCL  masked out 
3D refinement
C3 symmetry
Fab CHCL  masked out 
305k particles
4.39 Å
Postprocessing
Fab CHCL  masked out
305k particles
4.06 Å
305k particles
4.06 Å
8.7% 20.2%17.0%4.5% 18.8% 7.8% 11.5% 11.5%
Movie refinement and particle polishing
followed by 3D Classification, C3 symmetry
21c CHCL  and 8ANC195 Fab masked out 
3D refinement
C3 symmetry
21c CHCL  and 8ANC195 Fab masked out  
215k particles
4.29 Å
Postprocessing
21c CHCL  and 8ANC195 Fab  masked out
215k particles
4.24 Å
Best overall resolution
Best V1V2 local resolution
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Supplementary Figure 3.2. Data processing for the B41-sCD4-21c-8ANC195 complex 
structure, related to Figure 1.  
(A) Representative micrograph with examples of B41-sCD4-21c-8ANC195 complex in boxes. 
The defocus value was ~2.6 µm underfocus. (B) CTF fitting of the left micrograph using 
CTFFIND4 (Rohou and Grigorieff, 2015) showing a good fit to 4.7 Å. (C) Data processing 
scheme. 2D classification of autopicked particles resulted in 346k “good” particles that were 3D 
classified into four 3D classes using a 60 Å low-pass-filtered reference model assuming C3 
symmetry. The reference model was made by replacing 17b Fab with 21c Fab in partially-open 
BG505-sCD4-17b-8ANC195 structure (PDB 5THR). The 21c Fab binding angle was modeled 
using a gp120-sCD4-21c crystal structure (PDB 3LQA). During 3D classification and the 
following refinement steps the Fab CHCL domains were masked out. The 305k particles from the 
best three 3D classes were refined to 4.39 Å resolution. The particles in the 4.39 Å reconstruction 
were further movie refined and polished using RELION (Scheres, 2012), and then refined to 4.06 
Å. The final post-processing step generated a 4.06 Å structure with three bound sCD4 plus three 
21c and three 8ANC195 Fabs per Env trimer. After movie refinement and particle polishing we 
performed another round of 3D classification, during which the 21c CHCL domains and the 
8ANC195 Fabs were masked out, which improved the local resolution in the vicinity of V1V2. 
305k particles were classified into 10 different classes assuming C3 symmetry, and 5 classes with 
obvious V1V2 densities were selected for model building of the displaced V1V2. After post-
processing, the final resolution was 4.24 Å.  
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Supplementary Figure 3.3. 
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Supplementary Figure 3.3. Validation of the BG505-sCD4-17b-8ANC195 and B41-sCD4-
21c-8ANC195 complex structures, related to Figure 3.1. 
 (A) Gold-standard FSC of 3.54 Å BG505-sCD4-17b-8ANC195 structure, 4.06 Å B41-sCD4-
21c-8ANC195 structure, and 4.24 Å B41-sCD4-21c structure in which 8ANC195 Fabs were 
masked out. (B) Local resolution estimation and orientation distribution for the 3.54 Å BG505-
sCD4-17b-8ANC195 structure. (C) Local resolution estimation and orientation distribution for the 
4.06 Å B41-sCD4-21c-8ANC195 structure. (D) Local resolution estimation and orientation 
distribution for the 4.24 Å B41-sCD4-21c structure.  
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Supplementary Figure 3.4 
 
Supplementary Figure 3.4. Close-up views of cryo-EM maps, related to Figures 3.1 and 3.4.  
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Close-up views of selected density regions in the 3.54 Å BG505-sCD4-17b-8ANC195 and 4.24 Å 
B41-sCD4-21c-8ANC195 structures. Maps were contoured at 10.5 σ (0.0571 e/Å3) for the 
BG505-sCD4-17b-8ANC195 structure (A, C, E) and 9.0 σ (0.0305 e/Å3) for the B41-sCD4-
21c-8ANC195 structure (B, D, F, G). (A) Cryo-EM densities of conserved residues shown in 
Figure 4A in the partially-open BG505-sCD4-17b-8ANC195 structure. (B) Cryo-EM densities 
of residues in the partially-open B41-sCD4-21c-8ANC195 structure. (C, D) Cryo-EM 
densities of N-linked glycans attached to the indicated Asn residues for BG505-sCD4-17b-
8ANC195 (C) and B41-sCD4-21c-8ANC195 (D) structures. (E, F) Cryo-EM densities of 
fusion peptide regions in BG505-sCD4-17b-8ANC195 (E) and B41-sCD4-21c-8ANC195 (F) 
structures. (G) Cryo-EM density of the strand B–connecting loop–strand C region of the 
displaced V1V2 in the B41-sCD4-21c-8ANC195 structure. The density is shown as fit by 
strand B–connecting loop–strand C coordinates from the B41-sCD4-21c-8ANC195 structure 
(left), from a V1V2 scaffold structure (middle), and from a closed Env structure (right), 
demonstrating a consistent strand B–connecting loop–strand C geometry among different 
structures. 
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Supplementary Figure 3.5 
 
Supplementary Figure 3.5. Env sequence alignments and definitions of secondary structural 
elements, related to Figure 3.1, 3.2, and 3.3.  
(A) Left: gp120 sequence alignment of BG505 SOSIP and B41 SOSIP. Potential N-linked 
glycosylation sites (PNGSs) are highlighted in green. Disordered regions in the BG505-sCD4-
17b-8ANC195 and B41-sCD4-21c-8ANC195 structures are indicated by a grey background. 
Secondary structure elements are highlighted below the sequence alignments. Right: gp120 
structure from the 3.54 Å BG505-sCD4-17b-8ANC195 complex structure. Secondary structure 
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elements are highlighted in the same colors as in the sequence alignment. (B) gp41 sequence 
alignment and structure as in (A).   
  
70 
Supplementary Figure 3.6 
 
Supplementary Figure 3.6. gp120-gp41 interface residues, related to Figure 3.3.   
(A) gp120 sequence alignment for partially-open BG505-sCD4-17b-8ANC195 structure (this 
study), open Envs (PDBs 5VN3 and 5VN8), and closed Envs (PDB 5T3X). Disordered regions are 
indicated by an underscore. gp120-gp41 interface residues (defined as the gp120 and gp41 residues 
that include atoms within 5 Å of each other) are highlighted in green. Secondary structure elements 
are labeled below the sequence alignment. (B) gp41 sequence alignment as in (A). 
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Supplementary Figure 3.7 
 
Supplementary Figure 3.7. gp41 structures in different conformations, related to Figure 3.3.  
(A) Trimeric gp41 structures from partially-open Envs (BG505-sCD4-17b-8ANC195 and 
B41-sCD4-21c-8ANC195), open Envs (PDBs 5VN3 and 5VN8), closed Envs (PDB 5T3X), 
and a post-fusion gp41 core structure (PDB 1AIK). Upper panel: top views of gp41; middle 
panel: side views gp41; bottom panel: zoom-in view of fusion peptide residues (cartoon 
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representation) overlaid on surface representations of Env trimer structures. (B) 
Superimpositions of post-fusion gp41 HR1 structure with gp41 HR1 structures from Env in 
different conformations. Post-fusion gp41 HR1s are shown in black while gp41 HR1s from 
Env shown in white. (C) Proposed model of gp41 conformational changes during viral 
infection. 
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Supplementary Table 
 
Supplementary Table 3.1. Distances between key residues in different Env trimer conformations, 
related to Figure 3.2. Inter-subunit distances were measured for indicated Cα atom positions in 
PyMol. 
 
 
Trimer 
state 
Ligand Trimer type EMDB
/PBD 
ID 
Resolution 
(Å) 
Distance 
between 
V1V2 
base 
(P124) 
(Å) 
DIstance 
between 
CD4bs 
(D368) 
(Å) 
Distance 
between 
V3 base 
(H330) 
(Å) 
closed 8ANC195 BG505 
SOSIP.664 
5CJX 3.58   14 54 68 
closed PGT122, 
35O22 
BG505 
SOSIP.664 
4TVP 3.5 15 55 69 
closed PGT122 BG505 
SOSIP.664 
4NCO 4.7 14 56 70 
closed  3H+109L, 
35O22 
BG505 
SOSIP.664 
5CEZ 3 14 56 69 
closed IOMA, 35O22 BG505 
SOSIP.664 
5T3Z 3.5 14 54 69 
closed PGT151 JR-FL EnvDCT 5FUU 4.19 16 56 69 
          15±1 55±1 69±1 
                
partially 
open 
sCD4, 17b, 
8ANC195 
BG505 
SOSIP.664 
5THR 8.9 68 78 73 
partially 
open 
sCD4, 17b, 
8ANC195 
BG505 
SOSIP.664 
6CM3 3.54 67 79 76 
partially 
open 
sCD4, 21c, 
8ANC195 
B41 SOSIP.664 6EDU 4.06 69 79 73 
          68±1 79±1 74±2 
                
open sCD4, 17b B41 SOSIP.664 5VN3 3.7 79 84 73 
                
open b12 B41 SOSIP.664 5VN8 3.6 69 84 75 
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C h a p t e r  I V  
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies 
Abstract 
HIV-1 surface glycoprotein Env trimer binds to host cell receptors to mediate membrane fusion. 
The prefusion Env trimer is stabilized by V1V2 loops that interact at the trimer apex. Broadly 
neutralizing antibodies (bNAbs) against V1V2 loops, exemplified by PG9, bind asymmetrically as 
a single Fab to the apex of the symmetric Env trimer using a protruding CDRH3 to penetrate the 
Env glycan shield. Here we characterized a distinct mode of V1V2 epitope recognition by the new 
bNAb BG1 in which two Fabs bind asymmetrically per Env trimer using a compact CDRH3. 
Comparisons between cryo-EM structures of Env trimer complexed with BG1 (6.2Å resolution) 
and PG9 (11.5Å resolution) revealed a new V1V2-targeting strategy by BG1. Analyses of the EM 
structures provided information relevant to vaccine design including molecular details for different 
modes of asymmetric recognition of Env trimer and a binding model for BG1 recognition of V1V2 
involving glycan flexibility. 
 
 
 
 
 
Adapted from 
Wang, Haoqing, Harry B. Gristick, Louise Scharf, Anthony P. West Jr, Rachel P. Galimidi, 
Michael S. Seaman, Natalia T. Freund, Michel C. Nussenzweig, and Pamela J. Bjorkman. 
"Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies." Elife 6 
(2017): e27389. 
  
75 
 
Introduction 
The HIV-1 envelope (Env) glycoprotein trimer, a trimer of gp120-gp41 heterodimers, is the 
infectious machinery that targets host cell receptors CD4 and corecptors CCR5/CXCR4 to mediate 
fusion between the viral and host membranes (Wyatt and Sodroski, 1998). As the only viral protein 
on the surface of HIV-1 virions, Env trimer is the sole target of neutralizing antibodies that prevent 
viral infection (McCoy and Burton, 2017). 
 
Although an infected host produces antibodies against HIV-1 Env, most are non-neutralizing or 
exhibit strain-specific neutralization that is ineffective in the face of HIV’s ability to create 
resistant variants through rapid mutation (McCoy and Burton, 2017). Only a subset of HIV-1–
infected individuals produce potent and broadly neutralizing antibodies (bNAbs) (Klein et al., 
2013b; Landais et al., 2016), which can protect against and suppress infection in animal models 
(Barouch et al., 2013; Klein et al., 2012b; Shingai et al., 2013) and exhibit antiviral activity in 
human clinical trials (Caskey et al., 2015; Caskey et al., 2017; Lynch et al., 2015). HIV-1 bNAbs 
differ from most other antibodies in several ways. First, unlike most humoral immune responses, 
bNAbs usually take 1-3 years to develop (Klein et al., 2013b; Landais et al., 2016). Second, nearly 
all HIV-1 bNAbs exhibit high levels of somatic mutation, and many of these antibodies include 
long heavy chain complementarity determining region 3 (CDRH3) loops (West et al., 2014). These 
unusual features appear to be a significant barrier to eliciting such antibodies by immunization. 
 
HIV-1 bNAbs have been mapped to distinct epitopes on HIV-1 Env including the variable 1 and 2 
(V1V2) and variable 3 (V3) loops, the CD4 binding site (CD4bs) on gp120, the gp120-gp41 
interface, and regions of gp41 including the membrane-proximal external region and fusion peptide 
(Burton and Mascola, 2015; Landais et al., 2016; McCoy and Burton, 2017; West et al., 2014). The 
V1V2 epitope is of interest because this region of gp120 undergoes large structural changes after 
binding to the primary receptor CD4: the interaction between CD4 and the gp120 portion of Env 
trimer stabilizes an open Env conformation that can interact with a chemokine receptor to induce 
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further conformational changes resulting in insertion of the fusion peptide on gp41 into the target 
cell membrane (Wyatt and Sodroski, 1998). Structures of soluble native-like Env trimers in the 
closed, prefusion state (Garces et al., 2015; Gristick et al., 2016; Julien et al., 2013a; Kong et al., 
2015; Kwon et al., 2015; Lyumkis et al., 2013; Pancera et al., 2014; Scharf et al., 2015; Stewart-
Jones et al., 2016; Ward and Wilson, 2017) showed that the V1V2 regions from the three gp120s 
interact around the trimer axis of symmetry to form a top layer of the trimer that shields V3 and the 
coreceptor binding site. In the CD4-bound state, the gp120 protomers are separated from each 
other (Liu et al., 2008; Tran et al., 2012), and the V1V2 loops are displaced by ~40 Å from the 
trimer apex to interact with CD4 on the sides of the trimer (Wang et al., 2016a). 
 
Structural studies of V1V2 bNAbs include crystal structures of bNAb Fabs bound to monomeric 
V1V2 scaffolds (Gorman et al., 2016; McLellan et al., 2011; Pan et al., 2015; Pancera et al., 2013) 
and a low resolution single-particle EM structure of the V1V2 bNAb PG9 bound to a soluble, 
native-like Env trimer (Julien et al., 2013b). Crystal structures of monomeric V1V2 scaffolds 
bound to PG9 or to its PG16 relative revealed the V1V2 loop structure as a Greek key motif 
containing four b-strands that was recognized by the V1V2 bNAbs largely through interactions in 
which a long CDRH3 from the Fab reached through the Env glycan shield to contact a protein 
epitope in the V2 loop (McLellan et al., 2011; Pancera et al., 2013). The EM structure and 
complementary biophysical studies indicated that, unlike bNAbs in other epitope classes that bind 
symmetrically to Env trimers with three Fabs per trimer, only one PG9 bound per Env trimer, 
resulting in an asymmetric quaternary epitope at the Env apex (Julien et al., 2013b). Recent cryo-
EM structures of Env trimer complexes with the V1V2 bNAb PGT145 also revealed one V1V2 
Fab per Env trimer and details of quaternary contacts spanning the three gp120 protomers of Env 
(Lee et al., 2017; Liu et al., 2017). 
 
A new V1V2 bNAb, BG1, was isolated along with bNAbs targeting non-overlapping sites on Env 
from an HIV-1 controller who developed elite levels of HIV-1 neutralizing activity (Freund et al., 
2017). We characterized the binding properties of BG1 by performing biophysical studies to 
determine its stoichiometry of binding to an HIV-1 Env trimer and by solving structures of the 
BG1 Fab and a BG1 Fab-Env trimer complex. BG1 differs from other V1V2 antibodies in that two 
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BG1 Fabs bind per Env trimer to create a previously-unseen form of asymmetric recognition of 
the V1V2 loops at the Env trimer apex. This form of recognition does not require a protruding 
CDRH3, as found in other V1V2 bNAbs, and the BG1 epitope on Env trimer differs from 
previously-characterized V1V2 epitopes. The BG1 paratope may therefore represent a new target 
for HIV-1 vaccine development (Escolano et al., 2017).  
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Results 
The heavy chains (HCs) of V1V2-directed bNAbs isolated from multiple donors contain long (28 – 
35 residues) anionic CDRH3 loops (Figure 4.1A) that include sulfated/sulfonated tyrosines 
(Bonsignori et al., 2011; Doria-Rose et al., 2014; McLellan et al., 2011; Pan et al., 2015; Pancera et 
al., 2013; Walker et al., 2011; Walker et al., 2009). Structural studies of V1V2 bNAbs showed that 
the protruding CDRH3 is used to penetrate through the glycan shield on Env surrounding the 
Asn160gp120 and Asn156gp120 N-glycans to contact basic residues in the V2 loop (Gorman et al., 
2016; McLellan et al., 2011; Pan et al., 2015; Pancera et al., 2010; Pancera et al., 2013; Pejchal et 
al., 2010). The BG1 CDRH3 length, 22 residues, is shorter than CDRH3 loops in other V1V2 
bNAbs (Figure 4.1A), but longer than typical human antibody CDRH3s for which the most 
common length is 14 residues (Swindells et al., 2017). A 2.0 Å crystal structure of unbound BG1 
Fab (Figure 4.1B; Table 4.1) revealed that, in contrast to the protruding CDRH3s in other V1V2 
bNAbs, the BG1 CDRH3 does not extend notably beyond the antigen-binding site surface (Figure 
4.1C). The relatively compact CDRH3 of BG1 results from folding into an irregular structure 
whose conformation is stabilized by Tyr100CCDRH3 interactions with protein backbone atoms in 
CDRH1 and CDRH3 and by water-mediated H-bonds involving other residues (Figure 4.1D). 
None of the four tyrosines within the BG1 CDRH3 (Tyr100ACDRH3, Tyr100CCDRH3, Tyr100JCDRH3 
and Tyr100LCDRH3) or within other CDRs show electron density for a sulfate group 
(Supplementary Figure 4.1). By contrast, the CRH3s of other V1V2 bNAbs form stable 
subdomains involving regions of two-stranded b-sheet (Figure 4.1E), sometimes containing 
sulfated tyrosine sidechains (e.g., PG9’s Tyr100GCDRH3 and Tyr100HCDRH3) that interact with basic 
residues within V1V2 (Liu et al., 2017; McLellan et al., 2011; Pancera et al., 2013). 
 
The CDRH2 loop of BG1 is two residues longer than CDRH2s of other V1V2 bNAbs (Figure 
4.1A), and it extends further from the antigen-binding site than the CDRH2 loops of other V1V2 
bNAbs. (Figure 4.1E). The combined effects of the relatively compact CDRH3 and protruding 
CDRH2 result in the BG1 antigen-binding site being more flat than the combining sites of other 
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V1V1 bNAbs (Figure 4.1E). The BG1 CDRH2 includes a solvent-exposed tryptophan at 
position 52B (Figure 4.1D) (lysine in the VH3-49*04 germline sequence from which BG1 is 
derived). Protein-protein interfaces often include surface-exposed hydrophobic residues 
(Dall'Acqua et al., 1996; Kelley and O'Connell, 1993; Wells and DeVos, 1996), suggesting that the 
long CDRH2, and this residue in particular, could be involved in the binding interface of BG1 with 
Env.  
 
To characterize the BG1 interaction with Env, we determined the stoichiometry of binding of the 
BG1 Fab and Env trimer using size exclusion chromatography with multi-angle light scattering 
(SEC-MALS) and negative-stain EM single-particle analysis. SEC-MALS can be used to 
determine the stoichiometry of a complex by deriving the absolute molecular mass of the complex 
independent of shape and model (Wyatt, 1993). In the SEC-MALS experiment, we incubated a 
fully glycosylated soluble native-like Env trimer (BG505 SOSIP.664 (Sanders et al., 2013); 
hereafter called Env) with a 3-fold molar excess of a Fab from a V1V2 bNAb or with a Fab from 
the G52K5 variant of 8ANC195, a gp120-gp41–spanning bNAb (Scharf et al., 2014) (calculated 
assuming a molecular mass of 210 kDa for Env trimer). The molecular mass of the PG16 Fab–Env 
complex was consistent with a stoichiometry of 1 Fab per Env trimer (Figure 4.2A), as previously 
shown by SEC-MALS and negative-stain EM for PG9 (Julien et al., 2013b), and the 8ANC195–
Env complex stoichiometry was 3 Fabs per trimer (Figure 4.2A), consistent with crystal and EM 
structures of 8ANC195–BG505 Env complexes (Scharf et al., 2015; Wang et al., 2016a). By 
contrast, the SEC-MALS profile for the BG1 Fab–Env complex indicated a stoichiometry of 2 
Fabs per trimer (Figure 4.2A). 
 
To confirm the conclusions from the SEC-MALS experiments, we examined the structures of 
BG1-Env-8ANC195, PG9-Env-8ANC195, and PG16-Env-8ANC195 complexes by negative-stain 
EM. Single-particle 3D reconstructions of these complexes at resolutions between 27 Å and 32 Å 
resolution (Figure 4.2B; Supplementary Figure 4.2) revealed three 8ANC195 Fabs bound to 
BG505 Env trimer in the expected positions at the gp120-gp41 interface (Scharf et al., 2014; 
Scharf et al., 2015; Wang et al., 2016a) of each complex. The BG1-Env-8ANC195 complex 
showed density for two BG1 Fabs per Env trimer, while the PG9-Env-8ANC195 and PG16-Env-
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8ANC195 complexes each showed density for one Fab per trimer (Figure 4.2B). The positions 
of the single PG9 and PG16 Fabs at the apex of Env trimer were similar to each other and to a 
previous negative-stain PG9-Env structure (Julien et al., 2013b), whereas the BG1 Fabs bound Env 
in an orientation distinct from the orientations of PGT145 (Lee et al., 2017; Liu et al., 2017), PG9, 
and PG16 (Figure 4.2C). 
 
The close proximity of two BG1 Fabs at the apex of Env trimer (Figure 4.2B) raised the possibility 
that BG1 IgG binds bivalently to Env trimer, which would result in increased avidity due to intra-
spike crosslinking (Galimidi et al., 2015; Klein and Bjorkman, 2010). To evaluate this possibility, 
we compared the neutralization potencies of IgG and Fab forms of BG1 across multiple viral 
strains using in vitro neutralization assays (Montefiori, 2005) and calculated the molar 
neutralization ratio (MNR) for BG1 (defined as [IC50 Fab (nM)/IC50 IgG (nM)]; (Klein and 
Bjorkman, 2010)). This ratio would be 2.0 in the absence of avidity effects from intra-spike 
crosslinking or inter-spike crosslinking (which we argued is rare due to the low numbers and 
densities of spikes on HIV-1 virions (Galimidi et al., 2015; Klein and Bjorkman, 2010)), and no 
steric effects that would increase neutralization potencies for the larger IgGs versus the smaller 
Fabs (Klein and Bjorkman, 2010). Viruses with densely-packed spikes can exhibit MNRs over 
1000 (Klein and Bjorkman, 2010), whereas mean MNRs for anti-HIV-1 bNAbs tend to be low 
(Galimidi et al., 2015; Klein and Bjorkman, 2010; West et al., 2012). 
 
We found that the geometric mean MNR for BG1 was 8.4, sdgeom (geometric standard deviation) = 
2.4 (Supplementary Table 4.1). To put this result into context, we derived MNRs using published 
data (Galimidi et al., 2015; West et al., 2012) for bNAbs that should not be capable of bivalent 
binding to a single Env trimer: PG9 and PG16 (because only one Fab binds per trimer), and the 
CD4bs bNAbs VRC01 and 3BNC60, whose adjacent epitopes on neighboring gp120s are located 
in positions that would not permit simultaneous binding by both Fabs of an IgG. The mean MNRs 
for these bNAbs were comparable to the mean MNR for BG1 (PG9: 6.0, sdgeom = 4.1; PG16: 10.3, 
sdgeom = 3.4; VRC01: 4.8, sdgeom = 3.1; 3BNC60: 8.1, sdgeom = 3.2) (Supplementary Table 4.2, 4.3). 
By contrast, the mean MNR for a 3BNC60-based reagent that exhibited neutralization potency 
increases suggestive of intra-spike crosslinking (a bivalent form of 3BNC60 in which two 3BNC60 
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Fabs were joined by a double-stranded DNA linker (Galimidi et al., 2015)) was 141, sdgeom = 2.1 
(Supplementary Table 4.3). These results suggest that, like other natural HIV-1 bNAbs, BG1 IgG 
does not bind bivalently to Env trimers during neutralization.  
 
In order to explore the details of how two BG1 Fabs bind asymmetrically to the three V1V2 loops 
in an Env trimer, we used single-particle cryo-EM to solve the structure of a BG1-Env complex. A 
single-particle reconstruction of a BG1-Env-8ANC195 complex with two BG1 Fabs per Env 
trimer was obtained at a resolution of ~6.2 Å (calculated using the 0.143 gold-standard Fourier 
shell coefficient cutoff criterion) (Scheres and Chen, 2012) (Figure 4.3; Supplementary Figure 4.3, 
4.4; Table 4.2). To interpret the structure, the coordinates of BG1 Fab (this study) and 8ANC195 
Fab (PDB code 4P9M) were fit by rigid body docking into the cryo-EM densities, after which the 
coordinates for three gp41 monomers (PDB 5FUU) (Lee et al., 2016) and three gp120 monomers 
(PDB 5T3X) (Gristick et al., 2016) were fit independently (Figure 4.3A). Coordinates for ordered 
N-linked glycans from a natively-glycosylated BG505 Env trimer structure (PDB 5T3X) (Gristick 
et al., 2016) were fit separately as rigid bodies at potential N-linked glycosylation sites (PNGSs) at 
which EM density was apparent (Figure 4.3B). After initial rigid body docking, refinement of the 
protein portions of the complex was carried out with geometric restraints for protein and N-glycan 
residues (Adams et al., 2010; Agirre et al., 2015). Unlike the PG9 Fab, in which the CDRH3 loop 
is ordered only when bound to the V1V2 scaffold (McLellan et al., 2011), the CDRH3 of BG1 was 
ordered in both the unbound (Figure 4.1E) and bound (Figure 4.3C) states. Within the limits of the 
resolution of the cryo-EM structure, the CDRH3 and CDRH2 loops of BG1_A and BG1_B 
adopted the same conformation as their counterparts in the unbound BG1 crystal structure (Figure 
4.3C,D). In particular, the relatively compact CDRH3 loop observed in the unbound BG1 crystal 
structure (Figure 4.1E) was maintained in the 2:1 BG1-Env structure (Figure 4.3C). A 27 Å BG1-
Env-8ANC195 complex with three BG1 Fabs per Env trimer (3:1 BG1-Env) was also 
reconstructed from a minor subset of the total particles (<10%) (Supplementary Figure 4.3), and 
coordinates were fit to the density by rigid body refinement (Supplementary Figure 4.4). 
  
We also solved an 11.5 Å single-particle cryo-EM reconstruction of a PG9-Env-8ANC195 
complex (Figure 4.4; Supplementary Figure 4.5). As described for the BG1-Env-8ANC195 cryo-
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EM structure, coordinates of PG9 Fab (PDB 3U36) were fit, after which gp120 and gp41 
subunits were fit independently. Since the CDRH3 of unliganded PG9 Fab (PDB 3U36) is 
disordered, we modeled the unliganded PG9 coordinates and the ordered CDRH3 from the PG9 
Fab in the PG9-V1V2 scaffold structure (PDB 3U4E) (McLellan et al., 2011) separately into the 
EM density. The position of the single PG9 Fab on Env trimer in the cryo-EM structure was 
consistent with negative-stain structures reported here and previously (Julien et al., 2013b). The 
angle of approach of the PG9 Fab was different in the PG9-Env interaction predicted from 
modeling the PG9 Fab-monomeric V1V2 scaffold structure (McLellan et al., 2011) onto Env 
trimer versus in the PG9-Env EM structure (Figure 4.4B), likely due to accommodating glycans in 
a neighboring gp120 protomer in the trimeric Env that are not present in a monomeric V1V2 
scaffold.  
 
The 6.2 Å BG1-Env-8ANC195 structure with two BG1 Fabs (2:1 BG1-Env) showed interactions 
with two of the three gp120 protomers within Env trimer. To distinguish the structurally-distinct 
gp120 and BG1 subunits within the 2:1 BG1-Env structure, we defined the two gp120 subunits of 
Env that interact with BG1 Fabs as gp120_A and gp120_B, the corresponding BG1 Fabs as 
BG1_A and BG1_B, and the third gp120 subunit, which showed no contacts with BG1 Fabs, as 
gp120_C (Figure 4.3A; Figure 4.5A).  
 
To compare the BG1-Env and PG9-Env interactions, we calculated approximate footprints of the 
each antibody on Env trimer (epitopes) and of Env on each antibody (paratopes). For the BG1-Env 
interaction, we used coordinates fit to the 6.2 Å BG1-Env structure, and for the PG9-Env 
interaction, we used coordinates fit to the 11.5 Å PG9-Env structure. To account for low resolution 
and/or modeling errors, we assigned contacts using a criterion of a distance of ≤7 Å between 
antibody-antigen Ca atoms for protein-protein contacts and ≤7 Å between protein Ca and glycan 
C1 atoms for antibody-antigen-glycan contacts. As shown in Figure 5A, the contact analysis 
predicted that both Fabs reached through the glycan shield between the Asn156gp120 and 
Asn160gp120 glycans to contact underlying V1V2 protein residues, but only PG9 made contacts 
with basic residues in a lysine-rich region of the V2 loop (Lys168gp120 and Lys169gp120). This 
prediction was validated by an analysis of in vitro neutralization data demonstrating that 
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substitution of Lys169gp120 reduces neutralization potency for PG9, but has only minor effects on 
BG1 (Supplementary Figure 4.6). Conversely, substitution of Thr132gp120 had more of an effect on 
BG1 neutralization than on PG9 neutralization  (Supplementary Figure 4.6B).  
 
Predicted protein-protein contacts were mediated by different CDR loops for BG1 versus PG9: 
CDRH2 for BG1 and CDRH3 for PG9. Contacts with Env glycans were also made differently for 
BG1 and PG9: The Asn156gp120 glycan on both gp120_A and gp120_B was contacted by the BG1 
CDRL1, and the Asn160gp120 glycan was contacted on both gp120s by the CDRH2 and CDRH3 
loops of BG1 and also by the CDRL3 in the case of BG1_B. By contrast, PG9 contacted only the 
Asn160gp120 glycan on gp120_B, and these contacts were mediated exclusively by CDRH3. 
Examination of the paratopes on BG1 versus PG9 illustrated that BG1 uses several CDRs for 
interacting with Env, whereas PG9 uses only its protruding CDRH3 (Figure 4.5B; Figure 4.6A,B). 
In particular, Trp52B within CDRH2 of the BG1 heavy chain is in the vicinity of the protein 
portion of the V1V2 epitope (Figure 4.3D).  
 
Comparison of the BG1 and PG9 epitopes on Env trimer rationalize differences in their relative 
neutralization potencies across HIV-1 strains. To find Env sequence features that contribute to 
BG1 potency variations, we analyzed in vitro neutralization results using previously-described 
methods (West et al., 2013). The analysis revealed that the presence of a potential N-linked 
glycosylation site (PNGS) at position 130 of gp120 correlated with weaker BG1 neutralization 
(geometric mean IC50 = 25.7 µg/mL for strains including PNGS 130, versus 1.5 µg/mL for strains 
lacking PNGS 130) (Figure 4.5A; Supplementary Figure 4.6). PG9 was also more potent on strains 
lacking PNGS 130 (geometric mean IC50 = 0.76 µg/mL for strains including PNGS 130, versus 
0.24 µg/mL for strains lacking PNGS 130); however, the difference was larger for BG1 (17-fold 
for BG1 versus 3-fold for PG9). This result is rationalized by the BG1 and PG9 epitopes on Env 
trimer: although residue 130 (Gln130gp120) is not part of a PNGS in the BG505 strain of Env in our 
structural studies, residue 130 lies directly within the protein region contacted by BG1, but is 
outside of the PG9 footprint (Figure 4.5A), suggesting that addition of an N-glycan at position 130 
would more directly disrupt BG1 binding than PG9 binding.  
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To identify important common features of the BG1_A–gp120_A and BG1_B–gp120_B 
interactions, we aligned the two BG1-gp120 complexes by superimposing either the protein 
coordinates of the two V1V2 regions (Figure 4.7A) or by superimposing the Asn156gp120 and 
Asn160gp120 glycans of gp120_A and gp120_B (Figure 4.7B). When aligning the protein 
coordinates of the two V1V2 regions, the BG1 VH-VL domains superimposed with a root mean 
square deviation (rmsd) of 7.7 Å for 435 Ca atoms. The rmsd for the same number of Ca atoms 
decreased to 2.9 Å when we superimposed the Asn156gp120 and Asn160gp120 glycans of the two 
V1V2 regions. This comparison suggests that glycan contacts play a larger role than protein 
contacts in determining how BG1 recognizes the V1V2 epitope on Env.  
 
To address why the 6.2 Å BG1-Env-8ANC195 structure shows two BG1 Fabs arranged 
asymmetrically on Env trimer, rather than three symmetrically-arranged BG1 Fabs, we used 
modeling to construct an Env complex containing a third BG1 Fab. The VH-VL domains for a third 
BG1 Fab (BG1 model) were positioned onto the gp120_C subunit assuming that a third BG1 Fab 
would interact with the Asn156gp120 and Asn160gp120 glycans in the common interaction observed 
for BG1_A and BG1_B (Figure 4.7B). Predicted van der Waals clashes (red dots) demonstrated 
that a third BG1 Fab cannot be accommodated on the Env trimer structure without steric clashing 
(Figure 4.7C). However, as indicated by the minor population of Env trimers with three BG1 Fabs 
in the 3:1 BG1-Env structure (Supplementary Figure 4.4), binding of three Fabs is possible (Figure 
4.7D). When three Fabs were bound, the Env trimer appeared more open than Env in the 2:1 BG1-
Env structure, as shown by a comparison of the BG1 Fab positions in the 2:1 and 3:1 BG1-Env 
structures (Figure 4.7E).  
 
 
  
85 
 
Discussion 
The V1V2 epitope on HIV Env is targeted by bNAbs that make quaternary interactions that 
prevent opening of Env trimer to expose the V3 loop and coreceptor binding site, hence blocking 
conformational changes leading to fusion of the viral and host cell membranes (Bonsignori et al., 
2011; Doria-Rose et al., 2014; McLellan et al., 2011; Pan et al., 2015; Pancera et al., 2013; Walker 
et al., 2011; Walker et al., 2009). Quaternary interactions visualized thus far for V1V2 bNAbs 
involve the binding of a single Fab to the apex of Env trimer (Julien et al., 2013b; Liu et al., 2017), 
but here we demonstrate that the stoichiometry of binding for the new V1V2 bNAb BG1 (Freund 
et al., 2017) is two Fabs per Env trimer, with a minor population of 3:1 BG1-Env complexes 
(Figures 4.2, 4.3; Supplementary Figure 4.3).  
 
We previously noted that epitopes for HIV-1 bNAbs are located in positions not predicted to allow 
simultaneous binding of both Fabs from an IgG to a single Env trimer (Galimidi et al., 2015; Klein 
and Bjorkman, 2010). By definition, the two Fabs in IgG forms of V1V2 bNAbs that exhibit a 1 
Fab per Env trimer stoichiometry cannot bind with avidity to an Env trimer, and epitopes on HIV-1 
Env that show a 3:1 Fab-Env stoichiometry are located in positions that are too far apart to allow 
simultaneous binding of both Fabs in an IgG to one Env (Galimidi et al., 2015; Klein and 
Bjorkman, 2010). However, the V1V2 bNAb BG1 binds with a 2:1 Fab-Env stoichiometry to an 
epitope in close proximity on neighboring gp120 subunits at the apex of Env, suggesting that it 
might be possible for both Fabs of a single BG1 IgG to bind simultaneously to a single Env trimer. 
However, comparisons of neutralization potencies of BG1 Fab and IgG suggested that, as found 
for other HIV-1 bNAbs, potential avidity effects for BG1 IgG were marginal (Supplementary 
Table 4.1), consistent with no intra-spike crosslinking and only minimal inter-spike crosslinking or 
steric effects favoring an IgG over a Fab. The apparent absence of intra-spike crosslinking for BG1 
IgG can be rationalized by the angle of approach the Fabs adopted in the 2:1 BG1-Env structure: 
adjacent Fabs were oriented such that they point away from each so that the C-termini of the CH1 
domains (to which the N-terminus of an IgG Fc would be attached) are too far apart (~85 Å) to be 
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spanned by a natural IgG hinge region (e.g., the C-termini of the two Fabs in the crystal structure 
of intact IgG b12  (Saphire et al., 2001) (PDB 1HZH) are separated by ~18 Å). Thus it appears that 
HIV-1 Env has evolved to prevent bivalent binding by IgGs to Env trimer even when Fabs from 
two separate IgGs can bind to nearby epitopes.  
 
Previously-characterized V1V2 bNAbs made primary interactions with Env that involved a long, 
negatively-charged CDRH3 that reached through the Env glycan shield to contact basic residues in 
the V2 loop (Bonsignori et al., 2011; Doria-Rose et al., 2014; Julien et al., 2013b; Liu et al., 2017; 
McLellan et al., 2011; Pan et al., 2015; Pancera et al., 2013; Walker et al., 2011; Walker et al., 
2009). Although BG1 is directed against the same general region of Env, its epitope shows glycan 
interactions dominating over protein interactions, and the relatively long BG1 CDRH3 (Figure 
4.1A) is folded into a compact structure (Figure 4.1D,E) that is used to make contacts with Env 
glycans rather than Env protein residues (Figure 4.5A). The role of reaching through the glycan 
shield to contact protein residues is taken by BG1’s unusually long CDRH2 (Figure 4.1E), 
resulting in a different epitope footprint on Env than seen for typical V1V2 bNAbs such as PG9 
(Figure 4.5A).  
 
Examination of the interactions of the two BG1 Fabs in the 2:1 BG1-Env complex solved by single 
particle cryo-EM suggests differences in the BG1_A and BG1_B interfaces with Env. The BG1_B 
Fab interacts not only with glycans on its primary subunit contact gp120_B; the complex structure 
also suggests a potential secondary interaction with the Asn160gp120 glycan on a neighboring 
subunit, gp120_A, using CDRL1 (Figure 4.6A, right panel). By contrast to the BG1_B interactions 
with Env trimer, the 2:1 BG1-Env structure does not predict secondary contacts for BG1_A, a 
difference that may explain why BG1_A and BG1_B showed distinct angles of approach when we 
aligned the BG1_A–gp120_A and BG1_B–gp120_B complexes by superimposing the protein 
coordinates of the V1V2 regions (Figure 4.7A). Differences in the interactions of BG1_A and 
BG1_B with Env trimer suggests a model for BG1 Fab binding to Env (Figure 4.7F): If BG1_B 
binds first to the V1V2 epitope on gp120_B, its CDRL1 could then interact with the Asn160gp120 
glycan from gp120_A. After that, a second BG1 Fab, BG1_A, could recognize the Asn156gp120 and 
Asn160gp120 glycans from gp120_A. Because of the interaction between the BG1_B CDRL1 and 
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the Asn160gp120 glycan from gp120_A, the angle of approach of BG1_B is shifted further 
towards the Env trimer 3-fold axis as compared with the angle of approach of with BG1_A (Figure 
4.7C; fourth panel). In this model, the intrinsic flexibility of N-linked glycans would allow BG1_A 
to capture an Env conformation in which the glycans are shifted away from the trimer 3-fold axis 
such that a potential clash with BG1_B is avoided. In this binding mode, a third BG1 Fab cannot 
bind because it would clash with BG1_B. However, if the Fabs can capture a more open state of 
Env trimer in the absence of CD4 binding, three Fabs can be accommodated (Figure 4.7D,E). The 
low percentage of 3:1 BG1-Env complexes observed by cryo-EM (Supplementary Figure 4.3), 
despite incubation with a 9-fold molar excess of BG1 Fab (Methods), suggests that formation of 
3:1 BG1-Env complexes is rare.  
 
Our direct comparisons of BG1-Env and PG9-Env stoichiometry and cryo-EM structures illustrate 
the diversity of bNAb recognition of the V1V2 epitope at the apex of HIV-1 Env trimer. These 
results provide new information relevant to design of immunogens to raise antibodies against 
V1V2 (Escolano et al., 2017), an important target because the V1V2 loops are critical for 
maintaining the closed Env trimer structure in which the coreceptor binding site is shielded and 
conformational changes leading to fusion of the viral and host cell membranes are prevented. The 
more typical form of V1V2 recognition, in which a protruding CDRH3 from, e.g., PG9, is used to 
reach through the Asn156gp120 and Asn160gp120 glycans to contact protein residues on the V2 loop, 
results in a more potent bNAb (Figure 4.5A; Supplementary Figure 4.6). By contrast, the BG1 
mode of V1V2 recognition, which is less potent, relies more on glycan contacts using relatively 
compact CDRs, and BG1’s contacts with V1V2 protein residues are more easily disrupted by 
glycosylation at PNGS 130 (Figure 4.5A; Supplementary Figure 4.6). Thus immunogens designed 
to raise bNAbs against the V1V2 epitope would likely require removal of the Asn130gp120 glycan 
in order to target both BG1- and PG9-style V1V2 bNAbs.  
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Methods 
Protein Expression and Purification 
Fabs (BG1, PG9, PG16, and the G52K5 variant of 8ANC195 (Scharf et al., 2014)) and BG1 IgG 
were expressed and purified as described (Scharf et al., 2016). Briefly, IgGs and 6xHis-tagged 
Fabs were expressed by transient transfection of HC and LC expression plasmids into HEK293-6E 
cells. Fabs and BG1 IgG were purified from cell supernatants using Ni-NTA (GE Healthcare) (for 
Fabs) or protein A (GE Healthcare) (for IgG) affinity chromatography followed by SEC on a 
Superdex 200 16/60 column (GE Healthcare). Proteins were stored in 20 mM Tris, pH 8.0, and 150 
mM sodium chloride (TBS buffer) supplemented with 0.02% (wt/vol) sodium azide. 
 
Structural studies of Fab-Env complexes were done using BG505 SOSIP.664, a soluble clade A 
gp140 trimer that includes ‘SOS’ substitutions (A501Cgp120, T605Cgp41), the ‘IP’ substitution 
(I559Pgp41), the N-linked glycan sequence at residue 332gp120 (T332Ngp120), an enhanced gp120-
gp41 cleavage site (REKR to RRRRRR), and a stop codon after residue 664gp41 (Env numbering 
according to HX nomenclature) (Sanders et al., 2013). Protein was expressed in HEK293-6E cells 
(National Research Council of Canada) in the absence of kifunensine by transient transfection of 
plasmids encoding BG505 SOSIP and soluble furin at a ratio of 4:1 as previously described 
(Gristick et al., 2016). We isolated BG505 SOSIP protein from cell supernatants using a 2G12 
immunoaffinity column made by covalently coupling 2G12 IgG monomer to an NHS-activated 
Sepharose column (GE Healthcare). Protein was eluted with 3M MgCl2 followed by immediate 
buffer exchange into Tris-buffered saline pH 8.0 (TBS), and trimers were purified using Superdex 
200 16/60 SEC (GE Healthcare), and then stored in TBS. 
 
V1V2 Fab-Env-8ANC195 complexes were prepared for negative-stain and cryo-EM by incubating 
purified Env with a 9-fold molar excess of V1V2 Fab (either BG1, PG9, or PG16) overnight at 4 
˚C and then continuing the incubation with a 9-fold molar excess of 8ANC195 Fab. The ternary 
complex was isolated by SEC using a Superose 6 10/300 column (GE Healthcare).  
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X-ray Structure Determination 
Crystals of BG1 Fab were obtained by combining 0.2 mL of a 10 mg/mL protein solution with 0.2 
mL of 1.8 M ammonium sulfate, 0.1 M Bis-Tris pH 6.5, 2% v/v PEG 550 MME and 100 nM 
NDSB-256 at 20°C and cryoprotected in mother liquor supplemented with 20% (v/v) ethylene 
glycol. X-ray diffraction data were collected using a Pilatus 6M pixel detector (Dectris) at the 
Stanford Synchrotron Radiation Lightsource beamline 12-2. XDS was used to index, integrate and 
scale the data (Kabsch, 2010), and the structure was refined to 1.9 Å by iteratively refining with 
Phenix (Adams et al., 2010) and manual model building in Coot (Emsley and Cowtan, 2004). The 
BG1 Fab structure was solved by molecular replacement using 2909 Fab (PDB code 3PIQ) VHVL 
with CDR loops removed and CH1CL as search models. The final model (Rwork = 18.9%, Rfree = 
21.2%) omits the following disordered residues: Ser146HC-Gly154HC, Gly210HC-Thr211HC, 
Lys234HC-Thr239HC, and Cys214LC, and has 96.7%, 3.3% and 0% of residues in the favored, 
allowed and disallowed regions, respectively, of the Ramachandran plot (Table 4.1). Hydrogen 
bonds were assigned using the following criteria: a distance of < 3.5 Å, and an A-D-H angle of > 
90˚. Structures were superimposed and figures generated with PyMOL (Schrödinger, 2011) and 
UCSF Chimera (Pettersen et al., 2004). Rmsd calculations were done in PyMOL following 
pairwise Cα alignments without outlier rejection. 
 
SEC-MALS 
Purified Env, Fab, and Env-Fab complexes were characterized by SEC-MALS to determine 
absolute molecular masses (Wyatt, 1993). 80 µL of 1 mg/mL BG505 SOSIP.664 was mixed with a 
3-fold molar excess of Fab (PG16, BG1, or 8ANC195G52K5) relative to Env trimer, and the reaction 
volume brought up to 100 µL with sample buffer containing 20 mM Tris (pH 8.0) and 150 mM 
NaCl. For controls, reactions containing individual components of BG505 SOSIP.664 or Fab were 
prepared in the same manner. The proteins or protein complexes were then equilibrated overnight 
at room temperature and injected onto a Superdex 200 10/300 GL gel-filtration chromatography 
column equilibrated with our sample buffer. The chromatography column was connected with an 
18-angle light-scattering detector (DAWN HELEOS II; Wyatt Technology), a dynamic light-
scattering detector (DynaPro Nanostar; Wyatt Technology), and a refractive index detector 
  
90 
(Optilab t-rEX; Wyatt Technology). Data were collected at 25°C at a flow rate of 0.5 mL/min 
every 1 second. The molecular mass of each protein or protein complex was obtained by data 
analysis using the program ASTRA 6. 
 
Neutralization Assays.   
Pseudovirus neutralization assays were conducted as described (Montefiori, 2005) by the 
Collaboration for AIDS Vaccine Discovery (CAVD) core neutralization facility for calculation of 
MNRs (defined in (Klein and Bjorkman, 2010)) for BG1 (Supplementary Table 4.1). MNRs for 
other HIV-1 bNAbs came from data published in previous papers (Galimidi et al., 2015; West et 
al., 2012). Average IC50 values and MNRs are geometric means calculated using the formula 
(∏ai)(1/n); i = 1, 2, …, n. Geometric means are preferred statistics for data sets covering multiple 
orders of magnitude (Sheskin, 2004), as is found for neutralization data across multiple viral 
strains. For calculating mean IC50 values, strains with reported IC50s of >n µg/mL were included as 
n µg/mL. Geometric standard deviations were calculated as the exponential of the standard 
deviation of the logarithms of the individual MNRs. 
 
Negative-stain EM Data Collection and Processing 
Purified V1V2 Fab-8ANC195-Env complexes (where the V1V2 Fab was either BG1, PG9, or 
PG16) were diluted to 10 µg/mL in TBS immediately before adding 3 µL to a glow discharged 
ultrathin C film on holey carbon support film, 400 mesh, Cu grids (Ted Pella, Inc.). Samples were 
stained with 3% uranyl acetate. Data were collected using FEI Tecnai T12 transmission electron 
microscope at 120 keV on a Gatan Ultrascan 2k x 2k CCD detector. Images were acquired using a 
1 sec exposure time at a nominal magnification of 42,000x at 1 µm defocus, resulting in 2.5 Å per 
pixel. Particles were picked using manual picking in EMAN2.1 (Tang et al., 2007), and the CTF 
correction was done using EMAN2.1 (Huang et al., 2007). Initial reference-free 2D class averaging 
was performed using RELION (Scheres, 2012). After 2D classification, particles corresponding to 
good class averages were selected (Supplementary Figrue 4.2), and the particles were further 
sorted using 3D classification in RELION. A reference model was generated by docking a PG9-
V1V2 scaffold structure (PDB 3U4E) onto an Env trimer structure in complex with 8ANC195 
(PDB 5CJX) and low pass filtering the model to 60 Å. Refinement for each of the complex 
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structures was conducted using the best reconstruction from the 3D classification as a reference. 
The resolutions of final reconstructions were calculated with RELION (Scheres, 2012) using a 
gold-standard FSC and a 0.143 cutoff as recommended for resolution estimations for single 
particle EM reconstructions (Scheres and Chen, 2012) (Supplementary Figrue 4.2D). 
 
Cryo-EM Data Collection and Processing 
Purified BG1-Env-8ANC195 complex was diluted to 60 µg/mL in TBS and vitrified in liquid 
ethane using a Mark IV Vitrobot. Sample grids were prepared by adding 3 µL of complex to 
glow discharged 200 Mesh Quantifoil R1.2/1.3 copper grids. Images were recorded using 
SerialEM (Mastronarde, 2005) on a Titan Krios electron microscope equipped with Gatan K2 
Summit direct detector and an energy filter with a slit width of 20 eV. Exposures (15 sec) were 
divided into 50 subframes with a dose rate of 2.92 electrons⋅pixel−1⋅subframe−1. After binning by 
2 and motion correction, each image was 4k × 4k and 1.35 Å per pixel.  
 
The dataset was motion corrected and dose weighted using Unblur and Summovie (Brilot et al., 
2012; Campbell et al., 2012; Grant and Grigorieff, 2015). Motion-corrected micrographs without 
dose weighting were used for contrast transfer function (CTF) estimations. Motion-corrected 
micrographs with dose weighting were used for particle picking, and motion-corrected 
micrographs with dose weighting and restored noise power after filtering were used for all 
classification and refinement processes. 
 
Particles were picked using the SWARM method of EMAN2.1 (Tang et al., 2007) 
(Supplementary Figure 4.3A), and CTF estimations were done using CTFFIND4 (Rohou and 
Grigorieff, 2015) (Supplementary Figure 4.3B). A total of 2837 movies were collected. After 
motion correction and dose weighting, CTF curves were confidently fit beyond 6 Å in 1371 
micrographs; the others were discarded. A total of ~100,000 particles were picked. Particles were 
classified in 2D with RELION (Scheres, 2012), resulting in 1000 2D classes. Of these, 28 classes 
from 76k particles were selected as “good” classes (Supplementary Figure 4.3C). For 3D 
classification, the negative-stain BG1-Env-8ANC195 structure (Figure 4.2B) was used as a 
reference for initial 3D classification; eight 3D classes were then produced. After selecting three 
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3D classes as “good” classes, 66k particles remained for 3D refinement (Supplementary Figure 
4.3C). Post-processing, particle polishing, and gold-standard FSC estimations were done after 
3D refinement using RELION (Scheres, 2012) following procedures in the tutorial. Particle 
polishing did not improve the resolution of the reconstruction (data not shown), which was 
estimated to be 6.18 Å (Supplementary Figure 4.4A). Angular distribution plots showing were 
generated using RELION (Scheres, 2012) and visualized in UCSF Chimera (Goddard et al., 
2007) (Supplementary Figure 4.4B; Supplementary Figure 4.5C). Local resolution estimations 
were done using ResMap (Kucukelbir et al., 2014) (Supplementary Figure 4.4C; Supplementary 
Figure 4.5D). 
 
Using particles in the 6.18 Å reconstruction, we did another round of 3D classification in which 
the CH-CL domains of the two BG1 Fabs and the three 8ANC195 Fabs were masked out 
(Supplementary Figure 4.3C) to account for the ability of Fab CH-CL domains to adopt multiple 
conformations with respect to VH-VL domains due to different elbow bend angles (Stanfield et 
al., 2006). After selecting two 3D classes as “good” classes, 37k particles remained for 3D 
refinement (CH-CL domains were also masked out during 3D refinement), which generated a 
structure that was also estimated to be 6.18 Å resolution using the gold standard FSC 
(Supplementary Figure 4.4A). Unless otherwise noted, the reconstruction derived without 
masking out CH-CL domains was used for structural analyses.  
 
Although we used the 2:1 BG1-Env-8ANC195 reconstruction from negative-stain EM as the 
reference for 3D classification, one subclass (generated from 6.8% of all particles after 2D 
classification) contained density corresponding to three BG1 Fabs after the first round of 3D 
classification (Supplementary Figure 4.3C; Supplementary Figure 4.4E). Particles within that 
subclass were further refined (using a 60 Å low-pass-filtered reconstruction of that subclass during 
3D classification) and post-processed following the standard procedure described in the RELION 
tutorial, resulting in a 27 Å structure of three BG1 Fabs bound to the Env-8ANC195 complex.  
Purified PG9-Env-8ANC195 complexes were used to prepared sample grids as described for BG1-
Env-8ANC195 complexes. Images were recorded on a Titan Krios electron microscope equipped 
with a Falcon II direct detector using FEI’s automated data collection software EPU. 2-sec 
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exposures were divided into 7 subframes, and the dose rate was 13.125 
electrons⋅pixel−1⋅subframe−1. After binning by 2 and motion correction, each image was 4k × 4k 
and 1.75 Å per pixel. A total of 1767 movies were collected. The dataset was processed as 
described for the BG1-Env-8ANC195 complex. After motion correction and dose weighting, CTF 
curves were confidently fit to beyond 8 Å in 1223 micrographs; the others were discarded. A total 
of ~19k particles were picked. Particles were classified in 2D with RELION (Scheres, 2012), 
resulting in 200 2D classes. Of these, 15 classes from 12k particles were selected as “good” classes 
(Supplementary Figure 4.5A). For 3D classification, the negative-stain structure of PG9-Env-
8ANC195 (Figure 4.2B) was used as a reference for initial 3D classification; two 3D classes were 
then produced. After selecting one 3D class as a “good” class, 9.5k particles remained for 3D 
refinement (Supplementary Figure 4.5A). The angular distribution of all refinement particles were 
generated using RELION (Scheres, 2012) and visualized in UCSF Chimera (Goddard et al., 2007) 
(Supplementary Figure 4.5C). Local resolution estimations were done by using ResMap 
(Kucukelbir et al., 2014) (Supplementary Figure 4.5D). After 3D refinement, postprocessing and 
gold-standard FSC estimations were done by using RELION (Scheres, 2012) following procedures 
in the tutorial (Supplementary Figure 4.5B). 
 
Model Building 
Coordinates from crystal structures of individual components of the V1V2 Fab-Env-8ANC195 
were fit by rigid body docking into cryo-EM density maps. The coordinates of 8ANC195 Fab 
[Protein Data Bank (PDB 4P9M) and BG1 Fab (this study) were first docked into the 
corresponding densities, after which three gp41 monomer coordinates from a JR-FL trimer 
structure (PDB 5FUU) (Lee et al., 2016) were fit. We used the JR-FL gp41 coordinates because 
they included coordinates for the fusion peptide and HR1N regions (Lee et al., 2016). Residues that 
differed between the JR-FL and BG505 gp41 were altered, and residues outside of EM density 
were deleted. Three gp120 monomers from a natively-glycosylated BG505 Env structure (PDB 
5T3X) (Gristick et al., 2016) were fit individually into protomer densities. Coordinates for ordered 
N-linked glycans from the natively-glycosylated Env structure (PDB 5T3X) (Gristick et al., 2016) 
were fit separately as rigid bodies at potential N-linked glycosylation sites (PNGSs) at which EM 
density was apparent (Figure 4.3B). Glycan rings outside of EM density were removed. After 
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initial rigid body docking, refinement of the complex was carried out using 
phenix.real_space_refine with secondary structure restraints for protein and geometric restraints for 
protein and N-glycan residues (Adams et al., 2010; Agirre et al., 2015). 
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Figures 
Figure 4.1
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Figure 4.1. Comparison of BG1 and other V1V2 bNAbs.  
(A) Sequences of the HCs of BG1 and representative other V1V2 bNAbs. Residue numbering 
(Kabat) refers to BG1, and the CDRs were defined using AbM (Swindells et al., 2017). (B) Crystal 
structure of BG1 Fab with highlighted CDRs. (C) Space-filling representations of antigen-binding 
site of BG1 in two orientations with CDRs highlighted. (D) Hydrogen bonds (dotted yellow lines) 
contributing to compact structure of CDRH3. Water molecules shown as red spheres. (E) Top: 
Space-filling representations of VH-VL domains of selected V1V2 bNAbs (BG1: this study; PG9: 
PDB 3U4E; PG16: PDB 3MUG; PGT145: PDB 3U1S; CH03: PDB 5ESV; VRC26.03: PDB 
4OD1). Residues within CDRs are highlighted. CDRH3 (middle) and CDRH2 (bottom) loops 
shown in ribbon (left) and space-filling (right) representations. Electrostatic potentials are shown 
on the space filling representations using blue and red for positive and negative electrostatic 
potentials, respectively.   
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Figure 4.2 
 
 
Figure 4.2. Fab-Env binding stoichiometries for V1V2 bNAbs.  
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(A) SEC-MALS profiles for BG505 SOSIP.664 Env trimer and complexes of Env trimer with 
BG1, PG16, and 8ANC195 Fabs. The absorbance at 280 nm (left y-axis) is plotted against elution 
volume from a Superdex 200 10/300 GL gel filtration column and overlaid with the molar mass 
determined for each peak (right y-axis). Predicted and calculated molecular masses are shown in 
the table. (B) Negative-stain single particle EM reconstructions BG1-Env-8ANC195, PG9-Env-
8ANC195, and PG16-Env-8ANC195 complexes. EM density was fit with coordinates for the 
indicated Fabs and for BG505 Env trimer. (C) Density and coordinates from the BG1-Env portion 
of the BG1-Env-8ANC195 reconstruction (density for 8ANC195 Fabs removed) with coordinates 
for the indicated Fabs superimposed. The Env trimer portion from EM structures of complexes of 
PGT145-Env (PDB 5U1F), PG9-Env (panel B), or PG16-Env (panel B) were superimposed with 
the Env trimer portion of the BG1-Env-8ANC195 structure (panel B).  
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Figure 4.3 
 
Figure 4.3. ~6.2 Å cryo-EM reconstruction of a BG1-Env-8ANC195 complex.  
(A) EM density fit by coordinates for BG1_A (HC in brown; LC in yellow), BG1_B (HC in dark 
gray; LC in light gray), gp120s associated with BG1_A and BG1_B Fabs in purple and cyan, 
respectively; gp120_C in green, gp41 in orange, and 8ANC195 Fabs in dark blue (HC) and light 
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blue (LC). (B) Close-up views of densities contoured at 6.0σ (0.0378 e/Å3) for glycans attached 
to Asn156gp120 and Asn160gp120 in the three gp120 protomers of Env trimer. Glycan residues built 
into the cryo-EM map densities are shown as sticks with oxygen atoms in red and nitrogen atoms 
in blue. (C, D) Close-up views of densities contoured at 6.0σ (0.0378 e/Å3) surrounding CDRH3 
(panel C) and CDRH2 (panel D) in BG1-gp120_A and BG1_B-gp120_B interactions. Asn156gp120 
and Asn160gp120 glycans are shown as sticks. CDRH2 residue Trp54 (Figure 1D) is identified with 
an arrow. 
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Figure 4.4 
 
Figure 4.4. ~11.5 Å cryo-EM reconstruction of a PG9-Env-8ANC195 complex.  
(A) EM density fit by coordinates for PG9 (HC in dark gray; LC in light gray), gp120 subunits in 
dark blue, cyan, and green, gp41 in orange, and 8ANC195 Fabs in dark blue (HC) and light blue 
(LC). (B) Density and coordinates from the PG9-Env portion of the PG9-Env-8ANC195 
reconstruction (density for 8ANC195 Fabs removed) with coordinates for the PG9 Fab from the 
PG9-V1V2 scaffold structure (PDB 3U4E) superimposed. When the V1V2 scaffold from the PG9-
V1V2 complex structure was superimposed with the V1V2 portion of the PG9-Env-8ANC195 
structure (panel A), the angle of approach of the PG9 Fab differs from the angle observed in the 
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PG9-Env structure. (C) Hypothetical model of three PG9 Fabs bound per Env trimer. One PG9 
Fab (PG9_A) is shown its experimentally-determined position from the PG9-Env-8ANC195 
structure interacting mainly with gp120_A on Env trimer (view looking down the trimer three-fold 
axis). The VH-VL domains for second and third PG9 Fabs (PG9 model) were positioned onto the 
gp120_B and gp120_C subunits assuming the interaction observed for PG9_A with gp120_A. 
Predicted van der Waals clashes (red dots) were calculated using the show_bumps module in 
Pymol (Schrödinger, 2011).  
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Figure 4.5 
Figure 4.5. Comparison of BG1 and PG9 epitopes and paratopes.  
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(A) Epitopes on Env trimer (top view surface representations) were defined as protein or glycan 
residues whose Ca (for protein) or C1 (for glycans) atom was within 7 Å of the bound Fab. 
Contacts on Env are color-coded to indicate which CDR loop made the contact (CDRH3 in red, 
CDRH2 in green, and CDRH1 in dark blue). Glycans are shown as sticks with a nearby label to 
identify the glycan as attached to either Asn156gp120 or Asn160gp120, and locations of residues of 
interest (Lys168gp120, Lys169gp120, and Gln130gp120) are indicated by black dots. Center box 
compares geometric mean IC50 values for BG1 and PG9 IgGs evaluated against HIV-1 strains 
either containing or not containing a PNGS at position 130 (number of HIV-1 strains indicated in 
the parentheses). IC50 values >50 µg/mL set to 50 µg/mL for geometric mean calculations. (B) 
Paratopes on BG1_A, BG1_B, and PG9 Fabs indicated by spheres on ribbon representations of 
VH-VL domains shown in two orientations related by a 90˚ rotation. CDRs are color coded as in 
panel A.  
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Figure 4.6
 
Figure 4.6. BG1 and PG9 interactions with V1V2.  
(A) BG1 interactions with N-linked glycans attached to Asn156gp120 and Asn160gp120 shown for 
BG1_A (left) and BG1_B (right). (B) PG9 interactions with N-linked glycans attached to 
Asn156gp120 and Asn160gp120 from PG9-Env cryo-EM structure reported here (left) and from the 
crystal structure of PG9-V1V2 scaffold (PDB 3U4E) (right). The position of the CDRH3 loop in 
the PG9-Env cryo-EM structure is shown by a dashed line representing the position of CDRH3 in 
the PG9-V1V2 scaffold structure.  
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Figure 4.7 
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Figure 4.7. Asymmetry of BG1 interactions with Env trimer.  
(A,B) Superposition of the two BG1 binding sites in the 2:1 BG1-Env structure by aligning either 
the V1V2 regions of gp120_A and gp120_B (panel A) or the Asn156gp120 and Asn160gp120 glycans 
within gp120_A and gp120_B (panel B). (C) Hypothetical model of three BG1 Fabs bound per 
Env trimer based on Fab orientations in the 2:1 BG1-Env structure. The BG1_A and BG_1 B Fabs 
are shown in their respective positions on the gp120_A and gp120_B subunits of Env trimer (view 
looking down the trimer three-fold axis). A third BG1 Fab (BG1 model) was positioned onto the 
gp120_C subunit assuming that it would interact with the Asn156gp120 and Asn160gp120 glycans in 
the common interaction observed for BG1_A and BG1_B (panel B). Predicted van der Waals 
clashes (red dots) were calculated using the show_bumps module in Pymol (Schrödinger, 2011). 
(D) Positions of three BG1 Fabs in the 27 Å 3:1 BG1-Env structure (no predicted van der Waals 
clashes). (E) Comparison of BG1 Fab positions in the 2:1 BG1-Env structure (gray; the third Fab is 
from the model shown in panel C) and the 3:1 BG1-Env structure (green) after superimposing the 
BG1_A Fabs. (F) Model for binding of two BG1 Fabs to form the 2:1 BG1-Env structure. Panels 1 
and 2: BG1_B binds first to the V1V2 epitope on gp120_B such that its CDRL1 interacts with the 
Asn160gp120 glycan from gp120_A. Panels 3 and 4: BG1_A recognizes the Asn156gp120 and 
Asn160gp120 glycans from gp120_A. The flexible glycans are shifted away from the trimer 3-fold 
axis (indicated by arrows in the close-up view of the third panel) such that a potential clash with 
BG1_B is avoided. 
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Tables 
Table 4.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
#Number of xtals used for each structure during data processing. 
*Values in parentheses are for highest-resolution shell. 
 
 
 BG1 Fab 
Data collection  
Beamline 
Wavelength 
Temperature (°K) 
Space group 
SSRL 12-2 
0.9795 Å 
100 
P3221 
Cell dimensions    
    a, b, c (Å) 95.6, 95.6, 103.9 
    a, b, g  (°)  90, 90, 120 
Resolution (Å) 82.82-2.00 (2.05-2.00)* 
Rmerge 
Rpim 
.11 (.98) 
.07 (.72) 
I / sI 
CC (1/2) 
7.9 (1.6) 
.99 (.63) 
Completeness (%) 100 (100) 
Redundancy 5.5 (5.5) 
  
Refinement  
Resolution (Å) 38.5-2.0 (2.05-2.00) 
No. reflections 
Rfree Reflections 
43,296 
4,169 
Rwork / Rfree 0.189/0.212 
No. atoms  
    Protein 3,257 
    Ligand/ion 313 
    Water  
B-factors  
    Protein 39.83 
    Ligand/ion 43.17 
    Average 40.12 
R.m.s. deviations  
    Bond lengths (Å) 0.011 
    Bond angles (°) 1.15 
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Table 4.1 BG1 Fab crystal structure data collection and refinement statistics. 
Table 4.2 
Data collection/processing 
  
Microscope Titan Krios 
Voltage 300kV 
Camera Gatan K2 Summit 
Camera mode counting 
Defocus range 1.5-3.5 
Exposure time 15 sec 
Dosage rate 
2.92 
electrons⋅pixel−1⋅subframe−1 
Magnified pixel size 1.35 
Total Dose (e/A2) 80 
Reconstruction 
  
Software Relion-1.4 
Symmetry C1 
Particles refined    
Resolution(automask, Å) 6.18 
Resolution(masked out Fab CHCL domains, 
Å) 6.18 
Map sharpening B-factor ( Å2) -24.7274 
Model Statistics  
  
Map CC (whole unit cell):   0.931 
Map CC (around atoms):      0.731 
All-atom clashscore         17.66 
Ramachandran plot:   
outliers:  0.44% 
allowed:    7.44% 
favored:   92.12% 
rmsd (bonds):               0.01 
rmsd (angles):              1.11 
Rotamer outliers:           0.85% 
C-beta deviations:           0 
 
Table 4.2 BG1-Env-8ANC195 complex cryo-EM structure data collection and model statistics. 
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Supplementary Figures 
Supplementary Figure 4.1 
 
Supplementary Figure 4.1. Electron densities for tyrosines within BG1 Fab CDRs. (A) Tyrosine 
residues located within the antigen binding site are shown in stick representation together with 
their electron densities (contoured at 1.0σ) from a 2Fo-Fc simulated annealing composite omit map.  
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Supplementary Figure 4.2
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Supplementary Figure 4.2. Negative-stain EM structures of V1V2 bNAb-Env-8ANC195 
complexes.  
(A-C) 2D class averages and the final structures after refinement for BG1-Env-8ANC195 (panel 
A), PG16-Env-8ANC195 (panel B), and PG9-Env-8ANC195 (panel C). (D) Gold-standard FSC 
for each structure.  
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Supplementary Figure 4.3 
 
Supplementary Figure 4.3. Cryo-EM data processing for the BG1-Env-8ANC195 complex 
structure.  
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(A) Representative micrograph. Examples of complex particles are boxed. The accumulated 
dose and defocus values were ~80 e-/Å2 and ~1.8 µm underfocus. (B) CTF fitting of the left 
micrograph (generated using CTFFIND4) shows a good fit to 4.9 Å. (C) Data processing scheme. 
2D classification of autopicked particles resulted in 76K particles that were 3D classified using a 
low-pass-filtered negative-stain 2:1 BG1-Env EM structure as a reference model. The particles 
from the best three 3D classes were refined to 6.18 Å resolution. One 3D class showed three BG1 
bound to each Env trimer (see Figure 3–figure supplement 2). The particles in 6.18 Å 
reconstruction were further 3D classified with the Fab CHCL domains masked out. Then the best 
two 3D classes were refined to 6.18 Å resolution. (E) Gold-standard FSCs of reconstructions 
generated using different strategies (see Figure 3–figure supplement 2). (F) Local resolution 
estimation. The complex is shown from top (left), side (middle), and bottom (right) views. 
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Supplementary Figure 4.4 
 
Supplementary Figure 4.4 Validation of the 2:1 and 3:1 BG1-Env structures.  
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(A) Gold-standard FSCs of 2:1 BG1-Env reconstructions generated using different strategies. 
(B) Orientation distribution of the 6.2 Å 2:1 BG1-Env reconstruction without masking out Fab 
CHCL domains. (C) Local resolution estimation for the 2:1 BG1-Env structure. The complex is 
shown from top (left), side (middle), and bottom (right) views. (D) Cryo-EM map contoured to 
show densities for a-helices (red); other secondary structures shown in grey. (E) 27 Å cryo-EM 
structure of a 3:1 BG1-Env complex. Cryo-EM map with fitted components are shown from side 
(left) and top (middle) views. Right: Gold-standard FSC indicating 27 Å resolution for the 
reconstruction.  
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Supplementary Figure 4.5 
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Supplementary Figure 4.5. Cryo-EM data processing for PG9-Env-8ANC195 complex 
structure.  
(A) Data processing scheme. 2D classification of autopicked particles resulted in 12K particles that 
were 3D classified using a low-pass-filtered negative-stain PG9-Env-8ANC195 EM structure as a 
reference model. The particles from the best class were refined to 11.5 Å resolution. (B) 
Orientation distribution of the reconstruction. (C) Local resolution estimation. The complex is 
shown from top (left), side (middle), and bottom (right) views. (D) Gold-standard FSC indicating 
11.5 Å resolution for the reconstruction.  
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Supplementary Figure 4.6 
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Supplementary Figure 4.6. Coverage curves for results of in vitro neutralization across panels 
of viruses that do or do not include a lysine at position 169gp120 (panel A) or a threonine at position 
132gp120 (panel B). The number of strains used to calculate each curve is shown in parentheses in 
the key inside each graph. 
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Supplementary Tables 
Supplementary Table 4.1 
  
BG1 
Virus  Clade IgG Fab MNR 
C1080.c03 CRF01_AE 0.02 0.3 16.0 
WITO4160.33 B 0.03 0.2 9.0 
191955_A11 A (T/F) 0.01 0.2 12.0 
Q23.17 A 0.01 0.2 33.0 
AC10.0.29 B 0.1 1.2 12.9 
Ce1176_A3 C (T/F) 0.1 15.5 110.6 
BG505/T332N A 0.2 2.4 12.0 
X1193_c1 G 1.7 8.5 4.9 
CAP45.2.00.G3 C 0.6 3.8 6.1 
6535.3 B 1.4 4.7 3.3 
REJO4541.67 B 4.1 18.9 4.6 
CNE5 CRF01_AE 2.7 15.9 6.0 
62357_14_D3_4589 B (T/F) 12.0 55.8 4.7 
CNE52 BC 8.2 53.6 6.5 
3365.v2.c2 A 6.6 113.1 17.0 
ZM249M.PL1 C 9.7 44.7 4.6 
235-47 CRF02_AG 7.3 59.4 8.1 
1394C9G1(Rev-) C (T/F) 18.4 103.8 5.6 
Ce704809221_1B3 C (T/F) 38.9 264.6 6.8 
CNE20 BC 19.8 31.2 1.6 
HIV-16055-2.3 C 39.7 351.5 8.9 
  
  
  Geometric mean 
 
1.2 10.2 8.4 
Geometric std. dev.   
 
2.4 
 
Supplementary Table 4.1. Neutralization potencies of Fab and IgG forms of BG1.  Molar 
neutralization ratios (MNR) for BG1 was defined as IC50 Fab (nM)/IC50 IgG (nM).  
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Supplementary Table 4.2 
  
VRC01 PG9 PG16 
Virus Clade IgG Fab MNR IgG Fab MNR IgG Fab MNR 
6535.3 B 6.9 40 5.8 4.1 170 41.5 285 1800 6.3 
QH0692.42 B 7.5 14.0 1.9   
 
  
   SC422661.8 B 0.62 2.3 3.7 20 220 11.0 120 850 7.1 
PVO.4 B 4.4 10 2.3 80 500 6.3 89.5 260 2.9 
TRO.11 B 2.4 12 5.0 240 1900 7.9 19.4 390 20.1 
AC10.0.29 B 5.8 16 2.8 0.53 5.4 10.2 0.22 1.2 5.5 
REJO4541.67 B 0.21 1.0 4.8 0.1 7.5 57.7 0.11 26 236.4 
TRJO4551.58 B 0.62 1.6 2.6 3.9 200 51.3 25.5 240 9.4 
WITO4160.33 B 0.41 2.3 5.6 0.33 0.42 1.3 0.095 0.51 5.4 
CAAN5342.A2 B 5.8 16 2.8 80 240 3.0 140 590 4.2 
THRO4156.18 B 36 70 1.9 270 1500 5.6 85.5 2000 23.4 
RHPA4259.7 B 0.27 1.0 3.7 180 1500 8.3 3.4 53 15.6 
Du156.12 C 0.62 1.2 1.9 0.33 2.8 8.5 0.16 0.67 4.2 
Du172.17 C   
 
  3.3 9.30 2.8 0.41 2.6 6.3 
Du422.1 C   
 
  2.9 7.1 2.4 0.95 28 29.5 
ZM197M.PB7 C 4.3 6.9 1.6 6.7 13 1.9 8.1 73 9.0 
ZM214M.PL15 C 1.7 8.4 4.9   
 
  
   ZM233M.PB6 C 5.3 220 41.5 0.23 0.20 0.9 0.034 0.081 2.4 
ZM249M.PL1 C 0.62 1.4 2.3 1.4 0.99 0.7 0.81 4.3 5.3 
ZM53M.PB12 C 4.6 15 3.3 0.4 3.9 9.8 0.25 1.1 4.4 
ZM109F.PB4 C 1.5 7.2 4.8 1.0 260 260.0 
   ZM135M.PL10a C 4.9 41 8.4   
 
  
   CAP45.2.00.G3 C   
 
  0.020 0.12 6.0 0.027 0.061 2.3 
CAP210.2.00.E8 C   
 
  3.1 6.2 2.0 0.47 14 29.8 
Q23.17 A 0.41 4.3 10.5   
 
  0.014 0.20 14.3 
Q842.d12 A 0.34 0.62 1.8 0.20 1.3 6.5 0.18 0.63 3.5 
Q259.d2.17 A 0.69 110 159.4 1.5 0.99 0.7 0.068 19 279.4 
3718.v3.c11 A 2.5 130 52.0 0.47 2.9 6.2 0.068 2.1 30.9 
0330.v4.c3 A 0.41 1.2 2.9 0.13 0.97 7.5 0.14 0.69 4.9 
3415.v1.c1 A 0.34 1 2.9 0.53 1.8 3.4 0.14 2.3 16.4 
  
  
 
    
 
  
   Geometric mean 
 
1.6 7.4 4.8 2.2 13.3 6.0 1.0 10.5 10.3 
Geometric std. 
dev. 
 
  
 
3.1   
 
4.1 
  
3.4 
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Supplementary Table 4.2. Neutralization potencies of Fab and IgG forms of VRC01, PG9, 
and PG16.  Molar neutralization ratios (MNR) was defined as IC50 Fab (nM)/IC50 IgG (nM).  
 
 
Supplementary Table 4.3 
Virus Clade 
3BNC60-
62bp-
3BNC60 
3BNC60 
Fab MNR 
3BNC60 
IgG 
3BNC60 
Fab MNR 
6535.3 B 0.24 27 112.5 4.0 27 6.8 
SC422661.8 B 0.02 1.0 50.0 0.3 1.0 3.3 
PVO.4 B 0.01 1.3 130.0 0.1 1.3 13.0 
TRO.11 B 0.01 1.3 130.0 0.2 1.3 6.5 
TRJO4551.58 B 0.03 4.8 160.0    CAAN5342.A2 B 0.16 6.2 38.8 3.6 6.2 1.7 
THRO4156.18 B 0.43 23 53.5 3.5 23 6.6 
RHPA4259.7 B 0.007 1.5 214.3 0.3 1.5 5.0 
Du156.12 C 0.03 9.4 313.3 0.3 9.4 31.3 
Du172.17 C 1 210 210.0 16 210 13.1 
ZM197M.PB7 C 0.11 15 136.4 3.8 15 3.9 
ZM214M.PL15 C 0.07 6.9 98.6 1.7 6.9 4.1 
ZM233M.PB6 C 0.08 14 175.0 1.4 14 10.0 
ZM249M.PL1 C 0.01 2.7 270.0 0.3 2.7 9.0 
ZM53M.PB12 C 0.11 5.2 47.3 1.3 5.2 4.0 
ZM109F.PB4 C 0.05 39 780.0 0.3 39 130.0 
ZM135M.PL10a C 0.03 3.7 123.3 0.4 3.7 9.3 
Q842.d12 A 0.001 0.21 210.0 0.09 0.21 2.3 
Q259.d2.17 A 0.007 3.7 528.6 0.03 3.7 123.3 
0330.v4.c3 A 0.007 0.62 88.6 0.2 0.62 3.1 
3415.v1.c1 A 0.04 4.6 115.0 0.9 4.6 5.1 
  
  
 
  
   Geometric mean 
 
0.04 5.06 141.44 0.63 5.07 8.08 
Geometric std. dev.   
 
2.1 
  
3.2 
Supplementary Table 4.3. Neutralization potencies of Fab and IgG forms of 3BNC60 and 
3BNC60 based diFab.  
 
 
  
124 
Bibliography 
 
Abela, I.A., Berlinger, L., Schanz, M., Reynell, L., Gunthard, H.F., Rusert, P., and Trkola, A. 
(2012). Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed 
antibodies. PLoS Pathog 8, e1002634. 
Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, 
L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010). PHENIX: a comprehensive Python-
based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-
221. 
Afonine, P.V., Poon, B.K., Read, R.J., Sobolev, O.V., Terwilliger, T.C., Urzhumtsev, A., and 
Adams, P.D. (2018). Real-space refinement in Phenix for cryo-EM and crystallography. bioRxiv, 
249607. 
Agirre, J., Iglesias-Fernandez, J., Rovira, C., Davies, G.J., Wilson, K.S., and Cowtan, K.D. (2015). 
Privateer: software for the conformational validation of carbohydrate structures. Nat Struct Mol 
Biol 22, 833-834. 
Barouch, D.H., Whitney, J.B., Moldt, B., Klein, F., Oliveira, T.Y., Liu, J., Stephenson, K.E., 
Chang, H.W., Shekhar, K., Gupta, S., et al. (2013). Therapeutic efficacy of potent neutralizing 
HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224-228. 
Barre-Sinoussi, F., Ross, A.L., and Delfraissy, J.F. (2013). Past, present and future: 30 years of 
HIV research. Nat Rev Microbiol 11, 877-883. 
Blattner, C., Lee, J.H., Sliepen, K., Derking, R., Falkowska, E., de la Pena, A.T., Cupo, A., Julien, 
J.P., van Gils, M., Lee, P.S., et al. (2014). Structural delineation of a quaternary, cleavage-
dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity 40, 669-
680. 
Bonsignori, M., Hwang, K.K., Chen, X., Tsao, C.Y., Morris, L., Gray, E., Marshall, D.J., Crump, 
J.A., Kapiga, S.H., Sam, N.E., et al. (2011). Analysis of a clonal lineage of HIV-1 envelope V2/V3 
conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated 
common ancestors. J Virol 85, 9998-10009. 
Brilot, A.F., Chen, J.Z., Cheng, A., Pan, J., Harrison, S.C., Potter, C.S., Carragher, B., Henderson, 
R., and Grigorieff, N. (2012). Beam-induced motion of vitrified specimen on holey carbon film. J 
Struct Biol 177, 630-637. 
Burton, D.R., Ahmed, R., Barouch, D.H., Butera, S.T., Crotty, S., Godzik, A., Kaufmann, D.E., 
McElrath, M.J., Nussenzweig, M.C., and Pulendran, B. (2012). A blueprint for HIV vaccine 
discovery. Cell host & microbe 12, 396-407. 
  
125 
Burton, D.R., and Mascola, J.R. (2015). Antibody responses to envelope glycoproteins in HIV-
1 infection. Nat Immunol 16, 571-576. 
Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W., Sawyer, L.S., 
Hendry, R.M., Dunlop, N., Nara, P.L., et al. (1994). Efficient neutralization of primary isolates of 
HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027. 
Campbell, M.G., Cheng, A., Brilot, A.F., Moeller, A., Lyumkis, D., Veesler, D., Pan, J., Harrison, 
S.C., Potter, C.S., Carragher, B., et al. (2012). Movies of ice-embedded particles enhance 
resolution in electron cryo-microscopy. Structure 20, 1823-1828. 
Carr, C.M., and Kim, P.S. (1993). A spring-loaded mechanism for the conformational change of 
influenza hemagglutinin. Cell 73, 823-832. 
Caskey, M., Klein, F., Lorenzi, J.C., Seaman, M.S., West, A.P., Jr., Buckley, N., Kremer, G., 
Nogueira, L., Braunschweig, M., Scheid, J.F., et al. (2015). Viraemia suppressed in HIV-1-
infected humans by broadly neutralizing antibody 3BNC117. Nature 522, 487-491. 
Caskey, M., Schoofs, T., Gruell, H., Settler, A., Karagounis, T., Kreider, E.F., Murrell, B., Pfeifer, 
N., Nogueira, L., Oliveira, T.Y., et al. (2017). Antibody 10-1074 suppresses viremia in HIV-1-
infected individuals. Nat Med 23, 185-191. 
Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S. (1997). Core structure of gp41 from the HIV 
envelope glycoprotein. Cell 89, 263-273. 
Chan, D.C., and Kim, P.S. (1998). HIV entry and its inhibition. Cell 93, 681-684. 
Chung, N.P., Matthews, K., Kim, H.J., Ketas, T.J., Golabek, M., de Los Reyes, K., Korzun, J., 
Yasmeen, A., Sanders, R.W., Klasse, P.J., et al. (2014). Stable 293 T and CHO cell lines 
expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies. 
Retrovirology 11, 33. 
Dall'Acqua, W., Goldman, E.R., Eisenstein, E., and Mariuzza, R.A. (1996). A mutational analysis 
of the binding of two different proteins to the same antibody. Biochem 35, 9667-9676. 
Diskin, R., Marcovecchio, P.M., and Bjorkman, P.J. (2010). Structure of a clade C HIV-1 gp120 
bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat Struct Mol Biol 17, 
608-613. 
Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P., Jr., Klein, F., Gao, H., Gnanapragasam, 
P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C., et al. (2011). Increasing the potency and 
breadth of an HIV antibody by using structure-based rational design. Science 334, 1289-1293. 
Doria-Rose, N.A., Schramm, C.A., Gorman, J., Moore, P.L., Bhiman, J.N., DeKosky, B.J., 
Ernandes, M.J., Georgiev, I.S., Kim, H.J., Pancera, M., et al. (2014). Developmental pathway for 
potent V1V2-directed HIV-neutralizing antibodies. Nature 509, 55-62. 
  
126 
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta 
Crystallogr D Biol Crystallogr 60, 2126-2132. 
Endres, M.J., Clapham, P.R., Marsh, M., Ahuja, M., Turner, J.D., McKnight, A., Thomas, J.F., 
Stoebenau-Haggarty, B., Choe, S., and Vance, P.J. (1996). CD4-independent infection by HIV-2 is 
mediated by fusin/CXCR4. Cell 87, 745-756. 
Escolano, A., Dosenovic, P., and Nussenzweig, M.C. (2017). Progress toward active or passive 
HIV-1 vaccination. J Exp Med 214, 3-16. 
Freed, E.O. (2015). HIV-1 assembly, release and maturation. Nature Reviews Microbiology 13, 
484. 
Freund, N.T., Wang, H., Scharf, L., Nogueira, L., Horwitz, J.A., Bar-On, Y., Golijanin, J., Sievers, 
S.A., Sok, D., Cai, H., et al. (2017). Coexistence of potent HIV-1 broadly neutralizing antibodies 
and antibody-sensitive viruses in a viremic controller. Science translational medicine 9. 
Galimidi, R.P., Klein, J.S., Politzer, M.S., Bai, S., Seaman, M.S., Nussenzweig, M.C., West, A.P., 
Jr., and Bjorkman, P.J. (2015). Intra-spike crosslinking overcomes antibody evasion by HIV-1. 
Cell 160, 433–446. 
Garces, F., Lee, J.H., de Val, N., Torrents de la Pena, A., Kong, L., Puchades, C., Hua, Y., 
Stanfield, R.L., Burton, D.R., Moore, J.P., et al. (2015). Affinity Maturation of a Potent Family of 
HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity 43, 
1053-1063. 
Goddard, T.D., Huang, C.C., and Ferrin, T.E. (2007). Visualizing density maps with UCSF 
Chimera. J Struct Biol 157, 281-287. 
Gorman, J., Soto, C., Yang, M.M., Davenport, T.M., Guttman, M., Bailer, R.T., Chambers, M., 
Chuang, G.Y., DeKosky, B.J., Doria-Rose, N.A., et al. (2016). Structures of HIV-1 Env V1V2 
with broadly neutralizing antibodies reveal commonalities that enable vaccine design. Nat Struct 
Mol Biol 23, 81-90. 
Grant, T., and Grigorieff, N. (2015). Measuring the optimal exposure for single particle cryo-EM 
using a 2.6 A reconstruction of rotavirus VP6. Elife 4, e06980. 
Gristick, H.B., von Boehmer, L., West, A.P., Jr., Schamber, M., Gazumyan, A., Golijanin, J., 
Seaman, M.S., Fatkenheuer, G., Klein, F., Nussenzweig, M.C., et al. (2016). Natively glycosylated 
HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. Nat 
Struct Mol Biol 23, 906-915. 
Gristick, H.B., Wang, H., and Bjorkman, P.J. (2017). X-ray and EM structures of a natively 
glycosylated HIV-1 envelope trimer. Acta Crystallogr D Struct Biol 73, 822-828. 
  
127 
Harris, A., Borgnia, M.J., Shi, D., Bartesaghi, A., He, H., Pejchal, R., Kang, Y.K., Depetris, R., 
Marozsan, A.J., Sanders, R.W., et al. (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and 
native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular 
architectures. Proc Natl Acad Sci U S A 108, 11440-11445. 
Harrison, S.C. (2015). Viral membrane fusion. Virology 479-480, 498-507. 
Haynes, B.F., Fleming, J., St Clair, E.W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., 
Scearce, R.M., Plonk, K., Staats, H.F., et al. (2005). Cardiolipin polyspecific autoreactivity in two 
broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908. 
Hoffman, T.L., LaBranche, C.C., Zhang, W., Canziani, G., Robinson, J., Chaiken, I., Hoxie, J.A., 
and Doms, R.W. (1999). Stable exposure of the coreceptor-binding site in a CD4-independent 
HIV-1 envelope protein. Proceedings of the National Academy of Sciences 96, 6359-6364. 
Horwitz, J.A., Halper-Stromberg, A., Mouquet, H., Gitlin, A.D., Tretiakova, A., Eisenreich, T.R., 
Malbec, M., Gravemann, S., Billerbeck, E., Dorner, M., et al. (2013). HIV-1 suppression and 
durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in 
humanized mice. Proc Natl Acad Sci U S A 110, 16538-16543. 
Huang, C.C., Lam, S.N., Acharya, P., Tang, M., Xiang, S.H., Hussan, S.S., Stanfield, R.L., 
Robinson, J., Sodroski, J., Wilson, I.A., et al. (2007). Structures of the CCR5 N terminus and of a 
tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317, 1930-1934. 
Huang, J., Kang, B.H., Pancera, M., Lee, J.H., Tong, T., Feng, Y., Imamichi, H., Georgiev, I.S., 
Chuang, G.Y., Druz, A., et al. (2014). Broad and potent HIV-1 neutralization by a human antibody 
that binds the gp41-gp120 interface. Nature 515, 138-142. 
Julien, J.P., Cupo, A., Sok, D., Stanfield, R.L., Lyumkis, D., Deller, M.C., Klasse, P.J., Burton, 
D.R., Sanders, R.W., Moore, J.P., et al. (2013a). Crystal structure of a soluble cleaved HIV-1 
envelope trimer. Science 342, 1477-1483. 
Julien, J.P., Lee, J.H., Cupo, A., Murin, C.D., Derking, R., Hoffenberg, S., Caulfield, M.J., King, 
C.R., Marozsan, A.J., Klasse, P.J., et al. (2013b). Asymmetric recognition of the HIV-1 trimer by 
broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A 110, 4351-4356. 
Kabsch, W. (2010). XDS. Acta Crystallogr D Biol Crystallogr 66, 125-132. 
Kanki, P.J., Travers, K.U., Marlink, R., Essex, M., MBoup, S., Gueye-NDiaye, A., Siby, T., Thior, 
I., Sankale, J., and Hsieh, C. (1994). Slower heterosexual spread of HIV-2 than HIV-1. The Lancet 
343, 943-946. 
Kelley, R.F., and O'Connell, M.P. (1993). Thermodynamic analysis of an antibody functional 
epitope. Biochem 32, 6828-6835. 
  
128 
Kimanius, D., Forsberg, B.O., Scheres, S.H., and Lindahl, E. (2016). Accelerated cryo-EM 
structure determination with parallelisation using GPUs in RELION-2. Elife 5. 
Klein, F., Diskin, R., Scheid, J.F., Gaebler, C., Mouquet, H., Georgiev, I.S., Pancera, M., Zhou, T., 
Incesu, R.B., Fu, B.Z., et al. (2013a). Somatic mutations of the immunoglobulin framework are 
generally required for broad and potent HIV-1 neutralization. Cell 153, 126-138. 
Klein, F., Gaebler, C., Mouquet, H., Sather, D.N., Lehmann, C., Scheid, J.F., Kraft, Z., Liu, Y., 
Pietzsch, J., and Hurley, A. (2012a). Broad neutralization by a combination of antibodies 
recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope 
protein. Journal of Experimental Medicine 209, 1469-1479. 
Klein, F., Halper-Stromberg, A., Horwitz, J.A., Gruell, H., Scheid, J.F., Bournazos, S., Mouquet, 
H., Spatz, L.A., Diskin, R., Abadir, A., et al. (2012b). HIV therapy by a combination of broadly 
neutralizing antibodies in humanized mice. Nature 492, 118-122. 
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J.F., Scharf, L., and Nussenzweig, M.C. (2013b). 
Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199-1204. 
Klein, J.S., and Bjorkman, P.J. (2010). Few and far between: how HIV may be evading antibody 
avidity. PLoS Pathog 6, e1000908. 
Kong, L., Torrents de la Pena, A., Deller, M.C., Garces, F., Sliepen, K., Hua, Y., Stanfield, R.L., 
Sanders, R.W., and Wilson, I.A. (2015). Complete epitopes for vaccine design derived from a 
crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an 
HIV-1 Env trimer. Acta Crystallogr D Biol Crystallogr 71, 2099-2108. 
Kong, R., Xu, K., Zhou, T., Acharya, P., Lemmin, T., Liu, K., Ozorowski, G., Soto, C., Taft, J.D., 
and Bailer, R.T. (2016). Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. 
Science 352, 828-833. 
Kremer, J.R., Mastronarde, D.N., and McIntosh, J.R. (1996). Computer visualization of three-
dimensional image data using IMOD. J Struct Biol 116, 71-76. 
Kucukelbir, A., Sigworth, F.J., and Tagare, H.D. (2014). Quantifying the local resolution of cryo-
EM density maps. Nat Methods 11, 63-65. 
Kwon, Y.D., Finzi, A., Wu, X., Dogo-Isonagie, C., Lee, L.K., Moore, L.R., Schmidt, S.D., 
Stuckey, J., Yang, Y., Zhou, T., et al. (2012). Unliganded HIV-1 gp120 core structures assume the 
CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl 
Acad Sci U S A 109, 5663-5668. 
Kwon, Y.D., Pancera, M., Acharya, P., Georgiev, I.S., Crooks, E.T., Gorman, J., Joyce, M.G., 
Guttman, M., Ma, X., Narpala, S., et al. (2015). Crystal structure, conformational fixation and 
entry-related interactions of mature ligand-free HIV-1 Env. Nat Struct Mol Biol 22, 522-531. 
  
129 
Kwong, P.D., Doyle, M.L., Casper, D.J., Cicala, C., Leavitt, S.A., Majeed, S., Steenbeke, T.D., 
Venturi, M., Chaiken, I., and Fung, M. (2002). HIV-1 evades antibody-mediated neutralization 
through conformational masking of receptor-binding sites. Nature 420, 678. 
Kwong, P.D., and Mascola, J.R. (2012). Human antibodies that neutralize HIV-1: identification, 
structures, and B cell ontogenies. Immunity 37, 412-425. 
Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A. (1998). 
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a 
neutralizing human antibody. Nature 393, 648-659. 
Landais, E., Huang, X., Havenar-Daughton, C., Murrell, B., Price, M.A., Wickramasinghe, L., 
Ramos, A., Bian, C.B., Simek, M., Allen, S., et al. (2016). Broadly Neutralizing Antibody 
Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort. PLoS Pathog 12, 
e1005369. 
Laskey, S.B., and Siliciano, R.F. (2014). A mechanistic theory to explain the efficacy of 
antiretroviral therapy. Nature Reviews Microbiology 12, 772. 
Lee, J.H., Andrabi, R., Su, C.Y., Yasmeen, A., Julien, J.P., Kong, L., Wu, N.C., McBride, R., Sok, 
D., Pauthner, M., et al. (2017). A Broadly Neutralizing Antibody Targets the Dynamic HIV 
Envelope Trimer Apex via a Long, Rigidified, and Anionic beta-Hairpin Structure. Immunity 46, 
690-702. 
Lee, J.H., Ozorowski, G., and Ward, A.B. (2016). Cryo-EM structure of a native, fully 
glycosylated, cleaved HIV-1 envelope trimer. Science 351, 1043-1048. 
Li, Z., Zhou, N., Sun, Y., Ray, N., Lataillade, M., Hanna, G.J., and Krystal, M. (2013). Activity of 
the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, 
against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitors. 
Antimicrobial agents and chemotherapy 57, 4172-4180. 
Liu, J., Bartesaghi, A., Borgnia, M.J., Sapiro, G., and Subramaniam, S. (2008). Molecular 
architecture of native HIV-1 gp120 trimers. Nature 455, 109-113. 
Liu, Q., Acharya, P., Dolan, M.A., Zhang, P., Guzzo, C., Lu, J., Kwon, A., Gururani, D., Miao, H., 
Bylund, T., et al. (2017). Quaternary contact in the initial interaction of CD4 with the HIV-1 
envelope trimer. Nat Struct Mol Biol 24, 370-378. 
Ludtke, S.J., Durmaz, T., Chen, M., and Bell, J.M. (2017). New Strategies for Improving CryoEM 
Single Particle Analysis in EMAN2.2. Microscopy and Microanalysis 23, 810-811. 
Lynch, R.M., Boritz, E., Coates, E.E., DeZure, A., Madden, P., Costner, P., Enama, M.E., 
Plummer, S., Holman, L., Hendel, C.S., et al. (2015). Virologic effects of broadly neutralizing 
antibody VRC01 administration during chronic HIV-1 infection. Science translational medicine 7, 
319ra206. 
  
130 
Lyumkis, D., Julien, J.P., de Val, N., Cupo, A., Potter, C.S., Klasse, P.J., Burton, D.R., Sanders, 
R.W., Moore, J.P., Carragher, B., et al. (2013). Cryo-EM structure of a fully glycosylated soluble 
cleaved HIV-1 envelope trimer. Science 342, 1484-1490. 
Ma, X., Lu, M., Gorman, J., Terry, D.S., Hong, X., Zhou, Z., Zhao, H., Altman, R.B., Arthos, J., 
Blanchard, S.C., et al. (2018). HIV-1 Env trimer opens through an asymmetric intermediate in 
which individual protomers adopt distinct conformations. Elife 7. 
Mastronarde, D.N. (2005). Automated electron microscope tomography using robust prediction of 
specimen movements. J Struct Biol 152, 36-51. 
McCoy, L.E., and Burton, D.R. (2017). Identification and specificity of broadly neutralizing 
antibodies against HIV. Immunol Rev 275, 11-20. 
McCoy, L.E., and Weiss, R.A. (2013). Neutralizing antibodies to HIV-1 induced by immunization. 
Journal of Experimental Medicine 210, 209-223. 
McLellan, J.S., Pancera, M., Carrico, C., Gorman, J., Julien, J.P., Khayat, R., Louder, R., Pejchal, 
R., Sastry, M., Dai, K., et al. (2011). Structure of HIV-1 gp120 V1/V2 domain with broadly 
neutralizing antibody PG9. Nature 480, 336-343. 
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M.C., and Schiff, C. 
(2001). Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B 
cell development. The Journal of clinical investigation 108, 879-886. 
Merk, A., and Subramaniam, S. (2013). HIV-1 envelope glycoprotein structure. Curr Opin Struct 
Biol 23, 268-276. 
Montefiori, D.C. (2005). Evaluating neutralizing antibodies against HIV, SIV, and SHIV in 
luciferase reporter gene assays. Current protocols in immunology / edited by John E Coligan  [et al 
Chapter 12, Unit 12 11. 
Moore, J.P., McKeating, J.A., Weiss, R.A., and Sattentau, Q.J. (1990). Dissociation of gp120 from 
HIV-1 virions induced by soluble CD4. Science 250, 1139-1142. 
Mouquet, H., Scheid, J.F., Zoller, M.J., Krogsgaard, M., Ott, R.G., Shukair, S., Artyomov, M.N., 
Pietzsch, J., Connors, M., Pereyra, F., et al. (2010). Polyreactivity increases the apparent affinity of 
anti-HIV antibodies by heteroligation. Nature 467, 591-595. 
Munro, J.B., Gorman, J., Ma, X., Zhou, Z., Arthos, J., Burton, D.R., Koff, W.C., Courter, J.R., 
Smith, A.B., 3rd, Kwong, P.D., et al. (2014). Conformational dynamics of single HIV-1 envelope 
trimers on the surface of native virions. Science 346, 759-763. 
Munro, J.B., and Lee, K.K. (2018). Probing Structural Variation and Dynamics in the HIV-1 Env 
Fusion Glycoprotein. Curr HIV Res 16, 5-12. 
  
131 
Munro, J.B., and Mothes, W. (2015). Structure and Dynamics of the Native HIV-1 Env Trimer. 
J Virol 89, 5752-5755. 
Murphy, K.M., and Reiner, S.L. (2002). Decision making in the immune system: the lineage 
decisions of helper T cells. Nature Reviews Immunology 2, 933. 
Naydenova, K., and Russo, C.J. (2017). Measuring the effects of particle orientation to improve the 
efficiency of electron cryomicroscopy. Nat Commun 8, 629. 
Nicastro, D., Schwartz, C., Pierson, J., Gaudette, R., Porter, M.E., and McIntosh, J.R. (2006). The 
molecular architecture of axonemes revealed by cryoelectron tomography. Science 313, 944-948. 
Ozorowski, G., Pallesen, J., de Val, N., Lyumkis, D., Cottrell, C.A., Torres, J.L., Copps, J., 
Stanfield, R.L., Cupo, A., Pugach, P., et al. (2017). Open and closed structures reveal allostery and 
pliability in the HIV-1 envelope spike. Nature 547, 360-363. 
Pan, R., Gorny, M.K., Zolla-Pazner, S., and Kong, X.P. (2015). The V1V2 Region of HIV-1 gp120 
Forms a Five-Stranded Beta Barrel. J Virol 89, 8003-8010. 
Pancera, M., Changela, A., and Kwong, P.D. (2017). How HIV-1 entry mechanism and broadly 
neutralizing antibodies guide structure-based vaccine design. Curr Opin HIV AIDS 12, 229-240. 
Pancera, M., McLellan, J.S., Wu, X., Zhu, J., Changela, A., Schmidt, S.D., Yang, Y., Zhou, T., 
Phogat, S., Mascola, J.R., et al. (2010). Crystal structure of PG16 and chimeric dissection with 
somatically related PG9: structure-function analysis of two quaternary-specific antibodies that 
effectively neutralize HIV-1. J Virol 84, 8098-8110. 
Pancera, M., Shahzad-Ul-Hussan, S., Doria-Rose, N.A., McLellan, J.S., Bailer, R.T., Dai, K., 
Loesgen, S., Louder, M.K., Staupe, R.P., Yang, Y., et al. (2013). Structural basis for diverse N-
glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nat Struct Mol Biol 20, 
804-813. 
Pancera, M., Zhou, T., Druz, A., Georgiev, I.S., Soto, C., Gorman, J., Huang, J., Acharya, P., 
Chuang, G.Y., Ofek, G., et al. (2014). Structure and immune recognition of trimeric pre-fusion 
HIV-1 Env. Nature 514, 455-461. 
Pejchal, R., Walker, L.M., Stanfield, R.L., Phogat, S.K., Koff, W.C., Poignard, P., Burton, D.R., 
and Wilson, I.A. (2010). Structure and function of broadly reactive antibody PG16 reveal an H3 
subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A 107, 11483-
11488. 
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and 
Ferrin, T.E. (2004). UCSF Chimera--a visualization system for exploratory research and analysis. J 
Comput Chem 25, 1605-1612. 
  
132 
Pugach, P., Ozorowski, G., Cupo, A., Ringe, R., Yasmeen, A., de Val, N., Derking, R., Kim, 
H.J., Korzun, J., Golabek, M., et al. (2015). A native-like SOSIP.664 trimer based on an HIV-1 
subtype B env gene. J Virol 89, 3380-3395. 
Roberts, J.D., Bebenek, K., and Kunkel, T.A. (1988). The accuracy of reverse transcriptase from 
HIV-1. Science 242, 1171-1173. 
Rohou, A., and Grigorieff, N. (2015). CTFFIND4: Fast and accurate defocus estimation from 
electron micrographs. J Struct Biol 192, 216-221. 
Sanders, R.W., Derking, R., Cupo, A., Julien, J.P., Yasmeen, A., de Val, N., Kim, H.J., Blattner, 
C., de la Pena, A.T., Korzun, J., et al. (2013). A next-generation cleaved, soluble HIV-1 Env 
Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not 
non-neutralizing antibodies. PLoS Pathog 9, e1003618. 
Saphire, E.O., Parren, P.W., Pantophlet, R., Zwick, M.B., Morris, G.M., Rudd, P.M., Dwek, R.A., 
Stanfield, R.L., Burton, D.R., and Wilson, I.A. (2001). Crystal structure of a neutralizing human 
IGG against HIV-1: a template for vaccine design. Science 293, 1155-1159. 
Scanlan, C.N., Offer, J., Zitzmann, N., and Dwek, R.A. (2007). Exploiting the defensive sugars of 
HIV-1 for drug and vaccine design. Nature 446, 1038. 
Scharf, L., Scheid, J.F., Lee, J.H., West, A.P., Jr., Chen, C., Gao, H., Gnanapragasam, P.N., Mares, 
R., Seaman, M.S., Ward, A.B., et al. (2014). Antibody 8ANC195 reveals a site of broad 
vulnerability on the HIV-1 envelope spike. Cell reports 7, 785-795. 
Scharf, L., Wang, H., Gao, H., Chen, S., McDowall, A.W., and Bjorkman, P.J. (2015). Broadly 
Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env. Cell 162, 
1379-1390. 
Scharf, L., West, A.P., Sievers, S.A., Chen, C., Jiang, S., Gao, H., Gray, M.D., McGuire, A.T., 
Scheid, J.F., Nussenzweig, M.C., et al. (2016). Structural basis for germline antibody recognition 
of HIV-1 immunogens. Elife 5. 
Scheid, J.F., Mouquet, H., Feldhahn, N., Seaman, M.S., Velinzon, K., Pietzsch, J., Ott, R.G., 
Anthony, R.M., Zebroski, H., Hurley, A., et al. (2009). Broad diversity of neutralizing antibodies 
isolated from memory B cells in HIV-infected individuals. Nature 458, 636-640. 
Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Olivera, T.Y., Pietzsch, J., Fenyo, 
D., Abadir, A., Velinzon, K., et al. (2011). Sequence and Structural Convergence of Broad and 
Potent HIV Antibodies That Mimic CD4 Binding. Science 333, 1633-1637. 
Scheres, S.H. (2012). RELION: implementation of a Bayesian approach to cryo-EM structure 
determination. J Struct Biol 180, 519-530. 
  
133 
Scheres, S.H., and Chen, S. (2012). Prevention of overfitting in cryo-EM structure 
determination. Nat Methods 9, 853-854. 
Schrödinger, L. (2011). The PyMOL Molecular Graphics System (The PyMOL Molecular 
Graphics System). 
Sheskin, D. (2004). Handbook of Parametric and Nonparametric Statistical Procedures, 3rd edn 
(Boca Raton: Chapman & Hall/CRC). 
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O.K., Plishka, R., Buckler-White, A., 
Seaman, M., Piatak, M., Jr., Lifson, J.D., et al. (2013). Antibody-mediated immunotherapy of 
macaques chronically infected with SHIV suppresses viraemia. Nature 503, 277-280. 
Song, Y., DiMaio, F., Wang, R.Y., Kim, D., Miles, C., Brunette, T., Thompson, J., and Baker, D. 
(2013). High-resolution comparative modeling with RosettaCM. Structure 21, 1735-1742. 
Stadtmueller, B.M., Bridges, M.D., Dam, K.-M., Lerch, M.T., Huey-Tubman, K.E., Hubbell, 
W.L., and Bjorkman, P.J. (2018). DEER Spectroscopy Measurements Reveal Multiple 
Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native 
Virions. Immunity. 
Stanfield, R.L., Zemla, A., Wilson, I.A., and Rupp, B. (2006). Antibody elbow angles are 
influenced by their light chain class. J Mol Biol 357, 1566-1574. 
Stewart-Jones, G.B.E., Soto, C., Lemmin, T., Chuang, G.-Y., Druz, A., Kong, R., Thomas, P.V., 
Wagh, K., Zhou, T., Behrens, A.-J., et al. (2016). Trimeric HIV-1-Env Structures Define Glycan 
Shields from Clades A, B, and G. Cell 165, 813-826. 
Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., 
Moore, J., and Sodroski, J. (1998). CD4-Induced conformational changes in the human 
immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and 
neutralization. J Virol 72, 4694-4703. 
Sundquist, W.I., and Kräusslich, H.-G. (2012). HIV-1 assembly, budding, and maturation. Cold 
Spring Harbor perspectives in medicine, a006924. 
Swindells, M.B., Porter, C.T., Couch, M., Hurst, J., Abhinandan, K.R., Nielsen, J.H., Macindoe, 
G., Hetherington, J., and Martin, A.C. (2017). abYsis: Integrated Antibody Sequence and 
Structure-Management, Analysis, and Prediction. J Mol Biol 429, 356-364. 
Tang, G., Peng, L., Baldwin, P.R., Mann, D.S., Jiang, W., Rees, I., and Ludtke, S.J. (2007). 
EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157, 38-46. 
Tange, O. (2011). Gnu parallel-the command-line power tool. The USENIX Magazine 36, 42-47. 
  
134 
Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M.C., and Wardemann, H. 
(2007). Autoreactivity in human IgG+ memory B cells. Immunity 26, 205-213. 
Tran, E.E., Borgnia, M.J., Kuybeda, O., Schauder, D.M., Bartesaghi, A., Frank, G.A., Sapiro, G., 
Milne, J.L., and Subramaniam, S. (2012). Structural mechanism of trimeric HIV-1 envelope 
glycoprotein activation. PLoS Pathog 8, e1002797. 
Trkola, A., Dragic, T., Arthos, J., Binley, J.M., Olson, W.C., Allaway, G.P., Cheng-Mayer, C., 
Robinson, J., Maddon, P.J., and Moore, J.P. (1996). CD4-dependent, antibody-sensitive 
interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184. 
Walker, L.M., Huber, M., Doores, K.J., Falkowska, E., Pejchal, R., Julien, J.P., Wang, S.K., 
Ramos, A., Chan-Hui, P.Y., Moyle, M., et al. (2011). Broad neutralization coverage of HIV by 
multiple highly potent antibodies. Nature 477, 466–470. 
Walker, L.M., Phogat, S.K., Chan-Hui, P.Y., Wagner, D., Phung, P., Goss, J.L., Wrin, T., Simek, 
M.D., Fling, S., Mitcham, J.L., et al. (2009). Broad and Potent Neutralizing Antibodies from an 
African Donor Reveal a New HIV-1 Vaccine Target. Science 326, 285-289. 
Walls, A.C., Tortorici, M.A., Bosch, B.-J., Frenz, B., Rottier, P.J., DiMaio, F., Rey, F.A., and 
Veesler, D. (2016). Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. 
Nature 531, 114. 
Walls, A.C., Tortorici, M.A., Snijder, J., Xiong, X., Bosch, B.-J., Rey, F.A., and Veesler, D. 
(2017). Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane 
fusion. Proceedings of the National Academy of Sciences, 201708727. 
Wang, H., Barnes, C.O., Yang, Z., Nussenzweig, M.C., and Bjorkman, P.J. (2018). Partially Open 
HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and 
Fusion. Cell Host Microbe 24, 579-592 e574. 
Wang, H., Cohen, A.A., Galimidi, R.P., Gristick, H.B., Jensen, G.J., and Bjorkman, P.J. (2016a). 
Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements 
of the gp120 V1V2 loop. Proc Natl Acad Sci U S A 113, E7151-E7158. 
Wang, H., Gristick, H.B., Scharf, L., West, A.P., Galimidi, R.P., Seaman, M.S., Freund, N.T., 
Nussenzweig, M.C., and Bjorkman, P.J. (2017). Asymmetric recognition of HIV-1 Envelope 
trimer by V1V2 loop-targeting antibodies. Elife 6. 
Wang, R.Y.-R., Song, Y., Barad, B.A., Cheng, Y., Fraser, J.S., and DiMaio, F. (2016b). 
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. 
Elife 5. 
Ward, A.B., and Wilson, I.A. (2017). The HIV-1 envelope glycoprotein structure: nailing down a 
moving target. Immunol Rev 275, 21-32. 
  
135 
Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig, M.C. 
(2003). Predominant autoantibody production by early human B cell precursors. Science 301, 
1374-1377. 
Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., and Wiley, D.C. (1997). Atomic 
structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430. 
Wells, J.A., and DeVos, A.M. (1996). Hematopoietic receptor complexes. Ann Rev Biochem 65, 
609-634. 
West, A.P., Jr., Galimidi, R.P., Foglesong, C.P., Gnanapragasam, P.N., Klein, J.S., and Bjorkman, 
P.J. (2010). Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive 
anti-human immunodeficiency virus reagents. J Virol 84, 261-269. 
West, A.P., Jr., Galimidi, R.P., Gnanapragasam, P.N., and Bjorkman, P.J. (2012). Single-Chain Fv-
Based Anti-HIV Proteins: Potential and Limitations. J Virol 86, 195-202. 
West, A.P., Jr., Scharf, L., Horwitz, J., Klein, F., Nussenzweig, M.C., and Bjorkman, P.J. (2013). 
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential 
functional epitope residues. Proc Natl Acad Sci U S A 110, 10598-10603. 
West, A.P., Jr., Scharf, L., Scheid, J.F., Klein, F., Bjorkman, P.J., and Nussenzweig, M.C. (2014). 
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy. Cell 156, 633-648. 
White, T.A., Bartesaghi, A., Borgnia, M.J., de la Cruz, M.J., Nandwani, R., Hoxie, J.A., Bess, 
J.W., Lifson, J.D., Milne, J.L., and Subramaniam, S. (2011). Three-dimensional structures of 
soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins 
determined by using cryo-electron tomography. J Virol 85, 12114-12123. 
White, T.A., Bartesaghi, A., Borgnia, M.J., Meyerson, J.R., de la Cruz, M.J., Bess, J.W., 
Nandwani, R., Hoxie, J.A., Lifson, J.D., Milne, J.L., et al. (2010). Molecular architectures of 
trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in 
quaternary structure. PLoS Pathog 6, e1001249. 
Wyatt, P.J. (1993). Light scattering and the absolute characterization of macromolecules. Analytica 
Chimica Acta 272, 1-40. 
Wyatt, R., and Sodroski, J. (1998). The HIV-1 envelope glycoproteins: fusogens, antigens, and 
immunogens. Science 280, 1884-1888. 
Xiang, S.H., Doka, N., Choudhary, R.K., Sodroski, J., and Robinson, J.E. (2002). Characterization 
of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by 
neutralizing human monoclonal antibodies. AIDS Res Hum Retroviruses 18, 1207-1217. 
  
136 
Zheng, S.Q., Keszthelyi, B., Branlund, E., Lyle, J.M., Braunfeld, M.B., Sedat, J.W., and Agard, 
D.A. (2007). UCSF tomography: an integrated software suite for real-time electron microscopic 
tomographic data collection, alignment, and reconstruction. J Struct Biol 157, 138-147. 
Zheng, S.Q., Palovcak, E., Armache, J.P., Verba, K.A., Cheng, Y., and Agard, D.A. (2017). 
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron 
microscopy. Nat Methods 14, 331-332. 
Zhou, T., Xu, L., Dey, B., Hessell, A.J., Van Ryk, D., Xiang, S.H., Yang, X., Zhang, M.Y., Zwick, 
M.B., Arthos, J., et al. (2007). Structural definition of a conserved neutralization epitope on HIV-1 
gp120. Nature 445, 732-737. 
Zhu, P., Liu, J., Bess, J., Jr., Chertova, E., Lifson, J.D., Grise, H., Ofek, G.A., Taylor, K.A., and 
Roux, K.H. (2006). Distribution and three-dimensional structure of AIDS virus envelope spikes. 
Nature 441, 847-852. 
 
